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SUMMARY
1. Summary
1.1. Abstract
CHD4/Mi-2 is a highly conserved ATP-dependent chromatin remodeller. It is 
essential in processes like transcription regulation, DNA damage response, cell 
cycle progression, as well as differentiation and development in eukaryotes. It 
is one of the catalytic components of the NuRD (nucleosome remodelling and 
deacetlyation) complex. ATP-dependent chromatin remodellers, including 
CHD4, are frequently mutated in human cancers. In this study, the effects of 
several missense mutations derived from endometrial cancer patients were 
analysed using dMi-2, a Drosophila melanogaster homologue of human CHD4, 
as a model. 

Selected point mutants, covering key domains and regions in dMi-2, were 
biochemically analysed. It was demonstrated through enzymatic and non-
enzymatic assays that these mutations can have a wide variety of effects on 
nucleosome binding, ATP hydrolysis and nucleosome remodelling. 
Interestingly, this analysis uncovered that these mutations can impact dMi-2 in 
opposite manners, by lowering or increasing the protein’s remodelling ability. 
Some mutations caused changes in the coupling of ATP hydrolysis with 
nucleosome remodelling, revealing new roles of certain residues and regions in 
modulating protein activity. Additionally, a new regulatory region was identified 
in the C-terminal part of the protein, which is comparable to previously 
identified regulatory regions in CHD1, ISWI and Snf2. On the N-terminal side, 
analysis of chromodomain mutants allowed identification of a structural 
element in dMi-2, similar to one identified in CHD1, that likely contacts 
nucleosomal DNA during remodelling. 

Furthermore, in vivo genetic experiments in Drosophila melanogaster 
demonstrated that expression of selected dMi-2 point mutants can cause 
misregulation in development of epithelial wing structures. These phenotypes 
 9
SUMMARY
correlated with the nucleosome remodelling characteristics of dMi-2 point 
mutants. Together, the findings of this thesis give new insight into the 
consequences of mutations of chromatin remodellers in cancer and provide a 
basis for understanding molecular mechanisms used by the Mi-2 mutants to 
contribute to carcinogenesis. 
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1.2. Zusammenfassung
CHD4/Mi-2 ist ein hoch konservierter ATP-abhängiger Chromatinremodeller. Er 
ist essentiell für Prozesse der Transkriptionsregulation, der DNA-
Schadensantwort, der Zellzyklusprogression sowie der Differenzierung und 
Entwicklung in Eukaryonten. CHD4 ist eine der katalytischen Untereinheiten 
des NuRD (nucleosome remodelling and deacetylation)-Komplexes. ATP-
abhängige Chromatinremodeller, einschließlich CHD4, sind in humanen 
Karzinomen häufig mutiert. In dieser Studie wurden mehrere Missense-
Mutationen analysiert, die in Patienten mit Endometrialkarzinomen gefunden 
wurden. Hierzu wurde dMi-2 verwendet, ein Drosophila melanogaster Homolog 
des humanen CHD4.
In dieser Arbeit wurden ausgewählte Punktmutationen biochemisch analysiert, 
welche in wichtigen Domänen und Regionen in dMi-2 liegen. Durch 
enzymatische und nicht-enzymatische Assays wurde gezeigt, dass diese 
Mutationen breit gefächerte Effekte bezüglich der Nukleosomen-Bindung, der 
ATP-Hydrolyse und der Remodellierung von Nukleosomen haben können. Die 
vorliegende Analyse konnte offenlegen, dass diese Mutationen dMi-2 auf 
entgegengesetzte weise beeinflussen, seine Remodelling-Aktivität entweder 
senken oder steigern können. Einige Mutationen verursachten Veränderungen 
der Kopplung von ATP-Hydrolyse mit Nukleosomen-Remodelling. Dies offenbart 
neue Funktionen bestimmter Aminosäurenreste und Regionen und ihren 
Einfluss auf die Aktivität des Proteins. Außerdem wurde eine neue 
regulatorische Region im C-terminalen Teil des Proteins identifiziert, die 
vergleichbar mit bereits bekannten Regionen in CHD1, ISWI und Snf2 ist. 
Mutationen der Chromodomänen führten zur Identifikation eines 
Strukturelements im N-Terminus von dMi-2. Dieses ähnelt einem Motif in CHD1, 
welches nukleosomale DNA während des Remodelling-Prozesses kontaktiert. 
Des Weiteren zeigten genetische in vivo-Experimente in Drosophila 
melanogaster, dass die Expression ausgewählter dMi-2-Punktmutanten zur 
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Fehlregulation der Entwicklung von epithelialen Flügelstrukturen führen kann. 
Diese Phänotypen korrelierten mit den Remodelling-Eigenschaften der dMi-2-
Punktmutanten. Zusammenfassend geben die Ergebnisse dieser Arbeit neue 
Einblicke in die Folge von Mutation von Chromatinremodellern in 
Tumorerkrankungen und schaffen eine Grundlage, um die molekularen 
Mechanismen zu verstehen, mit denen Mi-2-Mutanten zur Karzinogenese 
beitragen.
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2. Introduction
2.1. Building chromatin
The function of DNA is to carry the genetic information of an organism, 
information that codes for proteins that make up all living organisms. In order to 
organise 2m long DNA molecules in an eukaryotic nucleus that is on average 
10µm in diameter, DNA is organised in chromosomes. Each chromosome is 
built out of a single negatively charged double-stranded DNA molecule wrapped 
around small basic histone proteins that function primarily as the scaffold for 
organising DNA. Together with other nonhistone chromosomal proteins that 
bind to DNA, they form a DNA-protein complex known as chromatin. The 
elementary repeating unit of chromatin is the nucleosome. Nucleosomes form 
long arrays or “beads on a string” that are coiled into higher order structures 
which allow packing of the DNA. 
2.1.1. Chromatin structure and organisation
The nucleosome is a fundamental repeating unit of chromatin, whose high 
resolution structure was solved in 1997 in a seminal paper from Timothy J. 
Richmond’s lab (Luger et al. 1997). It was revealed that 147 bp of DNA are 
tightly wrapped around a histone octamer core in 1.65 turns in a left-handed 
coil. Histones are 14-18 kDa proteins, basic in nature, that come in five different 
forms - four core histones (H2A, H2B, H3 and H4) that form the core histone 
octamer and histone H1, also known as the linker histone. H1 is involved in 
binding the DNA in between two nucleosomes, the linker DNA. H1 interacts with 
linker DNA at the entry and exit points of nucleosomal DNA, facilitating the 
formation of higher order structures. Histones are among the most conserved 
proteins in eukaryotes indicating the functional importance of each amino acid. 
Core histones share a common structural motif known as the histone fold, that 
is formed out of three ⍺ helices connected with two loops. During nucleosome 
assembly, each histone fold binds with a corresponding histone fold. H2A binds 
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H2B forming the H2A-H2B heterodimer, while H3 binds H4 forming the H3-H4 
heterodimer. Histone folds bind each other in an antiparallel arrangement 
creating a “handshake motif” (Arents et al. 1991, McGinty and Tan, 2014). H3-
H4 heterodimers form tetramers which then combine with two H2A-H2B 
heterodimers and give rise to the histone octamer. Histone core proteins are 
abundant in arginines and lysines with positive charges that counteract the 
negative charge of DNA and allow DNA of nearly any sequence to assemble 
around the histone octamer core. The interaction between DNA and histones is 
formed between the amino acids of the histone fold and the phosphodiester 
backbone of DNA. This interaction can come in two different forms; either 
hydrogen bonds and electrostatic interactions that form salt bridges or hydrogen 
bonds alone. In addition, each of the core histones has an N-terminal and a C-
terminal tail that extends outside of the nucleosome (Luger et al. 1997). These 
tails can be subjected to diverse forms of covalent modifications by a variety of 
histone modifying enzymes, through which many aspects of chromatin structure 
are being controlled. During replication-dependent chromatin assembly, 
histones are imported into the cell nucleus with help of a wide variety of histone 
chaperones (Burgess and Zhang, 2013). H2A-H2B are imported with the help of 
histone chaperone Nap1. Importing H3-H4 tetramers involves an array of 
histone modifications, primarily histone acetylation and histone chaperones like 
HSP90, NASP, and Asf1. In the cell nucleus, H3-H4 tetramers are deposited on 
the newly replicated DNA strand and form a tetrasome with DNA wrapped once 
around the tetrasome. After that, two H2A-H2B dimers are deposited, the rest of 
the DNA is wrapped around the histone octamer and the nucleosome is formed 
(Dennehey and Tyler, 2014) (Figure 2.1). 
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Figure 2.1. Nucleosome crystal structure
Nucleosome crystal structure at 1.9 Å resolution. Eight histone core proteins depicted in 
different colours; H3 in blue, H4 in green, H2A in yellow and H2B in red. 147 bp DNA is wrapped 
aroung core histones. DNA numbers are marking super helical locations (SHL), which represent 
super helical turns where the DNA minor grove faces the histone octamer. Figure was adapted 
from Davey et al. 2002 using Chimera software, PDB accession code 1KX5. 
2.2. Regulation of chromatin structure
Controlling chromatin structure is crucial for processes such as transcription, 
DNA replication, and DNA repair. Packing of DNA into chromatin hinders access 
of DNA binding factors, so in order for this molecular machinery to access DNA, 
chromatin states need to be highly dynamic. The switching between these 
different states, from tightly packed nucleosomes to a more loosely open 
chromatin state, is highly regulated. This regulation can involve DNA 
modifications, such as methylation, RNA regulation mediated through RNA 
interference (RNAi) or long non-coding RNAs, a wide variety of histone variants, 
covalent modification of histones by histone modifying enzymes and structural 
changes introduced by chromatin remodelling enzymes. In next few chapters, I 
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will focus on regulation by histone variants, posttranslational modifications and 
chromatin remodelling. 
2.2.1. Histone variants
During evolution a diverse array of histone variants has emerged from canonical 
histones to perform specific functions. They differ from core histones in 
sequence, function, and genomic localisation. They are incorporated into 
chromatin in a DNA replication independent manner in a process called histone 
exchange. Different histone variants can have distinct effects on nucleosome 
structure, stability, and binding of different proteins to the nucleosome (Talbert 
and Henikoff, 2010 and 2017). 
Histone H3 has two distinct variants; histone H3.3 and CenH3.3 (also known as 
CENP-A). H3.3 has a difference of 5 amino acids to canonical histone H3, and it 
forms more structurally unstable nucleosomes (Jin and Felsenfeld 2007, 
Tachiwana et al. 2011). It is incorporated into chromatin near the body of 
transcribed genes, more specifically at the promoters of transcriptionally active 
genes (Chow et al. 2005, Mito and Henikoff. 2005). H3.3 serine 31 (not present 
in canonical H3) is phosphorylated during mitosis in centromeres and telomeres 
(Hake et al. 2005; Wong et al. 2010). Post-translational modifications, such as 
acetylation of lysine 9, 18 and 23, as well as trimethylation of lysine 4 are 
common for active chromatin regions and found on H3.3, indicating its role in 
active transcription. The other histone H3 variant, CenH3 or CENP-A, is found 
in centromeric nucleosomes. An important difference between the canonical 
histone H3 and the centromeric CenH3 maps to the CATD domain contained in 
CenH3 which contributes to a more solid and compact structure and interacts 
with histone chaperones specific for the centromere region (Black et al. 2004). 
Histone H2A has four different variants, H2A.Z, H2A.X, H2AB, and macroH2A. 
Histone H2A.Z is highly conserved across different species and is expressed 
together with H2A in different organisms (Talbert and Henikoff, 2010). H2A.Z 
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builds nucleosomes structurally similar to H2A-containing canonical 
nucleosomes, but discrete changes in the amino acid sequence of H2A.Z give 
rise to less stable nucleosomes. H2A.Z incorporated in the nucleosome affects 
the connection of H2A.Z-H2B dimers and H3-H4 tetramers (Suto and Luger, 
2000. Venkatesh and Workman, 2015). Given the mentioned properties, H2A.Z 
nucleosomes are less stable which contributes to their role in transcriptional 
activation, DNA repair, and chromosome segregation (Venkatesh and 
Workman, 2015). Histone H2A.X is best known for its role in the DNA damage 
response (DDR). Upon the generation of DNA double strand breaks, H2A.X is 
phosphorylated (giving rise to γ-H2A.X) on serine 139 by DDR kinases. This is 
one of the earliest events in the DDR pathway (Rogakou et al, 1998). γ-H2A.X 
serves as the main coordinator of DDR, but it is not actively involved in repair 
itself. In mammals, γ-H2A.X serves as a recruiter of MDC1 (Mediator of DNA 
damage Checkpoint 1), which is crucial for recruitment of other important repair 
factors like the tumour suppressor p53 and BRCA1 (breast cancer type 1 
susceptibility protein). In addition to phosphorylation, acetylation and 
ubiquitylation were found as important modifications of H2A.X. These 
modifications are also relevant for the recruitment of the DDR repair machinery 
to DNA damage sites (Yuan et al, 2010). The largest and most unusual H2A 
variant is macroH2A, found only in vertebrates. This variant is defined by its 
long additional 30kDa domain in the C-terminal region, which extends out of the 
nucleosome and serves as an interacting region with various chromatin factors 
(Gamble and Kraus, 2010). Three isoforms of macroH2A exist in mammals; 
macroH2A1.1 and macroH2A1.2 are splice variants of a single gene, while 
macroH2A2 is encoded by a separate gene. Structurally, the macroH2A 
containing nucleosome is similar to the canonical nucleosome and they 
organise the same amount of DNA (Changolkar and Pehrson, 2002). MacroH2A 
is enriched in the inactive X chromosome in female mammals, where it is 
involved in transcriptional repression that leads to X inactivation (Costanzi and 
Pehrson, 1998). It is noteworthy that macroH2A is equally expressed in females 
and males, although X inactivation is restricted only to females (Rasmussen et 
al. 1999). This indicates a general role of macroH2A as a factor in repression of 
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transcription. Another vertebrate-specific H2A variant is H2ABbd (Bar-body 
deficient). H2ABbd localisation is strongly correlated with transcriptionally active 
regions and is mutually exclusive with macroH2A. It was shown that H2AB 
organises less nucleosomal DNA and builds less stable nucleosomes than 
canonical H2A (Gautier et al. 2004, Bao et al. 2004)
Histone H4, unlike H2A and H3, has no known variants. It is the most highly 
conserved histone, having only few amino acid changes when the H4 amino 
acid sequence is compared between different organisms. This level of 
conservation is somewhat expected since H4 makes protein-protein contacts 
with all other three core histones (Malik and Henikoff, 2003.). Histone H2B has 
few variants which are highly specific for certain developmental stages and their 
function remains mostly unknown. 
2.2.2. Post-translational histone modifications
Another mechanism of controlling different chromatin states is by modification of 
unstructured N-terminal tails of histones. An array of different modifications has 
been found on histones, including acetylation, methylation, and phosphorylation 
which are the most prevalent histone modifications. Less abundant 
modifications include ubiquitylation, sumoylation, ADP ribosylation, deimination 
and proline isomerization (Kouzarides, 2007). A variety of enzymes that act on 
chromatin function as epigenetic regulators. Epigenetic "writers" can modify 
DNA or histones by placing different marks. This function can be performed by 
DNA methyltranferases, HAT’s (histone acetyltransferases), HMT’s (histone 
methyltransferases), PRMT’s (protein arginine methyltransferases) and kinases 
that can modify histone tails. Epigenetic "readers" recognise the marks placed 
by these writers. They can alter chromatin state or recruit other proteins to 
change chromatin structure. This includes proteins that contain methyl binding 
domains, such as PHD (plant homeodomain) fingers, WD40 repeats (40 amino 
acid repeat terminating with tryptophan-aspartic acid dipeptide) and CW 
(cysteine and tryptophan) domains. They also include proteins of the Royal 
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superfamily that encompasses proteins with chromodomains, chromobarrels, 
Tudor domains and MBT (malignant brain tumour) repeats. Finally, epigenetic 
"erasers" remove these marks from histones. They are enzymes such as 
HDAC’s (histone deacetylases), KDM’s (lysine demethylases) and 
phosphatases. Adding and removing these marks can have an effect on 
addition and removal of other histone marks. Different histone marks can affect 
gene expression by recruiting different chromatin remodelers. Together, they 
can modulate a variety of processes, such as DNA transcription, replication and 
repair (Kouzarides, 2007, Greer and Shi, 2012, Falkenberg and Johnstone 
2014, Hoppman et al. 2011). 
Histone methylation can occur on basic residues like arginines and lysines. 
Lysines can be mono-, di- or trimethylated, while arginines can be 
monomethylated, symmetrically dimethylated (me2s), or asymmetrically 
dimethylated (me2a). Methylation of different residues can have different 
outcomes and lead to repression or activation of transcription. For example, 
H3K9me3 binds HP1 (heterochromatin protein 1, protein involved in gene 
repression by formation of heterochromatin) in heterochromatin and leads to 
more compacted chromatin that is inaccessible to the transcription maschinery. 
Another repressive mark is H3K27me3, that is generated and bound by PRC2 
(Polycomb repressive complex 2). On the other hand H3K4me3 is an active 
mark, that was shown to be associated with transcriptional start sites of active 
genes (Barski et al. 2007). Arginine methylation is also implicated in 
transcriptional regulation. For example, H4R3me2a, H3R2me2s and 
H3R26me2a mark active chromatin, while H3R2me2a and H4R3me2s are 
repressive marks (Blanc and Richard, 2017).
Numerous histone methyltransferases and demethylases have been identified 
that mediate addition or removal of methylation marks (Greer and Shi, 2012). 
Three different enzyme families catalyse addition of methyl groups on histone 
tails. SET-domain (Su(var)3-9, Enhancer-of-zeste and Trithorax) containing 
proteins and DOT1-like proteins methylate lysine residues, while PRMT family 
proteins methylate arginines (Bannister and Kouzarides, 2011). Removal of 
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methyl groups is performed by histone demethylases. One group comprises 
amino oxidases, like LSD1 (Lysine-specific histone demethylase 1A) that 
demethylates H3K4, an active mark, by which it functions as a transcriptional 
repressor (Shi et al. 2004). Another group of histone demethylases are the 
Jumonji C (JmjC) domain-containing proteins, for example JHDM1 that 
demethylates H3K36 (Tsukada et al. 2006). All taken together, histone 
methylation has a wide role in transcription control, from organising global 
chromatin architecture to the regulation of specific loci (Greer and Shi, 2012).
Histone acetylation is involved in the opening of chromatin structure. Addition 
of an acetyl group to lysine residues removes positive charge from lysine which 
in turn destabilises the interaction between DNA and histones, leading to a 
more open chromatin state. Acetylation can also have an effect on nucleosome/
nucleosome interactions. Specifically, H4K16 acetylation can destabilise the 
interaction between the H4 tail and an "acidic patch" on the neighbouring 
nucleosome, affecting higher order chromatin folding (Kalashnikova et al. 2013). 
Acetylation of histones is catalysed by histone acetyltransferases (HATs), which 
transfer acetyl to the ε-amino group on a lysine residue. The reverse reaction of 
histone deacetylation is catalysed by histone deacetylases (HDACs) 
(Shahbazian and Grunstein, 2007). Acetylation has an important role in 
nucleosome assembly; newly synthesised histones are transiently acetylated on 
H4K5 and H4K12 in all eukaryotes, while the acetylation of newly synthesized 
H3 is more variable: K9 and K14 are acetylated in Tetrahymena, while K14 and 
K23 are acetylated in Drosophila. These acetylations might have a role in the 
recognition of new histones by histone chaperones (Sobel et al. 1995, 
Shahbazian and Grunstein, 2007). The most prominent role of acetylation is to 
promote transcriptional activation. Histone acetylation strongly correlates with 
active gene transcription by creating a more open chromatin state that 
facilitates binding of the transcriptional machinery (Reid et al. 2000, Shahbazian 
and Grunstein, 2007). 
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Histone phosphorylation was discovered on serine, threonine and tyrosine 
histone residues. These residues can be phosphorylated by numerous kinases 
and dephosphorylated by phosphatases (Rossetto et al. 2012). Histone 
phosphorylation is best known for its role in DNA damage repair. As mentioned 
above, H2AX is phosphorylated upon DNA damage (Rogakou et al. 1998). 
Histone H3 tail phosphorylation is highly conserved throughout eukaryotes, it 
has been found on T3, S10, T11, and S28. The most thoroughly investigated H3 
phosphorylation is S10P, generated by the Aurora B kinase, which is important 
in chromatin condensation during mitosis and meiosis (Wei et al. 1998, 
Rossetto et al. 2012). This phosphorylation is important for ejection of HP1 from 
chromosomes during M phase, shifting the equilibrium to the HP1 unbound 
state. This indicated a role of H3S10 in mediating the release of HP1 from the 
mitotic chromosome (Fischle et al. 2005, Banerjee and Chakravarti, 2011). 
Dephosporylation of H3S10 is performed by PP1 (protein phosphatase 1) which 
is important for proper chromosome segregation (Rossetto et al. 2012).
Histone ubiquitination is most abundant on histone H2A and H2B in its 
monoubiquitinated form. They can be monoubiquitinated on H2AK119 and H2B 
K123 (Goldknopf et al. 1975, West and Bonner, 1980). Ubiquitinated histones 
play a significant role in transcription, where H2Aub is associated with gene 
silencing, while H2Bub is linked with transcriptional activation. Besides 
transcriptional control, ubiquitination has an important role during the DNA 
damage response, when H2A, H2AX, and H2B can be ubiquitinated at the sites 
of DNA damage (Cao and Yan, 2012, Uckelmann and Sixma, 2017).
2.2.3. Chromatin remodelling enzymes 
A plethora of ATP dependent chromatin remodelers are modulating gene 
expression by making chromatin more closed and compact or more open and 
accessible for the transcription machinery. Unlike histone/DNA modifying 
enzymes, they are not covalently changing chromatin, but use energy derived 
from ATP hydrolysis to change chromatin structure. Besides transcriptional 
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regulation, they have a role in DNA repair, recombination, and chromatin 
assembly.
2.2.3.1. Common ATPase motors
ATP-dependent chromatin remodelers belong to the helicase superfamily 2 
(SF2) of ATPases. Within the SF2 superfamily, they form their own Snf2 
subfamily, named after the first discovered chromatin remodeler. Their central 
feature is an ATPase motor consisting of two copies of RecA-like lobes. These 
lobes are derived from the ancestral bacterial RecA protein that performs ATP-
dependent strand exchange between single stranded DNA (ssDNA) and double 
stranded (dsDNA). RecA oligomerises on ssDNA, binds ATP and forms a helical 
filament which then binds to dsDNA and catalyses the exchange of 
complementary strands (Chen et al. 2008, Cox, 2007). During the reaction one 
RecA monomer provides ATP binding and hydrolysis motifs, while the 
neighbouring monomer brings in two lysine residues that stabilise the transition 
state and stimulate ATP hydrolysis, which leads to DNA release. This lysines 
are analogous to arginine finger motif in many GTPases and ATPases. In the 
SF2 family, duplication of the RecA lobe has transfered these enzymatic 
functions onto a single protein. Thus, the ATPase domain consists of the first 
lobe, also known as DExx, that retains ATP binding and hydrolysis and the 
second lobe, also known as HELICc, that provides the arginine finger motif 
(formed out of two arginines, separated with 2 other amino acids) for ATP 
hydrolysis and stabilisation of the transition state (Chen et al. 2008, Zhou et al. 
2016).
When an ATP-dependent chromatin remodeler is bound to DNA in its resting 
state, the two lobes are in an open conformation. Upon binding of ATP, the two 
lobes go through conformational changes that result in their closure. It was 
shown that ATPase motors bind to the DNA on the nucleosome at the SHL2 
(superhelical location 2) position and then translocate along the DNA, by pulling 
the DNA from the proximal side of the nucleosome (DNA entry site), towards the 
distal side of the nucleosome (DNA exit side). This translocation is propagated 
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in a wave-like manner and it leads to DNA translocation by one base pair. After 
hydrolysis and release of ADP, conformational changes reopen the two lobes 
and return them to the resting state. In that manner, ATP binding and hydrolysis 
are facilitating a series of structural changes that enables remodelers to move 
along the DNA substrate (Zhou et al. 2016, Wigley and Bowman, 2017, 
Farnung et al. 2017, Nodelman et al. 2017, Clapier et al. 2017). Highly 
conserved motifs and blocks within the ATPase motor act in concert to perform 
the remodeler’s enzymatic function. The ATPase motor of chromatin remodelers 
contains seven helicase-related motifs that cooperate in ATP binding, hydrolysis 
and translocation: Motifs I, Ia, II, III, IV, V and VI are scattered between the two 
lobes (Figure 2.2). Motif I, Ia, II and III are located in the first DExx lobe, while 
IV, V and VI are in the second HELICc lobe (Flaus et al. 2006). Motifs I, II and 
VI are equivalent to the Walker A and B boxes found in many ATPases and they 
are involved in ATP binding and hydrolysis. Highly conserved arginine fingers, 
which are part of motif VI, are interacting with the ATP binding motifs of the 
DExx lobe upon nucleosome binding (Zhou et al. 2016, Liu et al. 2017). Motif III 
is involved in the coupling of ATP hydrolysis with translocation. Motifs Ia, IV and 
V are involved in nucleic acid binding and translocation. Additionally, the Snf2 
family of enzymes contains conserved blocks that represent structural features 
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Figure 2.2. Conserved motifs of the Snf2 family of ATP-dependent 
chromatin remodelers
Diagram showing relative positions of conserved helicase motifs (shown in orange, red, dark 
blue, dark green, light green, yellow and light blue) in relation to two RecA-like lobes (shown in 
light red). Motifs I, Ia, II and III are located in the first DExx lobe. Motifs IV, V and VI are 
located in the second HELICc lobe. Brace domain in purple. Modified according to Flaus et al. 
2006.
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that are unique to the Snf2 family. These blocks are located throughout the 
ATPase domain, but also on the C terminal side following the second HELICc 
lobe where the alpha helical brace domain is located (Pyle, 2008, Dürr et al. 
2005, Flaus et al. 2006, Singleton et al. 2007).
Throughout the years it became clear that mechanism of nucleosome 
remodelling is a shared feature of all remodelers. During evolution, an ancestral 
protein that moved along the DNA aquired histone anchoring ability, which 
enabled interaction with the nucleosome and translocation of DNA along the 
surface of the octamer. Later, mechanisms for regulating the ATPase domain 
evolved: such regulation is provided by domains, insertions or accessory 
proteins that modulate the activity of the ATPase domain. For example, 
autoinhibition of the ATPase domain is a common mechanism of keeping the 
remodeler in its resting state. This inhibition is released when the remodeler 
contacts certain epitopes on the nucleosome (Clapier et al. 2017). This fine 
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Figure 2.3. ATP dependent chromatin remodeler families
Simplified representation of the domain structure of ATP-dependent remodelers. The two 
lobes of the ATPase domain - Dexx and HELICc - are depicted in red, Chromodomains in 
blue, HSA (helicase SANT domain) in orange, postHSA in dark orange, bromodomain in 
green. AutoN in purple, Neg C in dark blue, HSS (Hand-Sant-Slide domain) in yellow and 
SnAC in pink (Modified after Workman and Abmayr, 2014).
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tuning led to the specialisation of different remodellers. They are divided into 4 
main families according to similarities in their ATPase domain and associated 
domains: ISWI, SWI/SNF, INO80 and CHD. These remodelers are often part of 
multisubunit complexes that act on chromatin and perform diverse functions.
2.2.3.2. SWI/SNF family
SWI/SNF enzymes encompass a large family of multisubunit complexes. Snf 
(sucrose non fermenting) and swi (switch) genes were first found in genetic 
screens in yeast. These studies were aiming to find genes that regulate 
expression of (a) homothalic switching endonuclease (HO) that controls mating 
type switching (SWI) and (b) transforming enzyme sucrose invertase (SUC2) 
necessary for sucrose non-fermentation (SNF). Later, it became apparent that 
these studies identified genes that encode for the same large protein complex 
with important roles in the regulation of transcription through chromatin 
remodelling (Neigeborn and Carlson, 1984. Stern et al. 1984, Masliah-Planchon 
et al. 2015, Tang et al. 2017). This was named SWI/SNF complex according to 
the two phenotypes that led to its discovery (Masliah-Planchon et al. 2015). 
Further studies found that the SWI/SNF complex is a large multisubunit 
complex consisting of 11 proteins, with the Swi2/Snf2 ATPase being the 
catalytic subunit (Workman and Kingston, 1998). Another related SWI/SNF 
family complex is RSC (Remodelling the Structure of Chromatin), also found in 
yeast. These two complexes differ in their ATPase subunit, the SWI/SNF 
complex has Swi2/Snf2p, while RSC contains Sth1 (Cairns et al. 1994. Tang et 
al. 2010). Although, RSC ans SWI/SNF complexes contain several homologous 
subunits and share two identical subunits, these two complexes have important 
functional differences. Genome-wide gene expression studies have found that 
they control different sets of target genes. RSC is 10x more abundant than SWI/
SNF in yeast and is essential for growth and normal cell cycle progression. Both 
complexes can function as transcriptional activators and repressors (Muchardt 
and Yaniv, 2001, Mohrmann et al. 2004, Martens and Winston, 2003).
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SWI2/SNF2-containing complexes exist in other organisms, including 
Drosophila, human, and mouse. In Drosophila, the Swi2/Snf2-homolog brahma 
(BRM), which was discovered in the Tamkun lab in 1994, is a component of two 
different complexes - BAF and PBAF (Elfring et al. 1994). Human cells contain 
the homologous complexes hBAF, that can contain hBRM or BRG1 as its 
ATPase subunit, and hPBAF that contains only BRG1 (Tang et al. 2010). 
Interestingly, hPBAF is related to yeast RSC and has a functionally similar role 
in cell growth (Xue et al. 2000).
These ATPase motors have a central SF2 like ATPase domain which is flanked 
by additional functional domains (Figure 2.3). An N-terminal HSA (helicase-
SANT-associated) domain is important for the interaction with ARPs (actin 
related proteins) like Arp7 and Arp9 that are part of the both RSC and SWI/SNF 
complexes (Cairns et al. 1998). In Sth1, loss of the HSA domain causes loss of 
actin proteins and reduction of ATPase activity. An additional domain adjacent to 
the HSA, the postHSA domain, was also identified in Sth1 and is also present in 
other remodelers that contain ARPs (Szerlong et al. 2008). Subsequently, it was 
found that the postHSA domain has a role in downregulating ATPase activity 
and the rate of DNA translocation (Clapier et al. 2016). SWI/SNF remodelers 
have a bromodomain on the C-terminal side of the ATPase domain. First 
identified by the Kennison lab in the Drosophila brahma protein, it exists in 
many other proteins (Tamkun et al. 1992). Bromodomains have a role in 
recognising acetylated lysines in histone tails, by which they can contribute to 
targeting of the complex and modulate chromatin remodelling (Syntichaki et al., 
2000, Marmorstein and Berger, 2001). The most recently identified domain of 
SWI/SNF remodelers was found by the Bartholomew lab and named SnAC 
(Snf2 ATP coupling). Located in the C-terminal part of the protein, located 
immediately after ATPase domain, this domain has a role in pairing the 
energetically favourable ATP hydrolysis with the energetically unfavourable 
translocation reaction. Mutation or deletion of this domain severely affected 
ATPase and remodelling functions of SWI/SNF. The SnAC domain positively 
regulates the catalytic activity of SWI/SNF (Sen et al. 2011). This regulation 
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comes from the interaction between SnAC and histones, where SnAC is acting 
as an histone anchor. This interaction is a prerequisite for SWI/SNF remodeler 
to efficiently couple ATP hydrolysis to DNA translocation (Sen et al. 2013).
SWI/SNF chromatin activities include nucleosome sliding that mobilises 
mononucleosomes from the center to the end of a DNA fragment in vitro (Fan et 
al. 2003). Apart from sliding, SWI/SNF can also eject histones. Regulation 
between sliding and ejection is mediated by the HSA, postHSA and protrusion 1 
domains (located between the two ATPase cores), as well as by two ARPs that 
bind to the HSA domain. In this way translocation efficiency can be modulated 
from a lower activity that leads to sliding to a higher activity that results in 
histone ejection (Yanf et al. 2007, Clapier et al. 2017). Additionally, the RSC 
complex catalyses the transfer of the H2A/H2B dimer or the entire octamer from 
one DNA template to another (Rowe and Narlikar 2010).
2.2.3.3. ISWI family
After identification of the first ATP-dependent chromatin remodeller, the yeast 
SWI2/SNF2 complex, the search for similar proteins continued. John Tamkun’s 
lab identified ISWI (imitation switch), a protein with high sequence similarity to 
the human SNF2L remodeller (Elfring et al. 1994). Carl Wu’s, James 
Kadonaga’s and Peter Becker’s labs went on to identify three ISWI containing 
complexes in Drosophila - NURF, ACF, and CHRAC, respectively (Tsukiyama et 
al. 1995, Ito et al. 1999, Varga-Weisz et al. 1997). Afterwards, homologous 
complexes were purified from other organisms like Xenopus, yeast, and human 
(Oppikofer et al. 2017). 
ISWI containing complexes encompass many roles within the cell. This includes 
transcriptional activation and repression. The NURF complex can facilitate 
GAL-4 mediated transcription in vitro, which was the first hint that ISWI 
containing complexes can facilitate gene activation (Mizuguchi et al. 1997). 
Afterwards, a role in transcriptional activation was demonstrated for other ISWI 
complexes, like ACF (Levenstein and Kadonaga, 2002). On the other hand, 
transcriptional repression has been indicated for Drosophila ISWI - in polytene 
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chromosomes, ISWI associated with euchromatin regions that do not colocalize 
with RNA Pol II, suggesting that it could play a part in repression. The same 
study emphasised the importance of ISWI in organising chromatin higher order 
structures since ISWI null mutants showed X chromosome defects in male flies 
(Deuring et al. 2000. Corona and Tamkun, 2004). The wide variety of functions 
that ISWI containing complexes perform within a cell, posed the question of 
their mechanism of action. 
In vitro experiments showed that ISWI complexes perform two different actions 
on chromatin - nucleosome sliding and nucleosome assembly. (Hamiche et al. 
1999, Längst et al. 1999, Ito et. al. 1997). By sliding the ISWI remodelers are 
able to regulate gene expression. The ISWI ATPase moves nucleosomes on its 
own, but the precise outcome of this sliding activity often depends on other 
subunits of ISWI complexes, that modulate its activity. For example, ACF1, the 
noncatalytic subunit of the human ACF complex, modulates the activity of 
SNF2h in vitro by sensing linker DNA lengths, by which it can regulate 
nucleosome spacing (Yang et al. 2006). Another activity of ISWI ATPases is 
nucleosome assembly (Ito et al. 1997). ISWI complexes can turn “nascent” pre-
nucleosome particles (containing all histones, but in non-canonical 
conformations) that are formed immediately after passage of DNA replication 
forks into more canonical mature nucleosomes, as characterised by nuclease 
digestion and sedimentation properties (Torigoe et al. 2011, Zhou et al. 2016). 
More insight into the workings of ISWI ATPase motors was obtained from many 
structural studies that have elucidated domain structures and have shed some 
light on nucleosome-remodeler interactions. ISWI ATPases contain a C-terminal 
HSS domain, which consists of a SANT domain that is structurally similar to c-
MyB DNA binding domains (DBD) (Clapier and Cairns, 2009). Unlike the DBD 
of c-MyB, the SANT domain of ISWI lacks amino acid residues, that interact 
with DNA in c-MyB. (Grüne et al. 2003). Instead, the SANT domain interacts 
with unmodified histone tails (Boyer et al. 2002 and 2004). A DNA binding role 
of ISWI is contained in its SLIDE domain, that interacts with linker DNA at the 
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entry to the nucleosome. The HAND domain binds to extranucleosomal DNA 
near the entry site of the nucleosome, similarly to the SLIDE domain (Dang and 
Bartholomew, 2007). Together these domains help to regulate nucleosome 
recognition and stimulate ATPase activity (Clapier and Cairns, 2009). Two 
additional small domains of ISWI ATPases were recently identified - AutoN and 
NegC, which are flanking core 1 and core 2 of the ATPase domain, respectively, 
and are functioning as negative regulators of ISWI activity (Figure 2.2). AutoN 
negatively influences ATP hydrolysis. Mutations in or deletions of AutoN 
increase ATPase activity and nucleosome sliding and decrease the dependency 
on H4 tails for ATP hydrolysis. Nevertheless, reliance on the H4 tail to couple 
ATP hydrolysis with remodelling is still retained. This supports a model in which 
AutoN holds the ATPase domain in an inactive conformation. This conformation 
is changed upon binding to the H4 tail, that dislodges AutoN enabling 
conformational changes that activate the ATPase motor (Clapier and Cairns, 
2012). More insight into the structural workings of AutoN inhibition was obtained 
by recent studies from the Chen lab: AutoN keeps the two core domains ‘glued’ 
together, by bridging over core 1 and binding to the core 2 domain (Yan et al. 
2016). Another small negative regulator domain is NegC - identified as a 
negative regulator of coupling the ATP hydrolysis to remodelling (Clapier and 
Cairns, 2012). Further studies showed NegC plays a role in preventing 
translocation in the DNA length sensing state by controling the motor from 
transitioning to a translocation competent state (Leonard and Narlikar, 2015). 
Again, a study from the Chen lab showed that NegC - core2 interactions are 
necessary for regulation of this DNA length sensing (Yan et al. 2016). Results 
from these studies can likely be extended to related ATPases.
2.2.3.4. INO80 family
The INO80 family of chromatin remodelers consists of two different types of 
enzymes - INO80 and Swr1. Characterised in yeast, Drosophila, and mammals, 
INO80 family of remodelers are defined by their split ATPase domain, with a 
large insertion between motifs III and IV. The length of this insertion can range 
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from around 200 amino acids in yeast INO80 and Swr1, to >1000 amino acids 
in mammalian SCRAP (Watanabe and Peterson, 2010). This large insertion is 
important for interaction with other subunits like ARPs (Szerlong et al. 2008). 
This suggests that the subunit composition could be dictated by the amino acid 
content of this insertion, that in turn could regulate activities of Swr1 and INO80 
(Zhou et al. 2016). INO80 remodelers also contain an HSA (helicase SANT) 
domain that interacts with ARP (see SWI/SNF remodelers) (Szerlong et al. 
2008). 
These remodelers perform many different functions within the cell, from DNA 
repair, replication, chromosome segregation to telomere maintenance (Morrison 
and Shen, 2009). INO80 and Swr1 use distinct mechanisms to regulate 
chromatin. Swr1 catalyse the exchange of H2A/H2B dimers with H2A.Z/H2B 
dimers (Mizuguchi et al. 2004). It is proposed that Swr1-Z, a small N-terminal 
region of Swr1, and Swc2, a subunit of the SWR complex, regulate the ability of 
Swr1 to exchange the H2A/H2B dimer with the H2A.Z/H2B variant (Luk et al. 
2010, Zhou et al. 2016). On the other side, INO80 slides nucleosomes to the 
center of a DNA fragment and evenly spaces di- and trinucleosomes (Udugama 
et al. 2010). 
It has been proposed that Swr1 and INO80 might produce a common 
nucleosome intermediate that is unwrapped from one side. This nucleosome 
then could be used by Swr1 to mediate histone exchange to H2A.Z/H2B, while 
INO80 could use it to slide the histone octamer (Zhou et al. 2016). INO80 
remodelers could also have a role in reversing the Swr1 reaction; exchanging 
H2A.Z/H2B with canonical dimer H2A/H2B (Watanabe and Peterson, 2010). 
2.2.3.5. CHD family
The CHD family of chromatin remodelers is characterised by its N-terminal 
chromodomains and the central SNF2-like ATPase domain. This family 
encompasses a large group of chromatin remodelers divided into 3 subfamilies 
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according to the presence of additional domains. The first family member was 
identified in mouse and named CHD1 - chromodomain helicase DNA binding 
protein 1 (Delmas et al. 1993). Afterwards, many CHD family proteins were 
identified in Drosophila, yeast, human and many other organisms. 
2.2.3.5.1. Chromodomains as distinct domains of the CHD family
In CHD proteins the chromodomain region is located in the N-terminal part of 
the protein as tandem chromodomains. This domain was originally identified as 
a conserved 37 amino acid region in HP1 and Pc (Polycomb). The name 
chromodomain (chromatin organizer domain) signifies that both of these 
proteins are involved in chromatin organisation (Paro and Hogness, 1991, 
Marfella and Imbalzano, 2007). Today, the chromodomain is defined as a region 
of approximately 50 amino acids that is present in a growing number of proteins 
(Jones et. al. 2000). Many chromodomains bind methylated lysines of histone 
tails,  for example, Pc binds H3K27me3 and HP1 binds H3K9me3 (Jacobs et al. 
2001, Schwartz and Pirrotta, 2007). In the CHD family, chromodomains have 
somewhat different characteristics: human CHD1 binds H3K4me2/3, but the 
chromodomains of dMi-2, the Drosophila homolog of human CHD4, act as a 
DNA binding module, and they do not interact with methylated histone H3 tails 
(Flanagan et. al 2005, Bouazoune et al. 2002). In addition, deletion of the dMi-2 
chromodomains impairs nucleosome-stimulated ATP hydrolysis and 
nucleosome remodelling (Bouazoune et al. 2002). In humans, the CHD4 
chromodomains stimulate ATPase activity. In cross-linking experiments, it was 
shown that human CHD4 interacts with the ATPase domain, indicating a 
regulatory role of the chromodomains in human CHD4 (Watson et al. 2012). 
The crystal structure of yeast CHD1 was solved in the Bowman lab and 
revealed that chromodomains act as negative regulators of the ATPase motor 
that interact with both ATP lobes and keep the motor in an inactive open 
conformation. They identified two helices that connect the two chromodomains 
and named them the chromo-wedge. The chromo-wedge contacts the ATPase 
domain at its DNA binding surface. These interactions interfere with the binding 
of naked DNA to CHD1. Upon binding to the nucleosome, structural changes in 
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CHD1 release the chromodomains from the ATPase motor and bring them into 
an “ungated” position, enabling the ATPase motor to switch to the closed and 
active conformation ready for hydrolysis (Hauk et al. 2010). This model, in 
which chromodomains act as negative regulators of the ATPase motor and as 
modules for the distinction between DNA and nucleosomes, could apply to 
other members of the CHD family.
2.2.3.5.2. Members of CHD family
As mentioned previously, the CHD family consists of 3 subfamilies, where CHD 
proteins are divided according to their respective domains. Since CHD4/Mi-2 is 
a protein of interest in this thesis, it will be discussed in a separate chapter.
   
Figure 2.4. CHD subfamilies 
CHD proteins are divided in 3 subfamilies - CHD1-2, CHD3-5 and CHD6-9. Chromodomains in 
blue, ATPase lobes in red, DBD (DNA binding domain in yellow), PHD fingers in green, SANT 
domain in brown, BRK domain in orange. 
CHD1-2 subfamily
The first CHD subfamily consists of CHD1 and CHD2, that are highly 
homologous to each other. Both proteins contain a DNA binding domain. This 
domain preferentially binds to AT-rich DNA via minor-groove interactions 
(Stokes and Perry, 1995). Drosophila CHD1 localises to regions of extended 
chromatin on polytene chromosomes (interbands) and regions with high 
transcriptional activity (puffs). This strongly suggests that CHD1 is helping to 
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maintain open chromatin structures and facilitates transcription (Stokes et al. 
1996). Studies in Drosophila showed that CHD1 could be involved in 
nucleosome assembly - CHD1 can assemble histone H1-deficient chromatin, 
but not histone H1-containing chromatin, indicating a role in assembly of 
transcriptionally active DNA into chromatin (Marfella and Imbalzano, 2007, 
Lusser et al. 2005).
CHD6-9 subfamily
Members of the third CHD subfamily are characterised by additional domains 
not present in other CHD family members - the SANT domain and the BRK 
domain. The BRK domain is also found in many SWI/SNF proteins like 
Drosophila BRM, human BRM and human BRG1. This domain is not present in 
yeast chromatin remodelers related to BRM. This suggests that this domain 
could play a role in functions specific to higher eukaryotes, or interact with 
chromatin features that are unique to higher eukaryotes. There is also a DNA 
binding domain that can be found in first CHD subfamily, as well as in third 
subfamily (Marfella and Imbalzano, 2007). The DNA domains of CHD6-9 likely 
also bind AT-rich DNA, as was demonstrated for CHD9 (Shur and Benayahu, 
2005). CHD7 has been established as a regulator of vertebrate development. 
Mutations in this protein can cause developmental disorders like CHARGE 
syndrome (Bouazoune and Kingston, 2012). In vitro, CHD6, CHD7, and CHD8 
exhibited significant differences in nucleosome binding and mobilisation, 
indicating distinct roles in their action on chromatin (Manning and Yusufzai, 
2017).
CHD3-5 subfamily
Members of the second subfamily share a double PHD finger domain. An N-
terminal domain present in CHD3-5 is the double PHD (plant homeo domain) 
finger. Discovered in 1993 in Arabidopsis thaliana, it was identified as a Cys4-
His1-Cys3 evolutionary conserved motif (Schindler et al. 1993). This small 
domain encompasses 50-80 amino acid residues and contains a zinc binding 
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motif that is present in many chromatin proteins (Aasland et al. 1995). In the 
NURF complex, the NURF301 subunit contains this zinc finger structural fold 
that is able to ‘read’ histones, more specifically histone H3K4me3 (Wysocka et 
al. 2006). In human CHD4, the PHD fingers bind histone H3, more specifically 
the PHD finger 2 binds H3K9me3, H3K9ac as well as unmodified H3K4 
(Mansfield et al. 2011, Musselman et al. 2009). In addition, both PHD fingers, 
through interaction with histone H3, are essential for the transcriptional 
repressive activity of CHD4 (Musselman et al. 2011). In a further study from the 
Laue lab, it was demonstrated that the PHD fingers of human CHD4 are 
relevant for efficient nucleosome remodelling; a mutant lacking the PHD finger 
domain has diminished sliding activity compared to a construct with PHD fingers 
(Watson et al. 2012).
CHD3 and CHD4, also known as Mi-2⍺ and Mi-2β, respectively, and CHD5 are 
catalytic subunits of the NuRD (nucleosome remodelling and deacetylation) 
complex. Depending on the cell type, the NuRD complex can contain CHD3 or 
CHD4 and exhibit different nuclear localisation patterns (Hoffmeister et al. 
2017). CHD5 has been identified as a tumour suppressor gene involved in 
proliferation, apoptosis, and senescence. Inactivation of CHD5 has been found 
in wide array of human cancers, including neuroblastoma (Bagchi et al. 2007; 
Potts et al., 2011). It was first identified in the brain, where it is a component of 
the NuRD complex. CHD5 is also expressed at high levels in testis and required 
for male fertility (Bergs et al. 2014).
CHD4/Mi-2
CHD4 (chromodomain helicase DNA binding protein 4) was first identified in 
humans as an autoantigen in dermatomyositis, an inflammatory disease 
characterised by inflamed muscles and skin. The protein was named Mi-2, after 
a patient called Mitchell in whose serum Mi-2 antibodies were found. Patients 
diagnosed with dermatomyositis are more susceptible to developing cancer 
(Seelig et al. 1995 and 1996). Later, Danny Reinberg’s lab identified human 
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Mi-2 together with histone deacetylase HDAC1/2 and MTA2/3 (metastasis-
associated protein)  to be part of a complex with deacetylation and nucleosome 
remodelling activities.  It was named the NuRD complex, a complex with two 
distinct enzymatic activities (Zhang et al. 1998). Jürg Müller’s lab identified the 
Drosophila CHD4 homolog dMi-2 as a factor that interacts with the Hunchback 
protein and is important in Polycomb-mediated repression of HOX genes, the 
first indication of dMi-2’s involvement in repression in vivo (Kehle et al. 1998). 
dMi-2 is a chromatin stimulated ATPase, with distinct nucleosome remodelling 
properties compared to other remodelers (Brehm et al. 2000). In Drosophila, 
dMi-2 is also part of the dNuRD complex, a homologue to the human NuRD 
complex. However, it was shown that the bulk of dMi-2 in Drosophila is part of 
the dMec complex (Drosophila MEP-1-containing complex). This complex is 
composed of dMi-2 and dMEP-1, and represses proneural genes (Kunert et al. 
2009). 
CHD4 complexes are devoid of any subunits that could bind to DNA in a 
sequence specific manner, therefore, CHD4’s recruitment to chromatin must be 
mediated through other mechanisms. The NuRD complex subunit MBD2 
(methylated DNA binding domains 2) can recruit NuRD to methylated DNA and 
in that way promote transcriptional repression (Feng and Zhang, 2001). Further 
on, dMi-2 was shown to be recruited to heat shock genes in a PARP dependent 
manner. dMi-2 was shown to bind PARylated heat shock loci in respones to the 
heat shock in Drosophila (Murawska et al. 2011). Recently, dMi-2 was shown to 
be recruited by EcR (ecdysone receptor) to repress transcription of hormone 
regulated genes. This interaction results in stimulation of dMi-2-mediated 
chromatin remodelling, revealing new molecular mechanisms of chromatin 
remodeller regulation by a nuclear hormone receptor (Kreher et al. 2017).
Human CHD4, also acts as an ATP-dependent chromatin remodeller; 
recombinant CHD4, as well as the NuRD complex, disrupt histone-DNA 
contacts in an ATP-dependent manner. Unlike dMi-2, CHD4 is also activated by 
naked DNA (Wang and Zhang, 2001). As a part of the NuRD complex, CHD4 is 
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involved in a wide range of cellular processes, with transcriptional repression 
the most extensively studied (Deslow and Wade, 2007). NuRD was shown to 
interact with the protein kinase ATR (ataxia telangiectasia and Rad3 related), 
that has a prominent role in the DNA damage response (DDR). The NuRD 
components CHD4 and HDAC2 were shown to co-purify with ATR, suggesting a 
potential role of those two proteins or the NuRD complex in DDR (Schmidt and 
Schreiber, 1999). Another indication of CHD4 as a potential factor in DDR was 
provided by experiments that showed increased CHD4 protein levels upon UV 
exposure (Burd et al. 2008). NuRD is recruited to DNA damage sites in a 
poly(ADP-ribose) dependent manner. Upon CHD4 knockdown, DNA repair is 
impaired, establishing CHD4 as an important factor in the repair of DNA double-
strand breaks. In addition, a potential novel role of CHD4 in cell cycle control 
was suggested by the finding that NuRD deacetylates p53, thereby regulating 
G1/S cell cycle transition (Luo et al. 2000, Polo et al. 2010). Some studies 
identified CHD4 as a potential tumour suppressor in certain cancers: CHD4 
expression is reduced in gastric and colorectal cancers with microsatellite 
instability, as is often the case for tumour suppressor genes (O’Shaughnessy 
and Hendrich, 2013, Kim et al. 2011). Recent exome sequencing studies 
showed CHD4 to be mutated in 17% of endometrial cancers of the serous type. 
Most of the mutations identified map to the ATPase motor. Other mutations also 
map to its PHD fingers and chromodomains (LeGallo et al. 2012, Zhao et al. 
2013). CHD4 is also mutated in other cancers like thyroid, ovarian, malignant 
lymphoma, gastric, skin, and bladder cancer (Längst and Manelyte, 2015). 
Besides mutations in cancer, CHD4 mutations were identified in patients with 
intellectual disability syndromes (Weiss et al. 2016), congenital heart defects 
(Sifrim et al. 2016) and developmental disorders (Deciphering Developmental 
Disorders Study, 2017).
Collectively, these results link CHD4 to a variety of diseases. However, the 
molecular consequences of CHD4 mutations have not been defined.
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2.3. Objectives
Several independent studies have identified human CHD4 as a highly mutated 
gene in several different human malignancies, especially serous endometrial 
carcinoma where CHD4 mutations reach the high percentage of 17-19 % (Le 
Gallo et al. 2012, Zhao et al. 2013.). Recently, de novo mutations in CHD4 were 
also reported in patients with an intellectual disability syndrome (Weiss et al. 
2016.). Additionally, CHD4 mutations were reported in cancers like thyroid, 
ovarian, gastric, skin, bladder and malignant lymphoma, where numerous single 
somatic mutations were identified (Längst and Manelyete, 2015.). Many 
mutations affect highly conserved residues within functional domains of the 
protein, like the ATPase domain, chromodomains and PHD fingers (Figure 2.5). 
Figure 2.5. Schematic overview of CHD4 amino acid residues affected by 
point mutations in endometrial cancer, an ovarian cancer line and 
intellectual disability syndrome  Two PHD fingers depicted in green, chromodomains 
in blue and two ATPase domain cores in red (Le Gallo et. al. 2012., Zhao et al. 2013., Weiss et 
al. 2016., R. Müller, pers. comm.)
This study aims to determine consequences of selected cancer relevant point 
mutations on dMi-2, the Drosophila homolog of human CHD4. High 
conservation levels between these two proteins allows dMi-2 to be used as a 
paradigm for charachterisation of the enzymatic properities of CHD proteins in 
vitro (Bouazoune et al. 2002, Kreher et al. 2017, Murawska et al. 2008, Brehm 
 37
INTRODUCTION
et al. 2000.). Previously, dMi-2 was used in our lab as a model to study its role 
in development and differentiation (Murawska et al. 2011, Mathieu et al. 2012, 
Fasulo et al. 2012, Kim et al. 2017). Therefore, selected point mutations were 
introduced into dMi-2 and analysed in vitro to determine the effects on ATP 
binding and hydrolysis, nucleosome remodelling, DNA and nucleosome binding. 
Furthermore, this study investigates the in vivo effects of expression of selected 
mutants in the developing wing of Drosophila.
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3. Material and Methods
3.1 Material
3.1.1. Material sources
All common chemicals, reagents, instruments, and materials in this study were 
purchased from the following companies: Abcam, Alexis Biochemicals, 
AppliChem, Beckmann, BioRad, Calbiochem, Eppendorf, Fermentas, Fisher 
Scientific, Fujifilm, Gibco, Gilson, GE Healthcare, Greiner, Heraeus, Hartmann 
Analytic GmbH, Invitrogen, Kobe, Leica, Millipore, Merc, PAA, MWG Biotech, 
New England Biolabs, PeqLab, Polysciences, Promega, Qiagen, Roche, Roth, 
Santa Cruz Biotechnology, Sarstedt AG, Sigma, Stratagene, Thermo Scientific 
Inc., Whatman, Zeiss. 
3.1.1.1.  Enzymes
Fast AP Thermosensitive alkaline phosphatase Thermo Scientific
Restriction endonucleases Thermo Scientific, 
NEB
Micrococcal Nuclease (Nuclease S7) Roche
Taq DNA Polymerase Thermo Scientific
T4 DNA ligase Thermo Scientific
RNAse A Qiagen
Proteinase K Roth
RedTaq DNA polymerase Sigma
Phusion polymerase HT II Thermo Scientific
3.1.1.2. Enzyme inhibitors
Aprotinin Roth
Leupeptin Roth
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Pepstatin Roth
PMSF (phenyl-methane-sulfonyl-fluoride) Roth
3.1.1.3. Chromatographic material
Hydroxyl apatite resin Biorad
Chromatography system (ÄKTA, HPLC, FPLC) Amersham
Econ-Pac Chromatography columns Bio-Rad
TLC PEI Cellulose F  Millipore
3.1.1.4. Affinity purification material 
M2 Agarose (FLAG beads)
3.1.1.5. Dialysis and filtration material
Dialysis membranes Spectra/Por
Sterile syringe filters VWR
Cellulose nitrate filter Sartorius
Filtropur bottle top filters Sarstedt
Slide-A-Lyzer Dialysis Cassettes Thermo Scientific
Amicon Ultra-15 Centrifugal filter units Milipore
Amicon Ultra-0,5mL Centrifugal filter units Milipore
3.1.1.6. Consumable material
APS (ammonium persulfate) Merck 
6x DNA Loading Dye Thermo Scientific
GeneRuller 1kb DNA Ladder Plus Thermo Scietific
GeneRuller 100 bp DNA Ladder Thermo Scientific
TEMED (tetramethyl-ethylene diamine) Roth
PageRuler Prestained Protein Ladder Thermo Scientific
Rotiphorese Gel 30 Roth
Rotiphorese Gel 40 Roth
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Ethidium Bromide Roth
SyBr Gold Thermo Scientific
Protein Assay (Bradford solution) Bio-Rad
Whatman 3MM paper Whatman
Safety-Multifly-Needle Sarstedt
Ultracentrifuge tube Nalgene
PVDF membrane Roth
SuperRX Fuji Medical X-ray films Fuji
3.1.1.7. Radioactive material
(γ-32P)-ATP Hartmann Analytic
(⍺-32P)-dCTP Hartmann Analytic
3.1.1.8. Kits
Table 3.1: List of kits used in this study, their corresponding application and 
company
Kit Application Company
QuikChange II Site-Directed 
Mutagenesis Kit
Site-directed 
mutagenesis
Agilent 
Technologies
Bac-to-Bac Baculovirus Expression 
system
Transfection of Sf9 cell 
for production of 
baculoviruses
Life 
Technologies
QIAquick PCR purification kit DNA purification after 
PCR
Qiagen
QIAquick Gel Extraction kit DNA purification from 
agarose gels
Qiagen
Maxiprep kit Purification of large 
scale plasmid preps
Qiagen
Gateway LR Clonase II Enzyme mix Cloning Invitrogen
pENTR Directional Topo cloning kit Cloning Invitrogen
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3.1.2. Standard solutions and buffers
Buffers and stock solutions were prepared according to standard protocols. 
Additional buffers are described in Methods section.
Phosphate Buffered Saline (PBS) 140mM NaCl
2,7mM KCl
8,1mM Na2HPO4
1,5mMKH2PO4
pH adjusted to 7,4 with HCl
Tris-EDTA (TE) 10mM Tris-HCl, pH8
1mM EDTA
TBE buffer 90mM Tris
90mM Boric Acid
2mM EDTA
SDS-running buffer 192mM Glycin
25mM Tris
0,1% (w/v) SDS
3.1.3. Plasmids 
Table 3.2. Plasmids used for baculovirus generation and protein 
expression in Sf9 cells. 
Numbers in plasmid name indicate position of mutated amino acid residue.
Immobilon Western 
Chemiluminescent HRP Substrate 
Kit
Detection of proteins on 
PVDF membrane using 
chemiluminescence
Millipore
Kit Application Company
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Construct name Description Source
pFastBacDual-
dMi-2_WT-FLAG
Full length wild type dMi-2 with C-terminal 
FLAG tag for generation of recombinant 
baculovirus
Ulla 
Kopiniak
pFastBacDual-
dMi-2_C452Y-FLAG
Full length dMi-2 with cytosine at position 
452 mutated to tyrosine with C-terminal 
FLAG tag for generation of recombinant 
baculovirus
This 
study
pFastBacDual-
dMi-2_V538F-FLAG
Full length dMi-2 with valine at position 
538 mutated to phenylalanine with C-
terminal FLAG tag for generation of 
recombinant baculovirus
This 
study
pFastBacDual-
dMi-2_R552Q-FLAG
Full length dMi-2 with arginine at position 
552 mutated to glutamine with C-terminal 
FLAG tag for generation of recombinant 
baculovirus
This 
study
pFastBacDual-
dMi-2_L914V-FLAG
Full length dMi-2 with leucine at position 
914 mutated to valine with C-terminal 
FLAG tag for generation of recombinant 
baculovirus
This 
study
pFastBacDual-
dMi-2_R1164Q-FLAG
Full length dMi-2 with arginine at position 
1164 mutated to glutamine with C-
terminal FLAG tag for generation of 
recombinant baculovirus
This 
study
pFastBacDual-
dMi-2_H1153R-FLAG
Full length dMi-2 with histidine at position 
1153 mutated to arginine with C-terminal 
FLAG tag for generation of recombinant 
baculovirus
This 
study
pFastBacDual-
dMi-2_H1198Y-FLAG
Full length dMi-2 with histidine at position 
1198 mutated to tyrosine with C-terminal 
FLAG tag for generation of recombinant 
baculovirus
This 
study
pFastBacDual-
dMi-2_L1217P-FLAG
Full length dMi-2 with leucine at position 
1217 mutated to proline with C-terminal 
FLAG tag for generation of recombinant 
baculovirus
This 
study
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Table 3.3. Plasmids used for generation of transgenic flies
Numbers in plasmid name indicate position in mutated amino acid residue
Table 3.4 Other plasmids used in this study
Plasmid Description Source
pUASt-attB-dMi-2_WT-FLAG Full length wild type dMi-2 with 
C-terminal FLAG tag for 
generation of UAS transgenic 
flies
This 
study
pUASt-attB-dMi-2_C452Y-FLAG Full length dMi-2 with cytosine at 
position 452 mutated to tyrosine 
with C-terminal FLAG tag for 
generation of UAS transgenic 
flies
This 
study
pUASt-attB-dMi-2_R1164Q-
FLAG
Full length dMi-2 with arginine at 
position 1164 mutated to 
glutamine with C-terminal FLAG 
tag for generation of UAS 
transgenic flies
This 
study
pUASt-attB-dMi-2_H1153R-
FLAG
Full length dMi-2 with histidine at 
position 1153 mutated to 
arginine with C-terminal FLAG 
tag for generation of UAS 
transgenic flies
This 
study
pUASt-attB-dMi-2_H1198Y-FLAG Full length dMi-2 with histidine at 
position 1198 mutated to 
tyrosine with C-terminal FLAG 
tag for generation of UAS 
transgenic flies
This 
study
pUASt-attB-dMi-2_L1217P-FLAG Full length dMi-2 with leucine at 
position 1217 mutated to proline 
with C-terminal FLAG tag for 
generation of UAS transgenic 
flies
This 
study
Plasmid Description Source
pUC12x601 Contains 12 nucleosome positioning 
sequences (601). Used for assembly of 
nucleosome arrays.
G. Längst
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3.1.4. Oligonucleotides
Oligonucleotides used in this study were purchased from Eurofins MWG 
Operon and diluted to final concentration of 100µM with nuclease-free water. 
3.1.4.1. Oligonucleotides for site-directed mutagenesis
Table 3.5. Oligonucleotides used for site-directed mutagenesis. Mutated bases 
are indicated in bold, numbers in oligonucleotide name indicate the position of 
mutated amino acid position.
pUC1x601 Contains 1 nucleosome positioning 
sequence (601). Used for assembly of 
mononucleosomes.
G. Längst
pFastBacDual Baculovirus transfer vector used for 
generation of recombinant baculoviruses
Life 
Technologies
pUASt-attB Integration vector for Gal4/UAS mediated 
expression of transgenes. Attachment attB 
site in the plasmid is recognised by φC31 
integrase, that integrates construct into the 
attP site in transgenic fly genome. It carries 
lacZ reporter and white+  marker gene and 
ampicilin resistance
H. Jäckle, 
Generated by 
Basler lab 
(Bischof et al. 
2007) 
Plasmid Description Source
Oligo name Sequence (5’>3’)
dMi-2_C452Y_fwd TTGCTGTGCTACGACTCATGTCCCTCC
dMi-2_C452Y_rev GGAGGGACATGAGTCGTAGCACAGCAA
dMi-2_V538F_fwd TGCGAATGGTTCCCCGAAGTGCAACTGGAC
dMi-2_V538F_rev GTCCAGTTGCACTTCGGGGAACCATTCGCA
dMi-2_R552Q_fwd CTCATGATTCAGTCGTTCCAGCGCAAG
dMi-2_R552Q_rev CTTGCGCTGGAACGACTGAATCATGAG
dMi-2_L914V_fwd CTCGAGGAGGTGTTCCATCTGCTCAACTTC
dMi-2_L914V_rev GAAGTTGAGCAGATGGAACACCTCCTCGAG
dMi-2_H1153R_fwd AATCCCCGAAACGATATTCAGGCC
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3.1.4.2. Oligonucleotides for sequencing
Table 3.6. Oligonucleotides used for sequencing of dMi-2 and dMi-2 mutants.
 
dMi-2_H1153R_rev GGCCTGAATATCGTTTCGGGGATT
dMi-2_R1164Q_fwd CTTCTCCCGAGCCCATCAGATTGGCCAGGCT
AACAA
dMi-2_R1164Q_rev TTGTTAGCCTGGCCAATCTGATGGGCTCGGG
AGAAG
dMi-2_H1198Y_fwd CGTAAGATGATGTTGACTTATCTTGTGGTCC
dMi-2_H1198Y_rev GGACCACAAGATAAGTCAACATCATCTTACG
dMi-2_L1217P_fwd TTT ACA AAG CAA GAA CCG GAC GAT ATC CTT 
CGT
dMi-2_L1217P_rev ACG AAG GAT ATC GTC CGG TTC TTG CTT TGT 
AAA
Oligo name Sequence (5’>3’)
Oligo name Sequence (5’>3’)
fwd1_dMi-2 TGGCATCGGAGGAAGAGAAT
fwd2_dMi-2 CAGTGTGACAGGCGATGAG
fwd3_dMi-2 AGAGGGCAAGTGGTCGTG  
fwd4_dMi-2 CGACACAAGGACAAGGTTGG
fwd5_dMi-2 GCATTAACTGGTTGCGCTAC
fwd6_dMi-2 GCTGCAACCATCCGTATCTC
fwd7_dMi-2 CTCATCTTGTGGTCCGTCC 
fwd8_dMi-2 CCTCAATGCCATTATGCGGT
fwd9_dMi-2 GCGAGGTGAAGCAAGAACAA 
fwd10_dMi-2 GCATCTGAGCAAGGAATCGC
rev1_dMi-2 CTAGCTTTGGTGCCGCAATC 
rev2_dMi-2 CTCCGGGAAGTTCTTCGTTT 
rev3_dMi-2 CCGCCACATCCTGTTTCAG  
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3.1.4.3. Oligonucleotides for mononucleosome assembly DNA fragment
Table 3.7. Oligonucleotides used to generate DNA fragments for 
mononucleosome assembly. 
3.1.4.3. Other oligonucleotides
Table 3.8. Other oligonucleotides used in this study
3.1.5. Baculoviruses
Table 3.9. Baculoviruses used for protein expression in Sf9 cells
Oligo name Sequence (5’>3’)
601_147_fwd ctggagaatcccggtgcc
+80_601rev tcggtacccggggatcc
0-77fwd gat cca gaa tcc tgg tgc tga g
0-77rev gta cag aga ggg aga gtc aca aaa c
77-77fwd atc ttt tga ggt ccg gtt ctt t
77-77rev gta cag aga ggg aga gtc aca aaa c
Oligo name Sequence (5’>3’)
attB1-dMi-2-fwd caccatggcatcggaggaagagaatg
 attB2-dMi-2-rev ctacttgtcatcgtcgtccttgtagtcgacg
dMi-2_WT-FLAG Full length wild type dMi-2 with C-terminal FLAG tag
dMi-2_C452Y-FLAG Full length dMi-2 with cytosine at position 452 mutated 
to tyrosine with C-terminal FLAG tag
dMi-2_V538F-FLAG Full length dMi-2 with valine at position 538 mutated to 
phenylalanine with C-terminal FLAG tag
dMi-2_R552Q-FLAG Full length dMi-2 with arginine at position 552 mutated 
to glutamine with C-terminal FLAG tag
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3.1.6. Cell lines and tissue culture
Sf9 - cell line established from Spodoptera frugiperda ovaries used for 
recombinant protein expression in Baculovirus system (Vaughn et al. 1977). Sf9 
cells were cultured in Sf-900 II SFM media (Life Technologies), supplemented 
with 10% (v/v) FBS (Hyclone) and 1% of Penicillin/Streptomycin (10mg/mL) 
(PAA). Cells were kept in the incubator at 26°C. 
3.1.7. Bacteria strains and culture media
Escherichia coli strain XL1-Blue was used for cloning and plasmid DNA 
amplification. Genotype: recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F 
 ́proAB lacIqZ∆M15 Tn10 (Tetr)]
Escherichia coli strain DH10 Bac was used for recombination of FastBac 
plasmid DNA to bacmid. Genotype: F– mcrA Δ(mrr-hsdRMS-mcrBC) 
φ80lacZΔM15 ΔlacX74 recA1 endA1 araD139 Δ(ara, leu)7697galUgalKλ– 
rpsLnupG/bMON14272/pMON7124
Escherichia coli strain XL-Gold was used for transformation of plasmids 
generated by site-directed mutagenesis. Genotype: TetrΔ(mcrA)183 Δ(mcrCB-
hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 gyrA96 relA1 lac Hte [F ́proAB 
lacIqZΔM15 Tn10 (Tetr) Amy Camr]
dMi-2_L914V-FLAG Full length dMi-2 with leucine at position 914 mutated 
to valine with C-terminal FLAG tag
dMi-2_R1164Q-
FLAG
Full length dMi-2 with arginine at position 1164 mutated 
to glutamine with C-terminal FLAG tag
dMi-2_H1153R-
FLAG
Full length dMi-2 with histidine at position 1153 mutated 
to arginine with C-terminal FLAG tag
dMi-2_H1198Y-FLAG Full length dMi-2 with histidine at position 1198 mutated 
to tyrosine with C-terminal FLAG tag
dMi-2_L1217P-FLAG Full length dMi-2 with leucine at position 1217 mutated 
to proline with C-terminal FLAG tag
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Escherichia coli strain One shot TOP 10 was used for production of entry 
vector for Gateway system. Genotype: F- mcrA Δ(mrr-hsdRMS-mcrBC) 
φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara- leu)7697 galU galK rpsL (StrR) 
endA1 nupG
Escherichia coli strain NEB 5⍺ was used to transforamtion of LR recombination 
reaction for production of pUAST_attB_rf destination vectors. Genotype: fhuA2 
(argF-lacZ)U169 phoA glnV44 80 (lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 
hsdR17
3.1.7.1. Culture media 
LB Medium (Luria Bertani) 1% (w/v) Tryptone
0,5% (w/v) Yeast extract
1% NaCl
Agar plates 1,5% (w/v) Agar
LB medium
3.1.7.2. Antibiotics, selection markers, and inducers
Table 3.10. Antibiotics used for selection, X-gal in blue/white screening and 
IPTG as the inducer in LB agar plates and/or LB media in indicated 
concentrations. 
Antibiotic/selection markers/reagent Concentration (µg/mL)
Ampicilin 100
Gentamycin 7
Kanamycin 50
Tetracyclin 10
X-gal (5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside) 
100
IPTG (Isopropylthio-β-galactoside) 40
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3.1.8. Fly strains
Fly stocks were maintained at room temperature and all crosses were kept at 
26°C in a fly incubator. Fly stocks were sustained on standard food as 
described in Kunert and Brehm, (2008).
Table 3.11. Fly strains used in this study
Name Description and genotype Source
UAS_dMi-2_WT-FLAG Transgenic fly line carrying 
UAS_dMi-2_WT, inserted at 3rd 
chromosome. w(-);;dMi-2_WT/
dMi-2_WT
This study
UAS_dMi-2_C452Y-
FLAG
Transgenic fly line carrying 
UAS_dMi-2_C452Y, inserted at 3rd 
chromosome. w(-);;dMi-2_C452Y/
dMi-2_C452Y
This study
UAS_dMi-2_H1153R-
FLAG
Transgenic fly line carrying 
UAS_dMi-2_H1153R, inserted at 3rd 
chromosome. w(-);;dMi-2_H1153R/
dMi-2_H1153R
This study
UAS_dMi-2_R1164Q-
FLAG
Transgenic fly line carrying 
UAS_dMi-2_R1164Q, inserted at 3rd 
chromosome. w(-);;dMi-2_R1164Q/
dMi-2_R1164Q
This study
UAS_dMi-2_H1198Y-
FLAG
Transgenic fly line carrying 
UAS_dMi-2_H1198Y, inserted at 3rd 
chromosome. w(-);;dMi-2_H1198Y/
dMi-2_H1198Y
This study
UAS_dMi-2_L1217P-
FLAG
Transgenic fly line carrying 
UAS_dMi-2_L1217P, inserted at 3rd 
chromosome. w(-);;dMi-2_L1217P/
dMi-2_L1217P
This study
GAL4-engrailed P(engrailed), GAL4 expression in 
posterior part of fly wing
Bloomington
w1118 Isogenic strain Bloomington 
OrR Oregon R wild type flies P. Becker
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3.2. Methods 
3.2.1. Cell biological methods
3.2.1.1. General tissue culture procedures
Sf9 cells were propagated in T75 flask (Sarstedt/Greiner) at 26°C in Sf-900 II 
SFM media supplemented with 10% FBS and 1% Penicillin/Streptomycin (see 
3.1.6.). Every three to four days cells were removed using cell scraper and split 
by diluting with fresh media to approx. 2x106 cells/ml. Cell number was 
determined using hemocytometer. Collection of cells for experiments was done 
at 1000rpm for 5 minutes (Heraeus Megafuge 1.0).
3.2.1.2. Freezing and thawing the cells
For freezing, cells were collected from a dense flask, spun down and 
resuspended in 1mL of media containing 80% of supplemented Sf-900 II SFM 
media, 10% FBS and 10 % DMSO. Cells were transferred to cryovial and frozen 
in 50 mL Falcon tube which contained 100% isopropanol. Isopropanol ensures 
freezing rate of approximately -1°C/min and ensures viability of the cells. Cells 
are stored at -80°C. 
For thawing, cells were transferred from -80 to RT. When thawed, cells were 
transferred to 15 mL Falcon and resuspended in approx. 10 mL fresh media, 
pelleted with centrifugation, media containing DMSO was removed and 15mL 
fresh media was added. Cells were seeded in the 75cm2 flask. After 24h media 
was exchanged. 
3.2.2. Molecular biological methods
Standard molecular biology techniques such as plasmid DNA transformation 
into chemically-competent E.coli, amplification and purification of plasmid DNA 
from E.coli, digestion of plasmid DNA using restriction endonucleases, 
dephosphorylation of DNA, ligation of DNA, determination of DNA concentration 
and analysis of DNA on TBE or TAE agarose gels were carried out according to 
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standard protocols and manufacturer’s instructions (Thermo Scientific, 
Sambrook and Russell, 2001). 
Small-scale plasmid DNA preparation was performed using P1(resuspension), 
P2 (lysis) and P3 (neutralisation) buffers from QIAGEN. Shortly, bacteria were 
resuspended in P1 buffer containing RNase. Alkaline lysis was performed with 
P2 containing SDS and NaOH and P3 containing potassium acetate for 
neutralisation. DNA was precipitated using isopropanol according to the 
standard protocol. For large scale plasmid DNA preparation QIAGEN Plasmid 
Maxi Kit was used and DNA was precipitated using isopropanol according to the 
standard protocol. 
3.2.2.1. PCR for site-directed mutagenesis
To introduce specific changes into a DNA sequence, site-directed mutagenesis 
was performed using the Quick Change Site-directed Mutagenesis Kit (Agilent 
Technologies) according to the manufacturer's instructions. A general PCR 
reaction of 50µL was set up as follows:
5µL 10x Reaction buffer
1µL dNTP’s
1µL Forward Primer (125ng)
1µL Reverse Primer (125 ng)
1µL plasmid DNA (100ng)
1,5µL Quick solution buffer
0,50µL PfuUltra HF DNA Polymerase
39µL H2O
A general PCR reaction was incubated in a T3000 Thermocycler (Biometra) 
with the following programme:
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Initial Denaturation 95°C 3min 30sec
Denaturation 95°C 20 sec
Annealing 60°C 10sec 18 cycles
Elongation 68°C 1min/kb
Final elongation 68°C 7min
3.2.2.2. Genomic DNA isolation from flies
Fly genomic DNA was isolated from 30-40 transgenic flies. Flies were ground in 
200µL of extraction buffer in 1,5mL Eppendorf tube with an eppi pestle for 1 
minute, after which additional 200µL of extraction buffer was added to the 
solution and flies were ground until well homogenized. Additional 600µL of 
extraction buffer was added to the solution and incubated at 65°C for 30 
minutes. The solution was left to cool down to room temperature and 200µL of 
8M potassium acetate was added to the reaction, mixed and left to incubate on 
ice for 10 minutes. The reaction was pelleted with centrifugation at 13 000 rpm 
in table-top centrifuge for 15 minutes at room temperature. The supernatant 
was transferred to the 2mL tube and RNase A was added to digest any residual 
RNA, incubation was done for 10 minutes on ice. 600µL of isopropanol was 
added to the solution and mixed by tilting. The solution was centrifuged for 30 
minutes at 13000 rpm at 4°C. The supernatant was discarded and the pellet 
was washed with 70% Ethanol and centrifuged for 20 minutes at 13000 rpm. 
Supernatant was discarded, the pellet was dried at room temperature and 
dissolved in 100µL of nuclease-free H2O.
Extraction buffer 100mM Tris, pH 7,5
100mM EDTA
100mM KCl
0,5% SDS
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3.2.3. Protein biochemistry methods
Protein aliquotes were kept on ice in presence of protease inhibitors - 
Leupeptin, Aprotinin, Pepstatin A (1µg/mL), PMSF (0,2mM) and DTT (1mM) as 
a reducing agent. All buffers were freshly supplemented with protease inhibitors 
before the start of the experiment. Critical steps were performed in the cold 
room at 4°C.
3.2.3.1. Whole cell extract from Sf9 cells
Whole cell extract was prepared 72 hours post baculovirus infection. Cells were 
collected, centrifuged and washed with cold 1xPBS. The pellet was 
resuspended in 1mL LyBu200 per 15cm plate. Cells were lysed by three freeze-
thaw cycles in liquid nitrogen, after which cell extracts were centrifuged at 
13000rpm for 30 minutes at 4°C. Supernatant containing protein extract was 
transfered to 15mL Falcon tubes, frozen in liquid N2 and stored at -80°C until 
purification. 
LyBuX buffer 20mM HEPES KOH, pH 7,6
X mM KCl
10% Glycerol (v/v)
0,1% NP-40
+DTT, protease inhibitors (added freshly)
3.2.3.2. FLAG affinity purification
For FLAG affinity purification of dMi-2_WT-FLAG and dMi-2-FLAG mutants 
whole cell extract was prepared as described in 3.2.3.1. ⍺-FLAG M2 agarose 
beads (Sigma Aldrich) were equilibrated by washing three times in LyBu200. 
50µL of FLAG beads per 1mL of whole cell extract were used and incubated for 
4 hours on a rotating wheel. Beads were collected by centrifugation at 1000rpm 
for 2 minutes at 4°C. Beads were washed over 10mL Econ-Pac 
Chromatography columns (Bio-Rad) with LyBu buffers with increasing salt 
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concentration to remove unbound proteins and then with decreasing salt 
concentration, in the following order:
2 x 10 mL of LyBu500
2 x 10 mL of LyBu1000
1 x 10 mL of LyBu500
1 x 10 mL of LyBu200
1 x 10 mL Lybu150
1 x 10 ml elution buffer
Proteins were eluted three times with elution buffer (1:1 elution buffer:beads) 
supplemented with Flag peptide to the final concentration of 250ng/µL after 10 
minutes incubation. Eluted proteins were subjected to SDS-PAGE 
electrophoresis. All washing steps and elutions from the column were performed 
in the cold room.
Elution buffer 20mM Tris pH 7,6
150mM KCl
10% Glycerol (v/v)
+DTT, protease inhibitors (added freshly)
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Figure 3.1. Elution profiles of immunopurified mutants and WT dMi-2
Proteins are resolved on 8% SDS PAGE gel. Silver stain gel showing 1µg 
immunopurified FLAG-tagged Drosophila melanogaster WT protein and point 
mutants(upper panel) and Coomassie Brilliant Blue stained gel showing 
immunopurified FLAG-tagged H1196Y point mutant (lane 1 - input 1%, lane 2 - 
flowthrough 1%, lane 3 - beads 1%, lane 4 - 1µL eluate, lane 5 - 2µL eluate, lane 6 - 
3µL eluate, lane 7 - 1µg BSA, lane 8 - 2µL BSA) (lower panel)
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3.2.3.3. Determination of protein concentration
Protein concentration of purified recombinant dMi-2 proteins was determined 
using Bio-Rad Protein assay (Bio-Rad) which is based on a colorimetric assay 
described by Bradford (Bradford, 1976). Protein aliquots were compared to a 
protein standard of known concentration (BSA) and run on the SDS-PAGE gel, 
afterwards stained with Coomassie brilliant blue and quantified using ImageJ 
software (Ferreira and Rasband, 2012).
3.2.3.4. SDS-polyacrylamide gel electrophoresis
SDS-PAGE is a method used to qualitatively analyse proteins and protein 
mixtures. It can be used to asses purity of purified proteins and, since the 
method is based on separating proteins by size, it can be applied to assess the 
apparent molecular mass of the protein. SDS-polyacrylamide gels were 
prepared using disposable pre-assembled gel cassettes and gels were run in 
the XCell Sure Lock Mini-Cell Electrophoresis system (Thermo Scientific). 
Stacking and resolving gels were prepared with a ready-to-use acrylamide-
bisacrylamide mix (Rotiphoresegel 30, 37.5:1; Roth) and prepared according to 
the manufacturer's instructions. The stacking gel contained 4% and resolving 
gel contained 8%, 15% or 18% polyacrylamide, depending on the analysed 
protein. Protein samples were mixed with 1xSDS loading buffer, incubated for 5 
minutes at 95°C, cooled shortly on  ice and loaded onto the gel. Electrophoresis 
was performed in SDS running buffer at 100V until the dye reached the 
resolving gel, after which the voltage was increased to 150V and 
electrophoresis was stopped when the dye reached the end of the gel. To 
monitor proper separation through the gel, PageRuler Prestained Protein 
Ladder (Thermo Scientific) was loaded next to the sample of interest. After 
electrophoresis, the gel was stained with Coomassie Brilliant Blue or subjected 
to Western blot. 
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3.2.3.5. Coomassie Brilliant Blue staining of the protein gels
Visualisation of proteins from polyacrylamide gels was done using Coomassie 
Brilliant Blue staining solution. Gels were incubated on a shaker overnight. Gels 
were destained using destaining solution, until protein bands were visible. 
Coomassie Brilliant Blue staining solution 50% (v/v) Methanol
10% (v/v) Acetic Acid
0,1% (w/v) Coomassie Brilliant 
Blue R-250
Destaining solution 50% (v/v) Methanol
10% (v/v) Methanol
3.2.3.6. Western blot
Western blot is a method used to transfer proteins from gels and to immobilise 
them on a membrane, thereby maintaining the high resolution of the protein 
pattern on the membrane. When on the membrane, proteins are easily probed 
with antibodies which allows detection of specific proteins. 
Proteins were separated using SDS-PAGE (3.2.3.4.) and transferred to 
polyvinylidene difluoride membrane (PVDF), that was, prior to use, activated in 
methanol. The membrane was placed over the gel and stacked between 4 
Whatman-3M papers soaked in transfer buffer. Proteins were then transferred 
to PVDF membrane in a Wet Blot Module (Biorad) at 400mA for 1 hour and 15 
minutes. The chamber was kept cold with an ice block inside and was 
surrounded with ice to provide further cooling from the outside. After transfer, 
the membrane was placed in blocking solution (5% milk powder in PBSt) for 1 
hour to reduce non-specific binding of the antibody to the proteins on the 
membrane. After the blocking stage, the membrane was transferred to the 
appropriate dilution of the primary antibody and incubated overnight in the cold 
room or 2 hours at room temperature. Following the incubation with primary 
antibody, the membrane was washed 3 times in PBSt for 5 minutes at room 
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temperature and placed for incubation with appropriate HRP-labelled secondary 
antibody for two hours at room temperature. The membrane was washed again 
3 times for 5 minutes in PBSt and antibody-antigen complex was detected by 
chemiluminescence using Immobilon Western Chemiluminescent HRP 
Substrate Kit (Millipore) and SuperRX Fuji Medical X-ray films. Exposure time 
differed for different antibodies. 
Transfer buffer 192 mM Glycin
24 mM Tris
20% methanol
0,02% SDS
PBSt 1xPBS
0,1% Tween 20%
3.2.3.7. Non-denaturating-polyacrylamide gel electrophoresis
In order to analyse interactions between dMi-2 and nucleic acids or 
nucleosomes, nondenaturating polyacrylamide gels in absence of SDS were 
used. This way biological activity of proteins is preserved and can be visualised 
on the gel. In general for 100 mL 5% polyacrylamide native gels the following 
components were used:
12,5 mL polyacrylamide mix (Rotiphoresegel 40, 29:1; Roth)
5mL 10xTBE
1mL 10%APS
50µL TEMED
81,45mL H2O
Gels were prerun with 1x GelPilot Loading dye to monitor color separation for at 
least 30 minutes at 90V. Samples were loaded on the gel and run in 0,5XTBE 
buffer between 90-120V until the bromphenol blue dye reached 75% of the gel. 
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Following electrophoresis gels were stained with ethidium bromide or SyBr Gold 
reagent to visualise DNA or nucleosomes. In case of the radioactively labelled 
nucleosome, gels were dried and exposed to a Phosphoimager screen.
3.2.3.8. Recombinant protein expression using the Baculovirus 
Expression system
The Baculovirus expression system is very useful for expression and 
purification of recombinant eukaryotic proteins of large sizes. Unlike bacterial 
systems, the baculovirus system has higher size limit and in most cases 
ensures soluble, properly folded and functionally active protein. The coding 
sequence of dMi-2-WT was cloned in the FastBacDual vector and used for 
generation of point mutants by site-directed mutagenesis (3.2.2.1).
3.2.3.8.1. Bac-to-Bac Baculovirus Expression system 
pFastBacDual containing dMi-2 WT or an dMi-2 mutant was transformed into 
DH10 Bac E.coli cells. These cells contain a bacmid with the mini-attTn7 site in 
the sequence of LacZ⍺, that functions as an attachment site for mini Tn7 
element from FastBacDual. This transposition results in recombinant bacmid. 
Successful integration of the mini Tn7 element from plasmid to bacmid is 
confirmed by blue-white screening and by PCR according to manufacturer's 
instructions. 1x106 of Sf9 cells were seeded in 6-well plates and left to settle for 
20 min at 26°C. Meanwhile, the transfection mix was prepared in the following 
way: 500-1000ng of bacmid DNA (5µL volume) was diluted in 100µL of 
unsupplemented Sf-900 II SFM medium. 8µL of Cellfectin reagent (Thermo 
Scientific) was combined with 100µL of unsupplemented Sf-900 II SFM 
medium. This mixture was vortexed, then mixed with previously prepared 
bacmid DNA and incubated for 30 min at room temperature. After incubation, 
transfection mix (210µL) was added to the cells in a dropwise manner. Cells 
were left to incubate for 24h at 26°C. On the next day, transfection media was 
removed and replaced with supplemented (10% FBS, 1% Pen/Strep) Sf-900 II 
SFM. 6-well plate was wrapped with parafilm to prevent evaporation and 
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incubated at 26°C for 5 days. The medium was collected, centrifuged for 5 min 
at 1000rpm and the supernatant (P1) was transferred to a 15mL Falcon tube, 
which was stored at 4°C.  
3.2.3.8.2. Amplification of baculovirus
Virus amplification was performed by infecting Sf9 cells for two consecutive 
times. The first viral amplification was carried out by seeding 7,5x106 Sf9 cells in 
5mL supplemented Sf-900 II SFM medium in a 10 cm cell culture dish. Cells 
were left to settle for 20 minutes, after which 500µL of viral stock was added to 
the cells in a dropwise manner. Cells were left to incubate on a shaker for 1 
hour. Plates were turned by 90° every 15 minutes to ensure proper mixing. 
Additional 5 mL of supplemented Sf-900 II SFM medium was added to the cells, 
the plate was wrapped with parafilm and left to incubate for 6-7 days. The 
medium was collected, centrifuged and the supernatant (P2) was stored at 4°C. 
The second viral amplification was carried out by seeding 12,5x106 Sf9 cells in 
7mL of supplemented Sf-900 II SFM medium in a 15 cm cell culture dish and 
cells were left to settle for 20 minutes. 500µL of P2 viral amplification was 
added to the cells in a dropwise manner and incubated on a shaker for 1 hour, 
rotating plates by 90° every 15 minutes. Additional 8mL of media was added to 
the cells, the plate was wrapped with parafilm and incubated for 6-7 days at 
26°C. Medium was collected, centrifuged and supernatant (P3) was stored at 
4°C.
3.2.3.8.3. Infection for protein expression
Supernatant from the second viral amplification (P3) was used to infect Sf9 cells 
for protein expression. The same procedure as for the second viral amplification 
was used to infect the cells, with the only difference that the cells were collected 
72 hours post infection. For large scale infection, in general 30-35 15-cm cell 
culture dishes were used. Whole cell extracts were prepared as described in 
3.2.3.1. and subsequent protein purification was performed as described in 
3.2.3.2. 
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3.2.3.9. ATP binding assay
To determine effects of mutations on the ability of dMi-2 to bind ATP, a filter 
binding assay was established and performed in presence of ATP radioactively 
labelled on its γ phosphate ((γ-32P)-ATP., 3000Ci/mmol, 10mCi/mL). A typical 
reaction was performed in BC100 buffer, containing 90nM dMi-2, 0,25mM 
MgCl2 and 0,0375µL of (γ-32P)-ATP. Reactions were preincubated for 5 minutes 
in a waterbath at 26°C before addition of ATP to the reaction mix. ATP was 
added in 2µL volume in 20mM HEPES. Total reaction volume was 15µL. 
Reaction was then further incubated for additional 30 min. 2µL from the reaction 
was spotted on nitrocellulose membrane under vacuum using a vacuum 
filtration system and washed with approximately 150mL of BC100 buffer to 
remove unbound ATP. The membrane was left for 30 minutes to dry at room 
temperature and exposed to a Phosphoimager screen. Quantification of signals 
was done using Science Lab Image Gauge (FUJIFILM) software. To establish 
the specificity of the method and to exclude unspecific binding of ATP to protein, 
unlabelled GTP and ATP were used in competition with radioactive ATP. 
Difference in radioactive ATP binding was monitored. Protein was incubated 
with a constant amount of ATP and increasing amounts of unlabelled GTP or 
ATP. Unlabelled GTP did not have a major effect on the amount of radioactive 
ATP binding detected, but adding unlabelled ATP showed a clear reduction in 
binding of radioactive ATP to dMi-2, showing the specificity of the method. 
(Figure 3.2.).
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Figure 3.2. Establishing dMi-2 ability to bind ATP using ATP binding assay
(a) Quantification of reactions were performed with (+) or without (-) dMi-2 with only hot ATP 
(black bars), with hot ATP in competition with increasing amounts of GTP (blue bars) or with hot 
ATP in competition with cold ATP (red bars). (b) Competition reactions were carried out in 
presence of (γ-32P)-ATP and exposed to Phosphoimager screen. 
3.2.4. Chromatin specific methods
3.2.4.1. Histone octamer isolation from Drosophila embryos
In order to provide histones for nucleosome based enzymatic assays, embryos 
were isolated from Drosophila embryos collected 0-12 hours after egg 
deposition.
a
b
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3.2.4.1.1. Dechorionation of embryos
Embryos were collected from agar trays and washed with embryo wash buffer 
(EW - 0.7 % NaCl / 0.04 % Triton -X100) in a measuring cylinder. Depending on 
the embryo yield up to 100-200 mL of EW buffer was added to the cylinder, 
usually 1:1 - EW buffer:embryo ratio. In order to dechorionate embryos, 30-60 
mL of 12% sodium hypochlorite was added and stirred vigorously for 3 minutes. 
Embryos were washed with tap water over a fine collection sieve, transferred to 
a measuring cylinder and washed with EW. Floating chorions were aspirated. 
Embryos were settled once in EW and once in 0,7% NaCl. The pre-wetted filter 
paper was set up on the funnel and embryos were poured over the funnel and 
left to drain, after which they were washed with deionized water. After embryos 
were nearly dry, they were weighed and transferred to 50mL Falcon tube. 
3.2.4.1.2. Histone isolation
All buffers were supplemented with protease inhibitors before use and kept at 
4°C or on ice. For histone preparation, 50 g of dechorionated embryos were 
used. Embryos were resuspended in 40 mL Glycine buffer and homogenised 
using a Yamamoto homogeniser (1000rpm, 6 strokes, 4°C). After 
homogenisation, the embryo suspension was filtered through Miracloth filter 
(Calbiochem) to remove the residual yolk and unhomogenised parts of 
embryos. The filtered homogenate was then centrifuged for 10 minutes at 8000 
rpm at 4°C in a Sorvall RC-5B (HB-4 rotor). The supernatant was discarded and 
nuclei were resuspended in 50 mL SUC buffer and centrifuged as before. After 
centrifugation, nuclei were on top of biphasic pellet. They were resuspended 
again in SUC buffer and spun down as before. Finally, nuclei were resuspended 
in 60 mL SUC buffer. CaCl2 was added to the solution to a final concentration of 
3mM (using a 1M CaCl2 stock) and the entire reaction was warmed up to 26°C 
in a waterbath for 5 minutes, after which 12500U (166µL) of MNase (50U/µL - 
Nuclease S7 - Roche) was added for digestion of internucleosomal DNA. 
Incubation was continued for approximately 20 minutes. During 20 minute 
period, increase in DNA presence was monitored by Nanodrop, by taking 
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reaction aliquotes every 5 minutes. The flask was swirled every few minutes to 
mix the solution. The reaction was stopped with 1200µL of 0,5M EDTA, pH8 
and spun down immediately for 10 minutes(8000rpm, 4°C). In order to extract 
nucleosomal particles, the pellet was resuspended in 12mL 1xTE pH 7,6, 1mM 
DTT, 0,2mM PMSF and all the protease inhibitors (see 3.1.1.2) and the solution 
was incubated with rotation for 45 minutes at 4°C. The sample was centrifuged 
for 30 minutes, at 12000rpm, 4°C. The supernatant which contained 
nucleosomal particles was kept and salt was adjusted to 0,63M KCl with 2M 
KCl/100mM K-PO4 (pH 7,2). Octamer isolation was performed using 
Chromatography Systems from Amersham (ÄKTA, FPLC, and HPLC) on a 
hydroxylapatite column which was prepared one day before according to the 
manufacturer's instructions and let to settle overnight. The column material was 
washed several times with 0,63M KCl/100mM K-PO4 (pH 7,2) to remove the 
fines. Before loading the sample, the column was washed with 3 volumes of 
0,63M KCl/100mM K-PO4 (pH 7,2). The sample was loaded onto the column via 
a loop (1mL/min), flowthrough (histone H1) was collected and the column was 
washed overnight with 10 column volumes (300mL) of 0,63M KCl/100mM K-
PO4 (pH 7,2). In the morning, 2M KCl/100mM K-PO4 (pH 7,2) was used to elute 
the histones from the column. Elution was monitored at OD 215nm and 1mL 
fractions were collected. Peak fractions were analysed on an 18% SDS-PAGE 
gel and stained with Coomassie brilliant blue. Peak fractions containing only 
histone octamer were pooled together. Chosen peak fractions were 
concentrated over an Amicon Ultra-15 Centrifugal filter unit (Millipore) according 
to the manufacturer's instructions. An equal volume of 100% glycerol was 
added to concentrated fractions and histones were stored at -20°C. Different 
volumes of histones were loaded on 18% SDS-PAGE gel and analysed by 
Coomassie blue staining to determine if the pooled histones are in equimolar 
amounts.
Glycine buffer 15mM HEPES/KOH pH 7,6
10mM KCl
5mM MgCl2
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0,05mM EDTA
0,25mM EGTA
10% glycerol
Before use add: 1mM DTT 
0,2mM PMSF
protease inhibitors (see 3.1.1.2)
SUC buffer 15mM HEPES KOH pH 7,6
10mM KCl
5mM MgCl2
0,05mM EDTA
0,25mM EGTA
350mM Sucrose
Before use add: 1mM DTT 
0,2mM PMSF
protease inhibitors (see 3.1.1.2)
100mM K-PO4 0,2M KH2PO4 and 0,2M K2HPO4 were 
mixed and adjusted to pH 7,2, water 
was added until 100mM
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Figure. 3.1. Core histones from Drosophila embryos
Core histones were isolated from Drosophila embryos collected 0-12 hours after egg deposition. 
Pulled fractions in 50% glycerol were resolved on 18% SDS-PAGE and stained with Coomassie 
blue. Different volumes were loaded on the gel; Lane 1 - molecular weight marker, lane 2 
0,25µL, lane 3 - 0,5µL, lane 4 - 1µL.
3.2.4.2. Nucleosome assembly by salt dialysis
The most common approach for in vitro nucleosome assembly is the salt 
gradient method. This method depends on a tendency of H3-H4 tetramer to 
bind DNA at higher ionic strength than the H2A-H2B dimer. Core histones are 
first mixed in 2M salt where ionic strength is too high to form interactions 
between DNA and histones. By decreasing the salt concentration, and thereby 
the ionic strength of the mixture, histones are deposited on the DNA in a 
stepwise manner. First, between 1.2 and 0.85M salt the (H3-H4)2 tetramer is 
deposited on the DNA and a tetrasome is formed. H2A-H2B dimers bind 
progressively as the salt concentration is lowered further and are stably 
associated in the nucleosome at 0.25M salt. (Wilhelm et al. 1978.). Using this 
method various kinds on nucleosomes can be assembled, from nucleosomal 
arrays on a plasmid DNA to single nucleosomes on the linear DNA. 
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3.2.4.2.1. Polynucleosome assembly by salt dialysis 
Polynucleosomes were assembled using plasmid DNA that contains 12 repeats 
of the 147bp ‘601’ nucleosome positioning sequence. This sequence was 
identified to have high affinity for histone octamer binding and it gives a stable 
nucleosome (Lowary and Widom, 1998). In order to generate properly 
reconstituted nucleosomal arrays, DNA and histones have to be in specific 
molar ratios, so titration of different DNA:histone ratios was performed. Titration 
reactions were performed in the lid of a siliconized 1,5mL Eppendorf tube. The 
bottom of the tube was cut with a hot metal scalpel, the titration reaction was 
pipetted in the lid and covered with a dialysis membrane that was previously 
equilibrated in Hi buffer. Tubes were placed in 300mL of Hi buffer in a beaker 
with a magnetic stirrer and the salt gradient dialysis was performed by 
continuous addition of Lo Buffer (3L in total) using a peristaltic pump. Dialysis 
was performed over-night in the cold room. A typical titration assembly reaction 
contained 5µg of plasmid DNA and varying amounts of histone octamer in a 
50µL volume. To estimate the optimal ratio of DNA:histones, increasing 
amounts of histones were mixed with a constant amount of DNA. Due to the 
high concentration of histones, a 1:10 dilution of histones was prepared with Hi 
buffer, to increase pipetting accuracy. After dialysis, polynucleosomes were 
analysed by Not I digestion. All 12 repeats of ‘601’ sequence have NotI 
restriction site infront of it. This way it is possible to analyse quality of 
nucleosome assembly and determine the levels of assembled nucleosomes 
compared to levels of free DNA and over assembled nucleosomes. For large 
scale assemblies of approximately 100µg, the estimated histone amount was 
reduced by 10% to avoid histone precipitation and the DNA concentration was 
set to 100ng/µL. Large scale assemblies were performed in a dialysis 
membrane (Spectra/Por) using the same procedure as for a titration. After 
dialysis, assemblies were centrifuged at 14 000rpm, 2 min, 4°C to remove any 
precipitate. The concentration was measured using a Nanodrop. 
Hi buffer 10mM Tris pH 7,5
1mM EDTA
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2M KCl
1mM β-mercaptoethanol
Lo buffer 10mM Tris pH 7,5
1mM EDTA
50mM KCl 
1mM β-mercaptoethanol
3.2.4.2.2. Assembly of radioactively labelled mononucleosomes by salt 
dialysis
Mononucleosomes were assembled on a body labelled ((⍺-32P)-dCTP), 227bp 
linear DNA fragment that contained one ‘601’ nucleosome positioning 
sequence. The 227bp fragment was obtained by PCR from a plasmid 
cointaining one ‘601’ positioning sequence and an 80bp overhang (+80). A 
typical PCR reaction of 100µL was set up as follows:
10xTaq Polymerase buffer 10µL
Forward primer (10µM) 2,5µL
Reverse primer (10µM) 2,5µL
dNTP’s 2µL
MgCl2 (25mM) 8µL
‘601’ plasmid (330ng/µL) 0,6µL
(⍺-32P)-dCTP (>6000Ci/mmol) 0,20µL
Taq DNA Polymerase 0,50µL
H2O 73,70µL
The PCR reaction was incubated in a T3000 Thermocycler (Biometra) using the 
following programme:
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Initial Denaturation 94°C 3min
Denaturation 94°C 30 sec
Anneling 51°C 30 sec 30 cycles
Elongation 72°C 15 sec
Final elongation 72°C 5min
Typically, 50 PCRs were performed in parallel to obtain approximately 150µg of 
DNA. PCR reactions were pooled, purified and concentrated over an Amicon 
Ultra-15 Centrifugal filter unit (Millipore, 30K MWCO). Approximately 10 unit 
washes were done with 1xTE to remove residual nucleotides and salts. Finally, 
DNA was concentrated to a 300µL volume and the DNA concentration was 
determined by agarose gel electrophoresis (1% agarose) by loading different 
amounts of DNA and comparing band intensities to a 200bp DNA of known 
concentration. Quantifications were done using ImageJ software. 
In order to estimate the optimal DNA:histone ratio, a titration with a constant 
DNA amount and varying histone amounts was set up. In general, a titration 
reaction contained 1µg of radioactively labelled DNA and varying amounts of 
histones in a 30µL volume. Reactions were pipetted into the lid of a 1,5mL 
Eppendorf tube as described in 3.2.4.2.1. Step dialysis was performed by 
placing tubes in 250mL of 2M Hi buffer for 30 minutes, then the salt 
concentration was reduced to 1M by adding 250mL of 1XTE with β-
mercaptoethanol (1mM). Dialysis was continued for 1 hour, after which salt was 
further reduced to 0,5M by adding 500mL of 1XTE with β-mercaptoethanol 
(1mM) and dialysis was continued for 1 hour. Finally, salt was reduced to 50mM 
and dialysis was performed for an additional hour. Samples were collected from 
the lid of the tube and loaded on a prerun 5% PAA non-denaturating gel. 
Electrophoresis and analysis of the gel was performed as described in 3.2.3.6. 
In the example titration shown in Fig. 3.2 the histone:DNA ratio from lane 4 was 
chosen for the large scale assembly.
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Figure. 3.2. Histone octamer titration for mononucleosome assembly
Increasing amounts of core histones were titrated to a 227bp DNA fragment. 10µL of each 
titration reaction was separated on a 5% non-denaturating PAA gel and exposed to 
Phosphoimager screen. Lane 1 - free DNA without histones, lanes 2-6:increasing amounts of 
histones.
For large mononucleosome assemblies, at least 100µg of DNA was used. The 
histone amount determined in titration was reduced by 10% to avoid histone 
precipitation. The reaction was prepared in a 500µL volume, with DNA 
concentration fixed at 200ng/µL and 2M salt was adjusted using a 2xHi buffer. 
The reaction was pipetted into a dialysis membrane with 6-8 kDa MWCO 
(Spectra/Por) or into Slide-A-Lyzer Dialysis Cassettes (Thermo Scientific) with 
10kDa MWCO and step dialysis was performed as described for titration 
assembly. During the last dialysis step, a 10-30% glycerol gradient was 
generated using an ÄKTA prime (Amersham) and 10% and 30% glycerol 
gradient buffers (GGB). After dialysis, the assembly was centrifuged at 14 000 
rpm, 2 minutes, 4°C to remove any precipitates. The supernatant was then 
carefully layered on top of the 10-30% glycerol gradient and centrifuged in an 
ultracentrifuge (Beckman Optima LE-80K (rotor SW40i)) at 35 000 rpm for 18 
hours at 4°C to separate mononucleosomes from free DNA and any 
overassembled nucleosomes. 
Histones
Free DNA
Mononucleosome
Overassembled DNA
1 2 43 5 6
-
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10/30% Glycerol gradient buffer (GGB) 50mM KCl
50mM Tris pH 8
0,1% NP-40
10/30% glycerol
After centrifugation, fractions of 3-5 drops were collected by puncturing the 
centrifuge tube using a Safety-Multifly “butterfly” syringe (Sarstedt). Fractions 
were collected in a 96-well plate. Gradient central fractions are expected to 
contain mononucleosomes. To determine profile of each fraction and quality of 
assembly, central fractions were loaded in 3µL volume and resolved over 5% 
non-denaturating PAA gel. Peak fractions, containing only mononucleosomes, 
were pooled together and concentrated over Amicon Ultra-0,5mL Centrifugal 
filter units (Millipore). In order to determine nucleosome concentration, DNA of 
known concentration and nucleosomes were separated over the 5% PAA gel. 
Gel was dried, exposed to Phosphoimager and analysed using ImageJ.  
3.2.4.2.3. Assembly of non-radioactive mononucleosomes by salt dialysis
In order to analyse possible differences in dMi-2 remodell ing, 
mononucleosomes were assembled using different DNA templates, including a 
224bp long DNA fragment with a ‘601’ nucleosome positioning sequence that 
will give end positioned mononucleosome with a 77bp overhang (0-77) and a 
301 bp long DNA fragment with a ‘601’ nucleosome positioning sequence that 
will give a centrally positioned mononucleosome with 77bp overhang on both 
sides (77-77). These DNA fragments were a kind gift from G. Längst. In general, 
DNA and histones were titrated the same way as described in 3.2.4.2.2., Gels 
were stained with ethidium bromide or Sybr Gold after electrophoresis for 10 
minutes and exposed to UV for analysis. Large scale assembly was performed 
as described in 3.2.4.2.2. except for the ultracentrifugation step, which was 
omitted in this case. After dialysis, assemblies were centrifuged at 14000rpm for 
2 min at 4°C, and the DNA concentration was measured using a Nanodrop. 
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3.2.4.3. ATPase assay
In order to determine the ATPase activity of dMi-2 WT and mutants thin layer 
chromatography (TLC) was used. ATPase assays were performed in presence 
of dMi-2 WT or mutant protein, polynucleosomes and ATP radioactively labelled 
on its γ phosphate ((γ-32P)-ATP, 3000Ci/mmol, 10mCi/mL). Cold ATP was 
prepared as 10mM ATP with 30mM MgCl2. A typical reaction was performed in 
15µL in BC100 buffer in presence of 200ng polynucleosome array or naked 
plasmid DNA, varying concentrations of dMi-2, 20µM cold ATP, and 0,075µL 
(γ-32P)-ATP. Protein dilutions were prepared in BC100 buffer. Reactions were 
started by pipetting them in previously prepared 2µL of ATP mix (a mixture of 
hot and cold ATP in 20mM HEPES) that was prewarmed at 26°C for 5 minutes. 
Reactions were incubated for 30 minutes at 26°C. 1,5µL of each reaction was 
spotted on a TLC PEI Cellulose plate (Millipore) and dried at room temperature. 
Hydrolysed phosphate was separated from unhydrolysed ATP in 0,5M LiCl/1M 
formic acid buffer using thin layer chromatography. Samples were run until the 
buffer was 1cm from the top of the plate. Plates were dried for 1h at room 
temperature or 5 minutes at 60°C and exposed to a Phosphoimager screen. 
Signals for unhydrolysed ATP and hydrolysed phosphate were quantified using 
Science Lab Image Gauge (FUJIFILM) software. The percentage of hydrolysed 
ATP was determined using the following calculation:
[(γ-32Phydrolysed)/(γ-32Phydrolysed+γ-32Punhydrolyzed)] x 100
BC100 buffer 20mM HEPES, pH 7,9
100mM KCl
0,4mM EDTA
10% glycerol 
3.2.4.4. Restriction enzyme accessibility (REA) assay
The restriction enzyme accessibility assay is a sensitive method of assessing a 
remodeler’s ability to expose a MfeI restriction site at +28bp inside of the ‘601’ 
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sequence that is revealed upon dMi-2 remodelling. Alternatively, restriction site 
can also be revealed upon octamer disassembly (Kreher et al. 2017, Narlikar et 
al. 2001, Bouazoune and Kingston, 2012, Logie and Peterson, 1997). An 
excess amount of MfeI-HF (MfeI - High Fidelity - New England Biolabs) is used 
in the assay to ensure that DNA will be cleaved immediately upon remodelling. 
A typical reaction was performed in 20µL in BC100 buffer, in presence of 20nM 
of radioactively labelled +80 mononucleosome (3.2.4.2.2.), 114nM of dMi-2, 
1,5µL (30U) of MfeI-HF and 2mM/6mM ATP/MgCl2. Protein dilutions were made 
in BC100 buffer. Reactions containing protein, nucleosomes and MfeI-HF were 
pippeted and incubated for 5 minutes in a waterbath at 26°C. Reaction was 
started by transferring entire reaction to 2µL ATP/MgCl2 (from 10mM/30mM 
ATP/MgCl2 stock). Incubation was continued at 26°C in the waterbath. In order 
to observe rates of remodelling  over time, 4µL aliquots were taken after 5, 10, 
20 and 40 minutes. Reactions were stopped by adding the aliquots to 6µL of 
REA stop mix in separate tubes. Proteinase K was added to an end 
concentration of 1µg/µL and the entire reaction was incubated at 50°C for 2 
hours to digest proteins. After incubation, the reaction was loaded on a 5% non-
denaturating PAA gel and subjected to electrophoresis as described in 3.2.3.6. 
Gels were dried and exposed to a Phosphoimager screen, usually overnight, 
and quantified using Science Lab Image Gauge (FUJIFILMS) software. The 
percentage of cut DNA was determined using the following calculation:
[(cut DNA)/(cut DNA+uncut DNA)] x 100
REA stop mix 20mM Tris, pH 7,7
70mM EDTA
2%SDS
10% Glycerol
1% 6x DNA Loading dye (Thermo Scientific)
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3.2.4.5. Nucleosome sliding assay
Nucleosome sliding assays were performed on mononucleosome templates 
with end-positioned mononucleosome (0-77) and centrally positioned 
mononucleosome (77-77). A typical reaction was performed in a 10µL volume in 
BC buffer in presence of varying concentrations of dMi-2, 2mM/6mM ATP/MgCl2 
and 150nM of 0-77 or 77-77 nucleosome template. Reactions were 
preincubated for 5 minutes at 26°C in the waterbath and started by addition of 
ATP/MgCl2 mix. Reactions were further incubated for 45 minutes, after which 
they were stopped by addition of competitor plasmid DNA (to compete away the 
remodeler from the nucleosome) at a final concentration of 180ng/µL and 
incubated on ice for 10 minutes. 4µL of 50% glycerol was added to the reaction 
and it was loaded on a 5% non-denaturating PAA gel and run as described in 
3.2.3.6. Gels were stained with ethidium bromide or Sybr Gold for 10 minutes 
and exposed to UV for analysis. 
3.2.4.6. Nucleosome or DNA bandshift assay
Nucleosome or DNA bandshift assays were set up and performed under the 
same conditions as the nucleosome sliding assay, but since the ability of dMi-2 
or dMi-2 mutants to bind nucleosomal or free DNA was monitored, ATP and 
competitor DNA was not added to the reaction. Incubation proceeded at 26°C 
for 30 minutes and reactions were loaded on a 5% PAA native gel and run at 
80V at 4°C. Gels were stained with SyBr Gold or ethidium bromide. 
3.2.5. Fly work
3.2.5.1. Generation of dMi-2 WT and mutant transgenic UAS fly lines
Vectors for generation of recombinant UAS flies were generated by pENTR 
Directional Topo cloning kit (Invitrogen) and Gateway LR Clonase II Enzyme 
mix (Invitrogen). dMi-2 WT and selected mutants were amplified by PCR from 
the pFastBacDual vector containing dMi-2 WT or corresponding mutants using 
attB1 forward and attB2 reverse primers. The attB sequence (bacterial 
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attachment site) is necessary for successful integration into the attP (phage 
attachment site) site on the chromosome. Fragments were gel purified and 
cloned into pENTR d-TOPO vector according to manufacturer's instructions. 
Successful transformants were cloned into the pUAST-attB-rfa vector using 
Gateway LR Clonase II Enzyme mix (Invitrogen) according to manufacturer's 
instructions. For establishing transgenic lines, a φ-C31 based integration 
system was used (Bischof et al. 2007). In this system, bacteriophage φ-C31 is 
ectopically expressed in the germ-line where it mediates site-specific 
recombination between attB sites on the vector and attP site on the 
chromosome. Vectors were injected into Drosophila strain (y[1] M{vas-int.Dm}
ZH-2A w[*]; M{3xP3-RFP.attP}ZH-86Fb) which has an attP site docking site on 
the 3rd chromosome. The vector contains the white+ marker gene, that will be 
expressed upon successful integration of the construct. After injection of vectors 
into embryos, the F0 generation of flies was crossed with a w1118 isogenic strain, 
to make sure the integrase is removed. The F1 generation was screened for 
orange eyes. Flies with orange eyes were crossed between each other to 
produce flies with red eyes that are homozygous for the UAS constructs. 
Successful integration of constructs was confirmed by genomic DNA isolation 
(3.2.2.2) and sequencing. Injections into embryos were performed in 
collaboration with Christina Rathke’s lab. 
3.2.5.2. Ectopic expression of dMi-2 WT and mutants in fly wing
In order to determine potential consequences of selected dMi-2 mutations on 
cell differentiation, lines carrying UAS constructs were crossed with the 
engrailed driver strain. Engrailed (en) encodes a transcription factor that is 
important for the determination of posterior segments of the Drosophila wing 
(McNeill, 2000). Using this fly strain directs the ectopic expression of dMi-2 WT 
and mutants to the posterior part of the wing. Virgin female flies were collected 
from the engrailed driver strain and crossed to males from the UAS responder 
strain. Parental flies were discarded after 3-4 days. About 2 weeks after 
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crossing, the progeny of the engrailed-UAS cross hatched. Changes in the 
posterior part of the wing were analysed by microscopy. 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4. Results
4.1. Biochemical characterisation of cancer derived 
dMi-2 point mutants
4.1.1. Sequence homology between dMi-2 and hCHD4
In order to investigate the sequence homology levels between dMi-2 and 
hCHD4 and to determine if cancer affected amino acid residues are conserved 
between the two proteins, I used the CLUSTAL-Omega protein sequence 
alignment program. High sequence similarity was found in conserved domains, 
such as the PHD fingers, chromodomains and the ATPase domain. All affected 
residues are mostly falling within these highly conserved domains.
  
A
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Figure 4.1. Sequence alignment of dMi-2 and hCHD4. 
(A) Part of sequence in green showing PHD finger 1 (amino acid residue 370 to 417 in CHD4 
and 377 to 424 in dMi-2) and PHD finger 2 (amino acid residue 449 to 496 in CHD4 and 437 to 
484 in dMi-2), in blue chromodomain 1 (amino acid residue 494 to 594 in CHD4 and 488 to 566 
in dMi-2) and chromodomain 2 (amino acid residue 622 to 697 in CHD4 and 612 to 673 in 
dMi-2), in red ATPase domain core 1 (amino acid residue 738 to 922 in CHD4 and 742 to 924 in 
dMi-2) and ATPase domain core 2 (amino acid residue 1054 to 1176 in CHD4 and 1056 to 1179 
in dMi-2). Cancer associated residues that are biochemically analysed in this study are 
indicated with black boxes. Conserved helicase motifs of the ATPase domain are indicated by 
black lines above the alignment. Brace indicated in purple, Brace-II, NegC and C-terminal 
bridge region in green. (B) Schematic overview of mutations analysed in this study. 
The sequence alignment revealed that many amino acids in functional domains 
and regions are conserved between CHD4 and dMi-2. Several mutations 
identified in these domains and regions were selected for further work. More 
specifically, the PHD finger mutant C452Y, chromodomain mutants V538F and 
R552Q, ATPase domain region mutants L914V, H1153R and R1164Q, as well 
as C-terminal region mutants H1198Y (brace) and L1217P (putative brace-II/
NegC/C-terminal bridge region) are analysed in this thesis (Figure 4.1 A and B) 
(Le Gallo et al. 2012, Zhao et al. 2013.).
4.1.2. Characterisation of mutations in the N-terminal region of 
dMi-2 and the Core 1 region
4.1.2.1. A PHD finger point mutant shows moderately reduced enzymatic 
activity
The PHD fingers of human CHD4 contact histone H3 and bind methylated 
H3K9 or unmodified H3K4 (Mansfield et al. 2011, Musselman et al. 2011). One 
of the cancer derived point mutations (Cys452Tyr in Drosophila) changes one of 
the key cysteines located in the second PHD finger. This cysteine is part of 
highly conserved Cys4His1Cys3 residues that are responsible for coordinating 
zinc ions (Zhao et al. 2012, Mansfield RE et al. 2011) (Figure 4.2.).
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Previous studies from Watson and colleagues have shown that deleting both 
PHD fingers of human CHD4 leads to moderately decreased ATPase activity, 
while Musselman and colleagues have shown that PHD fingers are required for 
CHD4 mediated repression (Watson et al. 2012, Musselman et al. 2011). 
Considering these findings, it was interesting to investigate the biochemical 
activity of this novel PHD finger point mutant.
A C452Y point mutation was introduced 
into dMi-2 by site-directed mutagenesis 
as described in 3.2.2.1 and the protein 
was expressed and pur ified as 
described in 3.2.3.1 and 3.2.3.2. 
Considering that dMi-2 is a nucleosome stimulated ATPase (Wang et al. 2001), 
it was incubated with polynucleosomes that were assembled on a plasmid 
containing 12x601 Widom nucleosome positioning sequences as described in 
3.2.4.3. When nucleosomes were added to the reaction there was a strong 
increase in ATP hydrolysis. C452Y mutant was tested in an ATPase assay to 
investigate if this PHD finger point mutation had any consequence on ATP 
hydrolysis. The C452Y point mutant retained about 50% of WT activity (Figure 
4.3.A). To test wether this reduced ability to hydrolyse ATP is due to the 
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Figure 4.2. Structure of the second 
PHD finger showing positon of C452 
in complex with H3 
Crystal structure showing the second PHD 
finger of human CHD4 (2L75) with the 
conserved Cys4His1Cys3 motif indicated in 
yellow with the affected cysteine residue 
indicated in pink. Part of histone H3 is 
indicated in green (Modified from Mansfield RE 
et al. 2011).
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protein's inability to properly coordinate ATP binding, I performed a filter binding 
assay with radioactively labelled ATP as described in 3.2.3.9. Briefly, samples 
were incubated with radioactively labelled ATP and incubated for 30 minutes at 
26°C. 2µL of each reaction was spotted on nitrocellulose membrane under 
vacuum and washed with BC100 buffer to remove unbound ATP. Membranes 
were airdried and exposed to a phosphpoimager screen and radioactive signals 
were quantified. Quantification of signals showed that the point mutant still 
retains ATP binding near the level of the WT protein (Figure 4.3.B and C). This 
indicates that the C452Y point mutant's reduced ATPase activity is probably not 
due to its inability to properly bind ATP. To determine if this point mutation is 
affecting the protein’s ability to interact with and bind nucleosomes, I 
implemented a nucleosome bandshift assay as deccribed in 3.2.4.6. In this 
assay it is possible to detect differences in nucleosome binding. An unbound 
nucleosome has a faster electrophoretic mobility than a nucleosome-protein 
complex, which allows the detection of nucleosome binding activity. In this case 
the dMi-2-nucleosome complex is mostly too large to enter the gel and it is 
retained in the loading well. When tested for nucleosome binding ability, the 
C452Y point mutant was indistinguishable from the WT protein, indicating that 
this point mutation is not affecting dMi-2's ability to interact with nucleosomes. 
(Figure 4.3.D)
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Figure 4.3. PHD finger point mutant retains ATP hydrolyis, ATP binding 
and nucleosome binding ability
(A) ATPase assay with saturating amounts of polynucleosomes assembled on a plasmid 
containing 12x601 Widom nucleosome positioning sequence. ATP hydrolysis levels of WT 
protein compared to C452Y in presence (+) or abscence of polynucleosomes (-) are shown. 
Error bars represent SEM and are derived from 3 independent experiments. (B) ATP binding 
assay of sample without protein (1), WT protein (2) and C452Y point mutant (3) in presence of 
radioactive ATP. (C) Quantification of data from B, IgG served as negative control. (D) 
Nucleosome binding assay with 150nM of end positioned mononucleosome assembled on 601 
Widom sequence with 80bp DNA overhang, incubated with decreasing amounts (900nM, 
450nM, 225nM and 113nM) of dMi-2 WT (lanes 2-5) and C452Y point mutant (lanes 6-9). 
To test whether nuleosome remodeling activity was affected by the point 
mutation, a nucleosome sliding assay and a restriction enzyme accessibility 
assay (REA) were performed as described in 3.2.4.5 and 3.2.4.6. The 
nucleosome sliding assay was performed with two different nucleosomal 
templates, an end positioned mononucleosome (0-77) and a centrally 
positioned mononucleosome (77-77), to determine potential preferences of the 
mutant for differently positioned nucleosomes. These assays allow the detection 
of changes in nucleosome positioning that significantly alter nucleosome 
electrophoretic mobility. Nucleosomes were incubated with increasing amounts 
of protein and incubated for 45 minutes at 26°C. Reactions were stopped with 
competitor DNA, loaded on a 5% native polyacrylamide gel and run at 120V for 
approximately 3 hours. The samples with dMi-2 WT without ATP were included 
in the experiment to ensure that any nucleosome mobilisation detected is ATP 
dependent (Figure 4.4.A. Lanes 2-5). It is noticeable that the dMi-2 WT protein 
slides the nucleosome from the end (Figure 4.4.A. Lanes 6-9, lower bands) to 
more central positions (upper bands) with increasing protein concentrations. 
This is demonstrated by formation of three differently positioned 
mononucleosomes with decreased gel mobility, indicating shifts to more central 
positions. The dMi-2 C452Y point mutant displayed noticably diminished 
remodelling ability. This is shown by reduced population of centrally positioned 
nucleosomes at the two highest concentrations of C452Y used. (Figure 4.4.A.; 
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compare lanes 6 and 7, with lanes 10 and 11). Similar observations were made 
with the centrally positioned nucleosomal template that has 77 base pairs 
extending from each side of the nucleosome. Here, the centrally positioned 
nucleosome (highest band) was shifted towards the end of the DNA fragment 
(lowest bands) (Figure 4.4.B). While WT protein is able to slide nucleosomes 
from the center towards the end of DNA fragment at lower protein concetrations 
(Figure 4.4.B.; lanes 6-7), C452Y required higher protein concentration to 
achieve the same pattern of remodelling.
In order to more directly quantify the difference in remodelling activity, I 
performed an REA (restriction enzyme accessibility) assay (Kreher et al. 2017, 
Bouazoune and Kingston 2012, Narlikar et al. 2001, Logie and Peterson, 1997). 
With this assay it is possible to measure the ability of a remodeller to expose a 
MfeI restriction site (+28bp inside the nucleosome) that is usually protected by 
the nucleosome, as described in 3.2.4.5. This provides a more quantitive way of 
monitoring the remodelling reaction compared to the nucleosome sliding assay, 
since the REA assay couples the activity of the nucleosome remodeller that 
exposes DNA with the restriction enzyme that immediately and irreversibly cuts 
the exposed DNA. This way the amount of exposed DNA - as a measure of 
remodeling activity - can be monitored by quantifying the corresponding DNA 
fragment on the gel.
Radioactively body-labelled nucleosomes (20nM) were incubated with a 
constant concentration of protein (115nM) in presence of saturating amounts of 
MfeI restriction enzyme. Time points were taken at 5, 10, 20 and 40 minutes. 
With WT protein (Figure 4.4.C.; middle panel)  an increased percentage of DNA 
was cut over time, indicating that there is increased remodelling, as shown in 
the quantification panel (Figure 4.4.D.) Unlike the WT protein, the C452Y 
mutant showed a reduced remodelling ability, which results in a reduced 
exposure of MfeI restriction site (Figure 4.5.C.; lower panel and Figure 4.4.D.). 
All together, these results show that reduced hydrolysis levels, due to a PHD 
finger point mutation, correlate with reduced remodelling activity, suggesting the 
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possibility that remodelling is reduced due to reduction of ATP hydrolysis. This 
further emphasises the importance of PHD fingers for dMi-2 enzymatic activity.
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Figure 4.4. dMi-2 C452Y remodells nucleosomes in vitro 
(A) Nucleosome sliding assay with 150nM of ‘0-77’ end positioned mononucleosome incubated 
with decreasing amounts of protein (900nM, 450nM, 225nM, 113nM) incubated at 26°C for 45 
min. Samples without ATP were incubated with the aforementioned amounts of WT protein 
(Lanes 2-5). Rections were stopped with addition of 2 µg of competitor DNA and incubated for 
10 min on ice. Black star indicates a nucleosome-protein complex that was formed in the 
reaction independent of remodelling. All panels shown are derived from the same experiment, 
except C452Y. Gels were stained with SYBR Gold reagent. (B) Nucleosome sliding assay with 
150nM of ’77-77’ centrally positioned mononucleosome with increasing amounts of protein 
(900nM, 450nM, 225nM, 113nM) incubated at 26°C for 45 min. Samples without ATP were 
incubated with the aforementioned amounts of WT protein (Lanes 2-5). Reactions were stopped 
with addition of 2 µg of competitor DNA and incubated for 10 min on ice. Gels were stained with 
SYBR Gold reagent. Black star indicates a nucleosome-protein complex that was formed in the 
reaction independent from remodelling. (C) REA assays of WT (middle panel), C452Y mutant 
(lower panel) and samples with no remodeller (upper panel). Radioactively labelled DNA was 
visualised by exposing the gels to Phosphoimager screen. (D) Quantification of gel from C. Cut 
and uncut DNA was quantified and ratio of cut and total DNA (cut plus uncut) was plotted as ‘% 
DNA cut’. Error bars represent SEM and are derived from 3 independent experiments. Plotting 
was done in GraphPad Prism using the one phase decay equation. 
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4.1.2.2. Chromodomain point mutants show severely impaired enzymatic 
activity
Many chromodomain containing proteins bind methylated histone tails, like HP1 
(Jacobs et al. 2001, Schwartz and Pirrotta, 2007). It has been shown by our lab 
that the dMi-2 chromodomains bind the nucleosome through contacts with 
nucleosomal DNA. Deletion of both chromodomains causes a significant 
reduction in dMi-2 binding to nucleosomal DNA (Bouazoune et al. 2002). Two 
distinct mutations in the chromodomains were identified in CHD4 by exome 
sequencing (Le Gallo et al. 2012.). These mutations were separately introduced 
into dMi-2 by site directed mutagenesis and the enzyme was purified as 
described in 3.2.3.1 and 3.2.3.2. Val538Phe and Arg552Gln (from here on 
referred to as V538F and R552Q) are located in the first chromodomain of 
dMi-2. These point mutations were tested for their impact on the ATPase 
activity. An ATPase assay was performed as described in 3.2.4.3. and 4.1.2.1. 
Upon incubation with radioactively labelled ATP and polynucleosomes ATP 
hydrolysis by both mutants was severely reduced. This suggested that both 
mutated residues could have a direct role in ATP hydrolysis or that the 
mutations result in structural changes that have a negative effect on ATP 
hydrolysis. (Figure 4.5.A). A filter binding assay was used to investigate if these 
point mutations have an effect on ATP binding. The experiment was performed 
as described in 3.2.3.9. and 4.1.2.1. Quantification showed that both mutants 
still retain ATP binding ability. ATP binding by R552Q was more reduced and it 
measured 31% of WT protein ATP binding ability. On the other hand, V538F 
showed ATP binding levels similar to WT protein, measured at 90% of WT ATP 
binding ability (Figure 4.5.B and C). Given that deletion of the double 
chromodomain region abrogates nucleosome binding (Boauzoune et al. 2002) it 
was interesting to test if the two point mutations in the chromodomain were 
sufficient to affect nucleosome and DNA binding. Nucleosome bandshift 
experiments were performed as described in 3.2.4.6. and 4.1.2.1. DNA 
bandshift assays were performed the same way as the nucleosome bandshift, 
except naked DNA fragments were used, as described in 3.2.4.6. Interestingly, 
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both DNA (Figure 4.5.D) and nucleosome binding (Figure 4.5.E) were retained 
by the chromodomain mutants, but reduced. This reduction was most noticable 
at the two highest protein concentrations. Comparing the two highest protein 
concentrations used in the nucleosome binding assay (Figure 4.5.D) between 
WT (lane 2 and 3), V538F (lane 6 and 7) and R552Q (lane 10 and 11) it is 
noticeable that R552Q and especially V538F have reduced binding to 
nucleosome, discernible by less nucleosome-protein complex that is shifted 
upwards in the gel. Similar observations were made with the DNA bandshift 
assay (Figure 4.5.E). Again, it is visible at the two highest concentrations that 
both point mutants have reduced binding to the DNA. When comparing WT 
(lanes 2 and 3) with V538F (lanes 6 and 7) and R552Q (lanes 10 and 11), both 
mutants display weaker binding to the DNA than the WT. This is visualized by 
less DNA forming DNA-protein complexes. These results show that both 
mutations have an impact on formation of DNA - protein or nucleosome - protein 
complexes. This difference could be the result of changes in direct contact that 
the mutated residues have with the nucleosome or DNA, or of structural 
changes in the chromodomain, such that direct contact by other residues are 
weakened. 
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Figure 4.5. Chromodomain point mutants are severly impared in ATP 
hydrolysis, but retain ATP, DNA and nucleosome binding with moderately 
reduced affinity
(A) ATPase assay with saturating amounts of polynucleosomes assembled on a plasmid 
containing 12x601 Widom nucleosome positioning sequences. ATP hydrolysis levels of WT 
protein compared to V538F and R552Q in presence (+) or abscence of polynucleosomes (-) are 
shown. Error bars represent SEM and are derived from 3 independent experiments. (B) ATP 
binding assay of sample without protein (1)WT protein (2), V538F point mutant (3) and R552Q 
point mutant (4). (C) Quantification of data from B, IgG served as a negative control. (D) 
Nucleosome binding assay with 150nM of end positioned mononucleosome assembled on 601 
Widom sequence with 80bp DNA overhang, incubated with decreasing amounts (900nM, 
450nM, 225nM and 113nM) of dMi-2 WT (lane 2-5) and V538F point mutant (lanes 6-9) and 
R552Q point mutant (lanes 10-13). (E) DNA binding assay with 150nM of end positioned 
mononucleosome assembled on 601 Widom sequence with 80bp DNA overhang, incubated 
with decreasing amounts (900nM, 450nM, 225nM and 113nM) of dMi-2 WT (lanes 2-5),  V538F 
point mutant (lanes 6-9) and R552Q point mutant (lanes 10-13).
In order to examine how these chromodomain mutations impact the protein’s 
capability to remodel nucleosomes, REA and nucleosome sliding assays were 
carried out. Experiments were performed as described in 3.2.4.4, 3.2.4.5. and 
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4.1.2.1. Nucleosome sliding assays were performed with end positioned and 
centrally positioned nucleosomes. Again, nucleosomes were incubated with 
decreasing amounts of WT protein and the two chromodomain point mutants. 
Unlike WT dMi-2, chromatin remodelling by R552Q was undetectable in this 
assay. Nucleosome sliding to more cental positions is indicated by formation of 
a nucleosome with slower electrophoretic ability. For R552Q there was no 
detectable formation of centrally positioned nucleosomes (Figure 4.6.A. Lane 
14-17). The V538F chromodomain point mutant displayed severely reduced 
levels of remodelling, but unlike R552Q, low nucleosome sliding levels could be 
detected. V538F was able to slide nucleosomes to more central positions which 
was reflected by formation of nucleosomes with slower electrophoretic mobility 
(Figure 4.6.A. Lanes 10-13). Similar observations were made when incubating 
chromodomain mutants with centrally positioned nucleosomes. Nucleosomes 
were incubated with decreasing amount of protein. At the highest concentration 
of protein, 5 distinct nucleosomal positions were generated (Figure 4.6.B. Lanes 
6-9). Nucleosomes with faster electrophoretic mobility have the nucleosome 
shifted more to the end of the DNA fragment. The V538F point mutant showed 
modest remodelling ability by producing two bands of end positioned 
nucleosomes with faster electrophoretic mobility (Figure 4.6.B. Lanes 10-13). 
For the R552Q point mutant similar results as with end positioned nucleosomes 
were obtained: No nucleosome sliding was observed (Figure 4.6.B Lane 14-17). 
To more directly quantify these effects, REA assays were carried out. A constant 
amount of protein was incubated with radioactively labelled, end positioned 
nucleosomes and the reaction was stopped at different time points. Compared 
with the WT, no apparent remodelling was observed for either of the 
chromodomain mutants (Figure 4.6.C and D). Unlike in the nucleosome sliding 
assay, V538F showed no detectable remodelling in this assay. This might be 
due to the inability of this point mutant to remodel nucleosome enough to fully 
expose the MfeI restriction site. The R552Q point mutant showed no apparent 
remodelling, consistent with results obtained in nucleosome sliding assays. This 
analysis of chromodomain mutants showed that even one point mutation in the 
chromodomain might have an impact on dMi-2's ability to contact the 
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nucleosome and properly position itself for subsequent ATP hydrolysis and 
chromatin remodelling. When superimposing V538 and R552 onto the yeast 
CHD1 crystal structure it is noticeable how these two residues are flanking a 
recently identified basic loop (Figure 4.6.E). This loop was shown to cross link 
to nucleosomal DNA (Nodelman et al. 2017). It is possible that the mutations 
affect the interaction of the basic loop of CHD remodeler and the nucleosome.
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Figure 4.6. Chromodomain point mutanats are impaired for remodelling in 
vitro
(A) Nucleosome sliding assay with 150nM of ‘0-77’ end positioned mononucleosome incubated 
with decreasing amounts of protein (900nM, 450nM, 225nM, 113nM) incubated at 26°C for 45 
min. Samples without ATP were incubated with the aforementioned amounts of WT protein 
(lanes 2-5). Reactions were stopped with addition of 2 µg of competitor DNA and incubated for 
10 min on ice. Black star indicates nucleosome-protein complex that was formed in the reaction 
independent of remodelling. All panels shown are derived from the same experiment. Gels were 
stained with SYBR Gold reagent. (B) Nucleosome sliding assay with 150nM of ’77-77’ centrally 
positioned mononucleosome with increasing amounts of protein (900nM, 450nM, 225nM, 
113nM) incubated at 26°C for 45 min, stained with SYBR Gold reagent. Samples without ATP 
were incubated with aforementioned amounts of WT protein (lanes 2-5). Reactions were 
stopped with addition of 2 µg of competitor DNA and incubated for 10 min on ice. Gels were 
stained with SYBR Gold reagent. Black star indicates nucleosome-protein complex that was 
formed in the reaction independent from remodelling. (C) REA assays of WT, V538F and 
R552Q mutants and samples with no remodeller. Radioactively labelled DNA was visualised by 
exposing the gels to Phosphoimager screen. (D) Quantification of gel from C. Cut and uncut 
DNA was quantified and ratio of cut and total DNA (cut plus uncut) was plotted as ‘% DNA cut’. 
Error bars represent SEM and are derived from 3 independent experiments. Plotting was done 
in GraphPad Prism using the one phase decay equation. (E) yCHD1 structure (3MWY) with 
basic loop of chromodomain 1 indicated with green and superimposed relative positions of V538 
and R552 in yellow (Chromodomain 1 in light blue, chromodomain 2 in cyan, ATPase domain 
core 1 orange red, ATPase domain core 2 in red).
4.1.2.3. Core 1 region point mutant Leu914Val shows significantly reduced 
enzymatic activity
The core 1 region, with its helicase motifs I, Ia, II, and III, is responsible for 
important mechanistic aspects of enyzmatic function. Successful interplay 
between the two cores and their motifs is crucial for catalytic activity (more in 
chapter 2.2.3.). One of the point mutations identified in endometrial cancer 
exome sequencing was Leu914Val (from here on referred to as L914V), a 
mutation located in the core 1 domain in close proximity to helicase motif III 
(Figure 4.1.A). This point mutation was introduced into dMi-2 by site-directed 
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mutagenesis as described in 3.2.2.1 and the protein was expressed and 
purified as described in 3.2.3.1 and 3.2.3.2. An ATPase assay was performed to 
quantify ATP hydrolysis compared to WT protein. The ATPase activity of the 
L914V mutant was reduced to around 10% of WT activity. Since the ATP 
binding pocket is located in the core 1 region (helicase motifs I and II), I 
investigated whether this point mutation has an effect on ATP binding. ATP 
binding ability of the mutant was at 64% of WT binding ability. This suggests 
that the severe impact on ATP hydrolysis is seemingly not only due to the 
impact on ATP binding. I examined if the reduced ATP hydrolysis was due to the 
mutant’s inability to efficiently bind nucleosomes, for which I performed 
nucleosome bandshift assays (as described in 3.2.4.6) where decreasing 
amounts of protein were incubated with +80 mononucleosomes (Figure 4.7.D.). 
An effect on nucleosome binding of the L914V mutation was noticable at the 
450nM concentration of the point mutant (Figure 4.7.D., lane 7). At this 
concentration a significant amount of nucleosomes remained unbound whereas 
this was not the case for WT dMi-2 (Figure 4.7.D., lane 3).
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Figure 4.7. Core1 region point mutant L914V is significantly impaired in 
ATP hydrolysis, but retains ATP and nucleosome binding
(A) ATPase assay with saturating amounts of polynucleosomes assembled on a plasmid 
containing 12x601 Widom nucleosome positioning sequences. ATP hydrolysis levels of WT 
protein compared to L914V in presence (+) or abscence of polynucleosomes (-) are shown. 
Error bars represent SEM and are derived from 3 independent experiments. (B) ATP binding 
assay of sample without protein (1), WT protein (2) and L914V point mutant (3). (C) 
Quantification of data from B, IgG served as a negative control. (D) Nucleosome binding assay 
with 150nM of end positioned mononucleosome assembled on 601 Widom sequence with 80bp 
DNA overhang, incubated with decreasing amounts (900nM, 450nM, 225nM and 113nM) of 
dMi-2 WT (lanes 2-5) and L914V point mutant (lanes 6-9). 
After establishing that L914V is still binding nucleosomes, I wanted to determine 
if the significant impact on ATP hydrolysis, also reflects on the point mutant’s 
capability to remodel nucleosomes. Once again, nucleosome sliding and REA 
assays were carried out on 0-77 end-positioned, 77-77 centrally positioned and 
+80 end positioned nucleosomes. When the nucleosome sliding assay was 
performed on 0-77 end positioned nucleosomes, formation of a nucleosome 
with slower electrophoretic mobility was observed at the highest concentration 
of protein. This indicated a sliding of a nucleosome to a more centrally 
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positioned location (Figure 4.8.A Lane 10). This was well in line with ATPase 
activity of this mutant, indicating that the decreased ability to efficiently 
hydrolyse ATP is a possible reason for decreased remodelling activity. 
Incubating the mutant with centrally positioned nucleosome did not produce any 
noticable formation of more end postioned nucleosome, showing that end 
positioned nucleosome is a prefered substrate (Figure 4.8.B). To quantify these 
results, an REA assay was performed, as described previously (3.2.4.5). No 
detectable remodelling was observed (Figure 4.8.D). Again, this might be due to 
the inability of L914V to remodel nucleosomes enough to expose the MfeI 
restriction site. Analysis of this mutant showed that while still retaining the ability 
to perform ATP hydrolysis, albeit at very low levels of 10% WT protein 
hydrolysis activity, it was severly impaired in its remodelling ability. Extremely 
low levels of remodelling were detected for end positioned nucleosomes, while 
centrally positioned nucleosomes showed no apparent remodelling; it was also 
not able to expose nucleosomal DNA to the MfeI restriction enzyme in the REA 
assay. This indicates an important role of the L914 residue for ATP hydrolysis 
and chromatin remodelling. 
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Figure 4.8. L914V point mutant is severly affected in its remodelling ability
(A) Nucleosome sliding assay with 150nM of ‘0-77’ end positioned mononucleosome incubated 
with decreasing amounts of protein (900nM, 450nM, 225nM, 113nM) incubated at 26°C for 45 
min. Samples without ATP were incubated with the aforementioned amounts of WT protein 
(Lanes 2-5). Reactions were stopped with addition of 2 µg of competitor DNA and incubated for 
10 min on ice. Black star indicates nucleosome-protein complex that was formed in the reaction 
independent from remodelling. All panels shown are derived from same experiment. Gels were 
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stained with SYBR Gold reagent. (B) Nucleosome sliding assay with 150nM of ’77-77’ centrally 
positioned mononucleosome with increasing amounts of protein (900nM, 450nM, 225nM, 
113nM) incubated at 26°C for 45 min. Samples without ATP were incubated with the 
aforementioned amounts of WT protein (Lanes 2-5). Reactions were stopped with addition of 2 
µg of competitor DNA and incubated for 10 min on ice. Gels were stained with SYBR Gold 
reagent. Black star indicates nucleosome-protein complex that was formed in the reaction 
independent from remodelling. (C) REA assays of WT, L914V and samples with no remodeller. 
Radioactively labelled DNA was visualised by exposing the gels to Phosphoimager screen. (D) 
Quantification of gel from C. Cut and uncut DNA was quantified and ratio of cut and total DNA 
(cut plus uncut) was plotted as ‘% DNA cut’. Error bars represent SEM and are derived from 3 
independent experiments. Plotting was done in GraphPad Prism using one phase decay 
equation.
4.1.2. Characterisation of mutations in the Core 2 domain and in 
the region adjacent to core 2
Core 2 domain contains motifs IV, V and VI are important for nucleic acid 
binding, translocation along the DNA and binding of the ATP. Interaction 
between these motifs and core 1 motifs are crucial for efficient ATP hydrolysis 
and chromatin remodelling (Flaus et al. 2006, Liu et al. 2017). Furthermore, the 
region adjacent to core 2 on its C-terminal side has a regulatory role in many 
chromatin remodellers (Hauk et al. 2010, Clapier and Cairns, 2012, Liu et al. 
2017). In this study several cancer derived point mutants in core 2 and its C 
terminal adjacent region were biochemically analysed. 
4.1.2.3. Core 2 region point mutants His1153Arg and Arg1164Gln show a 
variety of effects on enzymatic activity
His1153 and Arg1164 are both located in a highly conserved part of the core 2 
region. His1153 is located between motifs V and VI, while Arg1164 is part of the 
helicase motif VI (arginine fingers) and it is involved in the interaction with core 
1 domain motif I during ATP hydrolysis (Liu et al. 2017. Flaus et al. 2006) 
(Figure 4.1.A). Considering the functional relevance and the level of 
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conservation of these residues, biochemical effects of two cancer derived point 
mutations were analysed - His1153Arg (from here on referred as H1153R) and 
Arg1164Gln (from here on referred as R1164Q). Point mutations were 
introduced into dMi-2 by site-directed mutagenesis as described in 3.2.2.1 and 
proteins were expressed and purified as described in 3.2.3.1 and 3.2.3.2. 
ATPase assay analysis showed very different effects of these point mutations. 
The H1153R mutant had moderately decreased ATPase activity of about 
60-70% of WT activity. R1164Q had a more severe effect on ATP hydrolysis: its 
ATP hydrolysis levels were decreased to 18% (Figure 4.9.A). I assessed the 
ATP binding activity of both mutants and found that they both retained their 
ability to bind ATP, although to a different extent; H1153R had moderately 
reduced ATP binding of 66% of WT binding activity, while the binding activity of 
R1164Q was increased to about 150% of WT binding activity. This indicates that 
the decreased ATPase activity of the R1164Q mutant can not be attributed to 
reduced ATP binding (Figure 4.9. B and C). Next, I investigated the impact of 
these mutations on dMi-2's ability to bind nucleosomes by nucleosome 
bandshift assays (3.2.4.6). Like WT dMi-2, both point mutants shifted the 
nucleosomes quantitatively at the two highest protein concentrations used 
(Figure 4.9. D, Lane 2-3, 6-7 and 10-11). This shows that the ability to bind 
nucleosome was not affected by these mutations.
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Figure 4.9. Core 2 region point mutants H1153R and R1164Q show distinct 
effects on ATP hydrolysis, but no significant effect on ATP binding, and 
retain nucleosome binding
(A) ATPase assay with saturating amounts of polynucleosomes assembled on a plasmid 
containing 12x601 Widom nucleosome positioning sequences. ATP hydrolysis levels of WT 
protein compared to H1153R and R1164Q point mutant in presence (+) or abscence of 
polynucleosomes (-) are shown. Error bars represent SEM and are derived from 3 independent 
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experiments. (B) ATP binding assay of sample without protein (1), WT protein (2) H1153R (3) 
and R1164Q (4). (C) Quantification of data from B, IgG served as negative control. (D) 
Nucleosome binding assay with 150nM of end positioned mononucleosome assembled on 601 
Widom sequence with 80bp DNA overhang, incubated with decreasing amounts (900nM, 
450nM, 225nM and 113nM) of dMi-2 WT (lanes 2-5) H1153R point mutant (lanes 6-9) and 
R1164Q point mutant (lane 10-13).
Furthermore, nucleosome sliding and REA assays were carried out to 
determine the effects of these mutations on dMi-2’s remodelling ability. In 
nucleosome sliding assays with end positioned mononucleosomes the R1164Q 
mutant was able to form an additional nucleosome position with slower 
electrophoretic mobility at the highest concentration of protein. This indicated 
movement of a nucleosome over a short distance to more central positon. 
(Figure 4.10.A. - lane 14). Suprisingly, H1153R was not able to slide 
nucleosomes (Figure 4.10.A. Lane 10-13). With centrally positioned 
nucleosomes, similar results were obtained; there was no apparent remodelling 
observed for H1153R as in the experiment with end positioned nucleosome. 
(Figure 4.10.B. Lane 10-13). Also, for R1164Q no remodelling was detected, 
indicating again that centrally positioned nucleosomes are less favourable 
substrates for dMi-2. (Figure 4.10.B) To verify and quantify these results, I 
performed REA assays with radioactively labelled end positioned nucleosomes, 
where similar results were observed; no detectable remodelling for H1153R, 
and about 2% remodelled nucleosomes for R1164Q mutant at the last time 
point. (Figure 4.10.C and D). 
In summary, the analysis of these two mutants which fall within core 2 domain 
showed different effects of these point mutations on dMi-2's enzymatic function. 
The arginine finger mutant R1164Q was significantly affected by this point 
mutation, with both drastically reduced ATP hydrolysis and remodelling 
activities. The other core 2 domain mutant - H1153R - showed varying effects 
on its enzymatic functions. While retaining more more than 60% of ATPase 
capability, it was not able to remodel end positioned, nor centrally positioned 
nucleosomes. These results confirm the importance of arginine finger motif VI 
 103
RESULTS
for chromatin remodelling and ATP hydrolysis. Moreover, they identify a mutant, 
H1153R, which decouples ATP hydrolysis from chromatin remodelling, 
indicating the importance of this residue for bringing these two different 
enzymatic functions together.
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Figure 4.10. Core 2 region mutants show impaired chromatin remodelling 
(A) Nucleosome sliding assay with 150nM of ‘0-77’ end positioned mononucleosome incubated 
with decreasing amounts of protein (900nM, 450nM, 225nM, 113nM) incubated at 26°C for 45 
min. Samples without ATP were incubated with the aforementioned amounts of WT protein 
(Lanes 2-5). Rections were stopped with addition of 2 µg of competitor DNA and incubated for 
10 min on ice. Black star indicates nucleosome-protein complex that was formed in the reaction 
independent of remodelling. All panels shown are derived from same experiment. Gels were 
stained with SYBR Gold reagent. (B) Nucleosome sliding assay with 150nM of ’77-77’ centrally 
positioned mononucleosome with increasing amounts of protein (900nM, 450nM, 225nM, 
113nM) incubated at 26°C for 45 min. Samples without ATP were incubated with the 
aforementioned amounts of WT protein (Lanes 2-5). Reactions were stopped with addition of 2 
µg of competitor DNA and incubated for 10 min on ice. Gels were stained with SYBR Gold 
reagent. Black star indicates nucleosome-protein complex that was formed in the reaction 
independent from remodelling. (C) REA assays of WT, H1153R, R1164Q and sample with no 
remodeller. Radioactively labelled DNA was visualised by exposing the gels to Phosphoimager 
screen. (D) Quantification of gel from C. Cut and uncut DNA was quantified and ratio of cut and 
total DNA (cut plus uncut) was plotted as ‘% DNA cut’. Error bars represent SEM and are 
derived from 3 independent experiments. Plotting was done in GraphPad Prism using one 
phase decay equation.
0 10 20 30 40
0
5
10
15
20
25
Control (no enzyme)
dMi-2 WT
dMi-2_H1153R
dMi-2_R1164Q
Time (min)
%
D
N
A 
cu
t
D
H1153R
R1164Q
Control - no enzyme
WT
t (min)     5         10       20       40
uncut DNA
cut DNA
uncut DNA
cut DNA
uncut DNA
cut DNA
uncut DNA
cut DNA
C
 105
RESULTS
4.1.2.3. Mutations adjacent to the Core 2 region of the ATPase domain 
show remarkably diverse effects on enzyme activity
Residues adjacent to the core 2 region have been shown to play a regulatory 
role in several different chromatin remodellers (Sen et al. 2011, Clapier and 
Cairns, 2012). In yeast CHD1 the C-terminal bridge connects both core regions 
of the ATPase domain (Hauk et al. 2010). In ISWI, the corresponding region 
forms the NegC domain which negatively regulates remodeling activity (Clapier 
and Cairns, 2012, Yan et al. 2016). In yeast SNF2 the corresponding region 
forms two alpha helices called Brace-I and Brace-II which together regulate 
remodelling activity. Two different mutations in this region of dMi-2 were 
biochemically analyzed. Leu1217Pro (from here on referred as L1217P) which 
resides in the putative Brace-II/NegC/C-terminal bridge region and His1198Tyr 
(H1198Y) which falls within the putative Brace region of dMi-2 (Figure 4.1.A). 
Point mutations were introduced into dMi-2 by site-directed mutagenesis as 
described in 3.2.2.1 and proteins were expressed and purified as described in 
3.2.3.1 and 3.2.3.2. ATPase assays were performed and the activities of mutant 
dMi-2 was compared to the activity of WT protein. Interestingly, the two 
mutations showed remarkably different effects on ATPase function; while 
H1198Y was almost indistinguishable from WT with approximately 90% of WT 
ATPase activity, L1217P showed extremely low levels of hydrolysis (Figure 
4.11). I analysed ATP binding of both mutants and found that they both fully 
retained their ability to bind ATP, showing that decreased ATPase activity of the 
L1217P mutant is not due to inability to bind ATP. When testing these point 
mutants in nucleosome bandshift assays, H1198Y bound nucleosomes with 
affinity equivalent to the WT protein. At the same time, the L1217P mutant 
displayed a moderately reduced affinity in binding to the nucleosome. At 
concentrations of 450nM and 225nM of L1217P protein the reduction in the 
binding to the nucleosome is readily apparent (Figure 4.11 D compare lanes 3 
and 4 with 11 and 12).
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Figure 4.11. Mutants in Core 2 region differ in ATP hydrolysis, while 
retaining WT levels of ATP and nucleosome binding 
(A) ATPase assay with saturating amounts of polynucleosomes assembled on a plasmid 
containing 12x601 Widom nucleosome positioning sequences. ATP hydrolysis levels of WT 
protein compared to H1198Y and L1217P point mutant in presence (+) or abscence of 
polynucleosomes (-) are shown. Error bars represent SEM and are derived from 3 independent 
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experiments. (B) ATP binding assay of sample without protein (1), WT protein (2) H1198Y (3) 
and L1217P (4) point mutant. (C) Quantification of data from B, IgG served as negative control. 
(D) Nucleosome binding assay with 150nM of end positioned mononucleosome assembled on 
601 Widom sequence with 80bp DNA overhang, incubated with decreasing amounts (900nM, 
450nM, 225nM and 113nM) of dMi-2 WT (lanes 2-5) H1198Y point mutant (lanes 6-9) and 
L1217P point mutant (lanes 10-13).
In order to determine their remodelling ability, I tested the mutants in 
nucleosome sliding and REA assays. Remarkably, in nucleosome sliding 
assays with end positioned mononucleosomes, the H1198Y mutant showed a 
higher remodelling capability than WT. H1198Y was able to move the histone 
octamer over a short distance at the lowest concentration of 14,12nM, while WT 
protein showed no detectable remodelling at concentrations lower than 56,5nM 
(Figure 4.12. A, lower panel, compare lanes 6-8, with lanes 13-15). At the higher 
concentration, it was observable that the WT protein preferred to slide 
nucleosomes from the end position to the central position (Figure 4.12.A, upper 
panel, lane 2-4). Unlike the WT protein, the H1198Y mutant generated a more 
equal distribution of nucleosomes at higher concentrations, suggesting that 
H1198Y slides nucleosomes both to the center and to the end of the DNA 
fragment with similar efficiency (Figure 4.13. A, lower panel, lanes 9-12). Similar 
results were obtained with centrally positioned nucleosomes. Moreover, the 
H1198Y mutant produced additional nucleosome positions with higher 
electrophoretic mobility, indicating a shift to the very end of the DNA fragment 
(Figure 4.12. B). In stark contrast, no remodelling was detected for the L1217P 
mutant using end or centrally positioned nucleosomes (Figure 4.12. A, lanes 
10-13, Figure 4.12. C, lanes 14-17). To confirm the results from the sliding 
assays, the point mutants were analysed in the REA assay. Again, H1198Y 
exposed the MfeI restriction site to restriction enzyme more efficiently than the 
WT protein. At the 5 minute time point, when remodeling by WT dMi-2 can 
barely be detected, H1198Y had already remodelled about 10% of 
nucleosomes. At the 40 minute time point, WT protein had exposed about 20% 
of restriction sites to MfeI, while the H1198Y mutant had exposed about 50%. 
The L1217P mutant showed no detectable remodelling activity in the REA 
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assay. In conclustion, these results indicate that H1198Y belongs to the brace 
regulatory region of dMi-2, while L1217P resides in a new regulatory region of 
dMi-2 that is similar to the Brace-II/NegC/C-terminal bridge region of other 
remodelers.
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Figure 4.12. H1198Y and L1217P show remarkably different effects on 
chromatin remodelling 
(A) Nucleosome sliding assay with 150nM of ‘0-77’ end positioned mononucleosome incubated 
with decreasing amounts of WT and L1217P (900nM, 450nM, 225nM, 113nM) incubated at 
26°C for 45 min. Samples without ATP were incubated with the aforementioned amounts of WT 
protein (Lane 2-5). Rections were stopped with addition of 2 µg of competitor DNA and 
incubated for 10 min on ice. Black star indicates nucleosome-protein complex that was formed 
in the reaction independent from remodelling. All panels shown are derived from same 
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experiment. Gels were stained with SYBR Gold reagent. (B) Nucleosome sliding assay with 
150nM of ‘0-77’ end positioned mononucleosome incubated with decreasing amounts of WT 
and H1198Y (900nM, 450nM, 225nM, 113nM, 56,5nM, 28,25nM, 14,12 nM) incubated at 26°C 
for 45 min. Reaction was stopped with addition of 2 µg of competitor DNA and incubated for 10 
min on ice. Black star indicates nucleosome-protein complex that was formed in the reaction 
independent from remodelling. Gels were stained with SYBR Gold reagent. (C) Nucleosome 
sliding assay with ’77-77’ centrally positioned mononucleosome with increasing amounts of 
protein (900nM, 450nM, 225nM, 113nM) incubated at 26°C for 45 min. Samples without ATP 
were incubated with aforementioned amounts of WT protein (Lanes 2-5). Reaction was stopped 
with addition of 2 µg of competitor DNA and incubated for 10 min on ice. Gels were stained with 
SYBR Gold reagent. Black star indicates nucleosome-protein complex that was formed in the 
reaction independent from remodelling (D) REA assays of WT, H1198Y, L1217P and sample 
with no remodeller. Radioactively labelled DNA was visualised by exposing the gels to 
Phosphoimager screen. (E) Quantification of gel from C. Cut and uncut DNA was quantified and 
ratio of cut and total DNA (cut plus uncut) was plotted as ‘% DNA cut’. Error bars represent SEM 
and are derived from 3 independent experiments. Plotting was done in GraphPad Prism using 
the one phase decay equation.
4.2. In vivo analysis of dMi-2 cancer derived point 
mutants
The biochemical analysis uncovered that cancer derived point mutations cause 
a variety of different effects of dMi-2 enzymatic function. The mutants analysed 
have shown a plethora of effects, including loss or gain of function and 
uncoupling of ATP hydrolysis from chromatin remodeling. Since all mutations 
identified in endometrial cancer are heterozygous, this suggests that the 
mutants exert dominant negative or gain of function effects to contribute to 
oncogenesis. The next step in the analysis was to introduce these mutations 
into an in vivo system. This way it is possible to investigate if ectopic expression 
of mutants can affect cell proliferation and differentiation in Drosophila 
melanogaster.
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4.2.1. Ectopic expression of dMi-2 point mutants using the UAS/
GAL4 system
After biochemical analysis of dMi-2 mutants, the question remained how are 
these biochemical effects manifested in an in vivo system? To answer that 
question, selected point mutants were introduced to Drosophila. C-terminally 
FLAG tagged dMi-2 WT and point mutants of interest were subcloned into the 
pUASt-attB target vector by Topo cloning and the Gateway system as described 
in 3.2.5.1. Using these plasmid constructs, transgenic flies carrying inducible 
UAS-dMi-2 WT or point mutant were created using the φ-C31 based integration 
system. In brief, vectors were injected into Drosophila embryos containing an 
attP docking site on the 3rd chromosome (3.2.5.1). Successful vector 
transformation into flies was confirmed by genomic DNA isolation and 
sequencing as described in 3.2.2.2. In the UAS/GAL4 expression system, the 
transgene of interest is under control of UAS (upstream activating sequence) 
sites that contain GAL4 binding sites. In order for the transgene to be 
expressed, flies carrying the transgene need to be crossed with driver lines 
containing an appropriate GAL4 gene, that will direct expression of the 
transgene to a particular tissue. In this study a GAL4 driver line called engrailed 
was used to direct the ectopic expression of dMi-2 to the posterior part of the 
developing wing. 5 different mutants - C452Y, R1164Q, L1217P, H1153R, 
H1198Y - and WT were used for ectopic expression in flies. Crosses were 
performed as described in 3.2.5.1 and the progeny of crossed flies was 
analysed for changes in posterior wing phenotype. The analysis of flies 
ectopically expressing WT dMi-2 revealed gain of posterior cross vein (PCV) 
material (Figure 4.13 A and C). This was an indication that it is possible to 
disrupt the differentiation of the PCV by an increase in dMi-2 activity. Ectopic 
expression of dMi-2 point mutants led to several different PCV phenotypes. 
These were divided into two main categories - gain of PCV and loss of PCV 
vein phenotype. The gain of PCV phenotype was further divided into two main 
classes - mild gain of PCV (ectopic PCV dot or ectopic PCV branch) and strong 
gain of PCV (ectopic PCV delta or ectopic PCV two branches) (Figure 4.13 A 
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and C). The loss of PCV vein phenotype is characterised by the loss of the 
connection to L4, L5 or both, indicating a disruption in the normal PCV 
differentiation programme and resulting irregular vein formations (Figure 4.13 B 
and C). Ectopic expression of any of the constructs, whether they were 
enzymatically active (WT, C452Y and H1198Y) or enzymatically impaired 
(L1217P, H1153R and R1164Q) gave rise to gain of PCV vein phenotypes, 
while the loss of PCV material phenotypes were exclusive to enzymatically 
impaired dMi-2 point mutants, indicating that they have a dominant negative or 
gain of function effect over endogenous dMi-2 protein. Over-expression of wild 
type dMi-2 showed mostly mild gain of PCV vein phenotypes (45,42%), a very 
low percentage (2,89%) of strong PCV vein phenotype and 51,69% of flies had 
no phenotype. Very similar effects were scored for the PHD finger point mutant 
which produced only mild gain of PCV phenotypes and no strong gain of PCV 
phenotype, with 0,65% of flies showing a loss of vein phenotype. For the 
hyperactive H1198Y mutant a high percentage of 20,63% wings displayed a 
strong gain of PCV phenotype and 67,92% a mild gain of PCV phenotype. 
Ectopic expression of L1217P, H1153R and R1164Q produced noticably 
different effects in fly wings. L1217P fly wings showed loss of PCV phenotype in 
5,88 % of wings and gain in 62,95%, while the R1164Q point mutant showed a 
remarkably higher effect of 28,29% loss and 60,23% gain of vein phenotype. 
H1153R, the decoupling mutant, showed 8,89% of lost vein material, with 
76,35% gain of phenotype (Figure 4.13 C). In all cases, loss of vein material 
manifested in shortening of PCV and loss of contact between L4 or L5, or both 
(Figure 4.13. B).
In conclusion, these results show that ectopic expression of dMi-2 WT, 
remodeling impaired point mutants or a hyperactive point mutant all affect wing 
development. Proteins that are still enzymatically active had an overall gain of 
PCV material, while loss of function mutants produced in addition loss of vein 
phenotypes. This suggests that dMi-2 could have a role in vein formation and 
regulation of wing patterning. 
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Figure 4.13. Over-expression of dMi-2 WT and point mutants leads to 
disruptions in the formation of wing structures
(A) Gain of PCV material phenotypes. Mild phenotype is characterised by formation of an 
additional ‘dot’ of PCV cells that is disconnected from the PCV (upper panel, left) or branching 
out of the PCV - ectopic PCV branch (upper panel, right). Strong gain phenotypes are 
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Table 2-2
No phenotype % Strong ectopic 
PCV phenotype %
Mild ectopic PCV 
phenotype %
PCV disconnected 
from L5 %
PCV disconnected 
from L4 %
PCV disconnected 
from L4 and L5 %
WT 51,693851944793 2,88582183186951 45,4203262233375 0 0 0
C452Y 70,6185567010309 0 28,7371134020619 0,128865979381443 0,515463917525773 0
H1198Y 11,4583333333333 20,625 67,9166666666667 0 0 0
H1153R 14,7505422993492 15,1843817787419 61,1713665943601 4,12147505422994 4,77223427331887 0
R1162Q 11,4792899408284 9,11242603550296 51,1242603550296 20,1183431952663 5,79881656804734 2,36686390532544
L1217P 31,1888111888112 1,67832167832168 61,2587412587413 3,63636363636364 1,53846153846154 0,699300699300699
ATPase activity + + + + + - + + + + + - + - - - - -
Nucleosome 
remodelling
+ + + + + - + + + + - - - + - - - - -
3,64
1,54
0,70
4,12
4,77
C
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characterised by additional formation of a PCV delta (lower panel, left) or two ectopic PCV 
branches (lower panel, right). Malformed PCV structures are indicated by red arrows. The 
positions of longitudinal veins (L1 to L5), the anterior (ACV) and posterior (PCV) crossveins are 
indicated in the first panel on the left. (B) Loss of PCV material phenotypes. Loss of PCV 
connection to L4 (upper panel, left) or L5 (upper panel, right). Strong loss of PCV material is 
characterised by disconnection from both L4 and L5 (lower panel, left). A small percentage of 
wings showed a mixed phenotype with both gain and loss of vein material (lower panel, right). 
(C) Graph showing distribution (in %) of gain (blue) and loss (red) of PCV material for 
expression of WT and mutant dMi-2 as indicated. Relative ATPase and nucleosome remodelling 
activities are given for WT and point mutants below as determined in chapter 4.1. 
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5. Discussion
This thesis describes the first systematic analysis of the effects of endometrial 
cancer-derived point mutations on the enzymatic abilities of an ATP-dependent 
nucleosome remodeler. Several point mutations were introduced into PHD 
fingers, chromodomains and ATPase domain, as well as the C-terminal region 
of dMi-2. The biochemical analysis included ATP binding, nucleosome binding, 
ATP hydrolysis, nucleosome sliding, as well as ability to make nucleosomal 
DNA accessible for a restriction enzyme. This analysis revealed a plethora of 
effects that these mutations have on dMi-2's enzymatic and non-enzymatic 
functions. Studying these mutants revealed a new regulatory region outside of 
the ATPase domain that is important for modulating its activity. Additionally, this 
study used Drosophila as a model system, to investigate the effects of these 
point mutations in an in vivo system and demonstrated that cancer-derived point 
mutations in a nucleosome remodeler can change cell fate.
5.1. Point mutations produce a variety of effects on 
dMi-2's enzymatic activities 
Cancer relevant point mutations in the chromatin remodeller dMi-2 are analysed 
in vitro and in vivo for the first time in this study. All identified mutations were 
predicted to severely effect enzymatic properties, since most of them map to the 
protein’s functional domains. Mutated residues within these domains are highly 
conserved throughout the CHD family and some, like R1164Q, in the entire SF2 
superfamily. This study has revealed that these mutations do not always result 
in an inactive enzyme. Mutations impacted dMi-2 ATPase and remodelling 
functions in a variety of ways. Some mutants showed a moderate decrease in 
ATP hydrolysis and nucleosome remodelling, like the PHD finger mutant C452Y. 
On the other hand, H1198Y, a mutation located in putative brace region resulted 
in significantly higher activity in remodelling. Other mutations affected ATP 
hydrolysis in a relatively graded manner, while remodelling was severely 
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affected in all of them. This study provides new insights into how the chromatin 
remodelling machinery is affected in endometrial cancer. 
5.2. Decoupling of ATP hydrolysis and nucleosome 
remodelling in dMi-2 mutants
In the past, amino acid substitutions and deletions of certain regions within 
chromatin remodellers have been shown to decouple ATP hydrolysis from 
chromatin remodelling. In yeast SWI/SNF, deletion of the highly conserved 
STRAGGLG sequence located in core 2, corresponding to helicase motif V, 
significantly reduced nucleosome sliding, while ATP hydrolysis was not affected 
(Smith and Peterson, 2005). Decoupling point mutants were also identified in 
other remodellers. In yeast CHD1, the N-terminal region between ATPase 
domain and DNA binding domain was identified to have a significant role in 
coupling ATPase activity with nucleosome remodelling. More specifically, 
mutations of amino acid residues in proximity of the core 2 domain of the 
ATPase motor were shown to severely impair nucleosome sliding. At the same 
time, ATP hydrolysis was only slightly reduced, indicating that the mutated 
residues are important for coupling efficiency of ATP hydrolysis and nucleosome 
remodelling (Patel et al. 2011). In yeast RSC, mutations located in the 
protrusion 1 domain of Sth1, positioned between the two ATP core domains, 
can improve coupling of ATP hydrolysis and nucleosome remodelling (Clapier et 
al. 2016). 
In this study, two different mutants were identified to affect the coupling of ATP 
hydrolysis and nucleosome remodelling. H1153R in the core 2 domain and 
H1198Y in the brace region adjacent to the core 2. This is the first time 
decoupling mutants were identified in cancer cells. In both cases of decoupling 
mutants, histidine was the amino acid that was affected. Histidine is a polar 
amino acid with an imidazole side chain. It is often found in enzyme active sites. 
The pKa of histidine is around 6.5, which is close to the physiological pH, 
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meaning that its side chain can relatively easily switch from neutral to positive 
charge. Because of this, it can be found both at positions that are buried inside 
of the protein core and exposed on the surface of the protein. Given all of its 
unique properties, histidine mutations can severly impact protein structure and 
function. 
The H1153 residue is located in a highly conserved region, between motif V and 
VI of the second HELICc lobe (Figure 5.1.). Both of these motifs have significant 
roles in protein function. Motif V is involved in DNA binding, translocation and 
was shown to be crucial in coupling ATP hydrolysis with nucleosome 
remodelling (Smith and Peterson 2005). Motif VI contains highly conserved 
arginine finger that is important for ATP binding and hydrolysis. H1153 and the 
region surrounding it are not a part of these motifs and their role in protein 
enzymatic function has been so far unknown. Considering the high level of 
conservation of residues surrounding H1153 as well as motifs V and VI in 
relative proximity, it is expected that mutation of this residue could have 
significant consequences on the catalytic function of dMi-2. Indeed, mutation to 
arginine seemed to disrupt translocation ability of dMi-2, since this mutant was 
inactive in both remodelling assays in this study (Figure 4.10.). At the same 
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Figure 5.1. Decoupling mutant H1153R is located between helicase motif 
V and VI
Part of multiple sequence alignment of yeast CHD1, yeast Snf2, Myceliophthora thermophila 
ISWI, human CHD4 and Drosophila Mi-2 showing the motif V in blue and motif VI in red. 
Position of H1153R is marked in yellow.
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time, this mutant kept relatively robust levels of ATP hydrolysis (Figure 4.9.A). 
This is reminiscent on deletions of motif V in related the chromatin remodeler in 
yeast Swi2/Snf2. Deletion of the entire motif V significantly impaired remodelling 
function of the protein, while leaving ATP hydrolysis mostly intact (Smith and 
Peterson, 2005).
In related proteins, it is noticeable that often histidine can be changed with 
glutamine, which could perform similar function to histidine, as it is also often 
found in protein active sites. Mutation to arginine, brings in a positively charged 
residue. Arginine is often involved in the formation of salt bridges, so it is 
conceivable that introducing this residue could form new interactions with 
neighbouring residues. This could affect communication between catalytically 
important parts of the protein. Taking all this into consideration, these results 
show that this residue is important for successful interaction between parts of 
the protein important for DNA and ATP binding and for its translocation along 
the DNA. It is conciveable that H1153 and its surrounding area are part of an 
important conserved catalytical motif. This mutation could also introduce 
changes to the structure of the region in a fundamental way. This change can in 
turn influence the interaction between key parts of the protein that would 
ultimately lead to the decoupling effect.
The second identified mutant to show altered coupling of ATP hydrolysis and 
nucleosome remodelling is H1198Y. This mutation is located in the C-terminal 
region of CHD4/dMi-2, adjacent to the core 2 domain. In other related 
remodellers, like Drosophila ISWI and yeast Snf2, this region is corresponding 
to the brace helix (Figure 5.2). This helix functions in the core 1 - core 2 
communication in many SF2 proteins and it is important for coupling ATP 
hydrolysis with nucleosome remodelling (Yan et al. 2016, Liu et al. 2017). The 
brace helix interacts with other parts of the protein to regulate enyzmatic 
function. In Snf2 it interacts with another brace helix, known as brace II. In ISWI 
it interacts with the NegC domain and in CHD1 with the C-terminal bridge. They 
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all have an inhibitory effect on ATPase domain. Inhibition is released after 
binding of the protein to the nucleosome. 
Unlike the other decoupling mutant H1153R, this mutant showed highly 
increased translocation ability. In both remodelling assays it was able to 
remodel more nucleosomes than the WT protein (Figure 4.12.). This indicates 
that an inhibitory role of the brace helix is weakened by introduction of tyrosine 
at this position. Nevertheless, although weakened, the brace helix is still able to 
maintain its inhibitory role, as the H1198Y mutant was still depending on the 
nucleosomes for effective ATP hydrolysis (Figure 4.11.A). ATP hydrolysis levels 
of this mutant were not significantly different from the WT protein. This result 
indicates that ATP hydrolyis is not a reason for increased nucleosome 
remodelling. It goes in favour of the hypothesis, that the increased nucleosome 
remodelling is a consequence of a diminished inhibitory effect of the brace helix 
on the ATPase domain. 
Mutation of histidine to tyrosine introduced significant changes to dMi-2 
enzymatic properties. The question remains how does this change arise? Both 
histidine and tyrosine contain an side chain with aromatic properties. Aromatic 
rings are often involved in stacking interactions with other aromatic side chains. 
However, functional groups of histidine and tyrosine could have different impact 
on enzymatic reaction, due to different pKa values of their side chain, histidine 
at 6.5, while tyrosine is at 10.4. Additionally, the histidine side chain has lower 
rotational degree of freedom and higher free energy compared to tyrosine due 
to its chemical structure (Doig, 1996). Taking all this together, this mutation 
could lead to lowering of the energy of the transition state during the enzymatic 
reaction, finally leading to more product, in this case a remodelled nucleosome. 
Interestingly, the corresponding residue to dMi-2 H1153 in yeast CHD1 is 
tyrosine. Introducing more neutral mutations, like alanine, at this position in 
dMi-2, could answer the question if the observed effects are really due to 
tyrosine at this position. Furthermore, mutating this residue in other related 
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remodelers could give more insight into the function of this residue, as well as 
the brace helix in CHD proteins. 
This results demonstrate that H1198Y has improved coupling of ATP hydrolysis 
and nucleosome remodelling. These effects are reminiscent of mutations in the 
Sth1 protrusion 1 domain, where point mutations increase the levels of 
nucleosome sliding, while largely retaining the ATP hydrolysis levels (Clapier et 
al. 2016). In nucleosome sliding H1198Y showed that, besides an increased 
levels of remodelling with both end-positioned and centrally positioned 
nucleosomes, its remodelling produced a different nucleosome positioning 
patterns when using an end-positioned nucleosome template (Figure 4.12.B 
and C). These results reveal another potential consequence of this mutation in 
vivo. It is possible this mutant could produce differently positioned nucleosomes 
which could affect transcription of some genes in the cell. Aberrant transcription 
of some genes could lead to development of cancer. All taken together, these 
results show that coupling of ATP hydrolysis and nucleosome remodelling can 
be positively and negatively affected in cancer cells. 
 
Figure 5.2. Decoupling mutation H1198Y resides in the Brace regulatory 
region of dMi-2 
Part of multiple sequence alignment of yeast CHD1, yeast Snf2, Myceliophthora thermophila 
ISWI, human CHD4 and Drosophila Mi-2 showing the Brace region in purple and the Brace-II/
NegC/C-terminal bridge regions in green. Position of H1198Y is marked in yellow.
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5.3. Mutations of PHD finger and chromodomains have 
distinct effects on enzymatic activity 
Mutation of C452 affected dMi-2 in a modest manner. This residue in the PHD 
finger is involved in coordinating zinc binding together with other highly 
conserved residues of a Cys4His1Cys3 motif. Considering the high conservation 
and functional importance of this residue it was interesting to investigate its 
consequences in a biochemical manner. Indeed, this mutant showed reduction 
in ATP hyrdolysis, which consequently resulted in a similar decrease of 
nucleosome remodelling (Figure 4.3. A and 4.4.). This reduction was observed 
with both end positioned and centrally positioned nucleosomes. These results 
agree well with previously published data from human CHD4, where deletion of 
the PHD fingers resulted in a moderate reduction in ATPase and remodelling 
capabilities. This reduction of ATP hydrolysis of the PHD finger mutant was only 
apparent with unmodified nucleosomes, while H3K4me modified histones did 
not show this reduced activity (Watson et al. 2012). This might be due to H3K4 
methylation reducing the binding affinity of the CHD4 PHD fingers (Mansfield et 
al. 2011). In this study, nucleosomes were assembled with histones purified 
from Drosophila embryos. This means they contain a mixture of modified and 
unmodified histones. In the future, to determine how this mutation affects 
binding in the context of histone modifications, experiments will need to be 
performed with unmodifed and H3K4 methylated histones separately. In 
summary, these results reveal that a point mutation in one of the key cysteines 
in the PHD finger can have an effect on dMi-2 ATP hydrolysis and nucleosome 
remodelling abilities. Previously, it was demonstrated that deletion of PHD2 in 
vivo in B cells, causes a strong activation of the NuRD complex repressed gene 
mb-1, compared to deletion of PHD1 finger which caused weaker derepression 
(Musselman et al. 2012). Subsequently, it was shown that PHD2 has a role in 
the initiation of CHD4 recruitment to the nucleosome and that PHD1 interacts 
with the nucleosome after PHD2 binding, underlining the more important role of 
PHD2 for CHD4 nucleosome recruitment (Gatchalian et al. 2017). This taken 
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into account, it is conceivable, that C452Y could have similar consequences on 
CHD4’s interaction with the nucleosome, hence reducing the protein’s 
recruitment and stabilisation on the nucleosome. However, considering that 
C452Y demonstrated WT levels of nucleosome binding, this outcome seems 
unlikely (Figure 4.3.D.). Therefore, it is more likely that overall reduction in 
enzymatic activity of this mutant is due to disruption of intramolecular 
interactions. In addition, it is possible that this point mutation could have an 
effect on subunit interactions within the NuRD complex in cancer cells, as it is 
known that PHD fingers are required for CHD4 interaction with the HDAC1 
subunit of the NuRD complex (Zhang et al. 1998). 
Mutations within the chromodomains had strikingly different effects compared to 
the PHD finger mutation. Two mutations in the first chromodomain had a strong 
negative effect on the protein’s ATP hydrolysis and nucleosome remodelling 
abilities (Figure 4.5 and 4.6). This indicated a functional importance of the 
region to which these mutation reside. The results presented in this thesis 
demonstrated that even a single point mutation in the chromodomains can have 
a severe impact on enzymatic functions. In the past, it was shown that dMi-2’s 
chromodomains are DNA binding modules, which are binding to the 
nucleosome mostly through DNA-protein interactions. Deletion of the 
chromodomains critically impairs ATP hydrolysis, as well as nucleosome binding 
and remodelling (Bouazoune et al. 2002). More recently crystal structure 
studies of the related chromatin remodeler CHD1, revealed that 
chromodomains act as negative regulators of CHD1 ATPase activity. 
Chromodomains interact with both ATPase cores through a negatively charged 
alpha helix - the chromo wedge - and keep it in an inactive open conformation 
that is less susceptible to hydrolysis (Hauk et al. 2010). In this structure, 
residues corresponding to dMi-2 V538 and R552 are located on the opposite 
side from the ones making contacts with the ATPase domain (Figure 5.3). The 
question that is posed here is, why do single point mutations in this region affect 
the protein activity in such a dramatic way? 
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Some recent studies could provide an answer to this question. A study from the 
Bowman lab identified a short basic loop in the chromodomain 1 of Chd1 that 
directly contacts nucleosomal DNA at SHL1 (Nodelman et al. 2017). This 
interaction was also identified in the recent cryo-EM structure of yeast CHD1 
bound to the nucleosome from the Patrick Cramer lab (Farnung et al. 2017). It 
is suggested that when CHD1 first interacts with the nucleosome, the 
chromodomains rotate from the ATPase domain and bind the nucleosome via 
this small basic loop. This rotation is supposed to disrupt the inhibitory effect of 
the chromo-wedge on the ATPase domain, by which it promotes ATP hydrolysis 
and chromatin remodelling. Interestingly, when overlapping dMi-2 amino acid 
residues V538 and R552 onto the crystal structure of yCHD1 it is revealed that 
these amino acid residues fall in the region flanking this basic loop (Figure 5.3. 
A and B). This suggests that these dMi-2 residues could have a role in 
interacting with nucleosomal DNA. It is also possible that mutations are bringing 
in structural changes that are affecting binding of other residues to nucleosomal 
DNA. These results support the hypothesis that the basic loop and the region 
between V538 and R552 are critical for establishing contacts between 
nucleosome and protein that are crucial for ATP hydrolysis and chromatin 
remodelling.
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Figure 5.3. Role of chromodomain V538 and R552 residues in dMi-2 
chromatin remodelling 
(A) yCHD1 in complex with nucleosome (5O9G) with basic loop of chromodomain 1 indicated 
with green and superimposed relative positions of V538 and R552 in yellow (Chromodomain 1 
in light blue, chromodomain 2 in cyan, ATPase domain core 1 orange red, ATPase domain core 
2 in red. Core histones are shown in different colours; H3 in blue, H4 in green, H2A in yellow 
and H2B in red, nucleosomal DNA in gray), modified after Farnung et al. 2017 (B) Part of 
multiple sequence alignement of yeast CHD1, human CHD4 and Drosophila Mi-2 with basic 
loop indicated in blue. V538 and R558 residues indicated in red in CHD4 and dMi-2.
A
V538
R552
Dyad
B
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5.4. A mutation in a putative regulatory region which 
lies adjacent to the core 2 region
One of the mutations identified in endometrial cancer is affecting a leucine 
residue at the C-terminal side of the ATPase domain core 2 of CHD4. Mutation 
from leucine to proline in this position had a strong effect on ATP hydrolysis of 
dMi-2, which was strongly decreased (Figure 4.11). Accordingly, this reduction 
affected levels of nucleosome remodelling, which were not detectable in all of 
the remodelling assays in this study (Figure 4.12). The question that is 
presented here is why does a mutation to proline at this position, outside of any 
identified catalytical and regulatory regions in dMi-2, so dramatically affect 
protein enzymatic abilities? In related chromatin remodelers, a C-terminal side 
of the ATPase domain core 2 and brace has been identified as a regulatory 
region that controls the activity of the ATPase motor. In CHD1 this is a C-
terminal bridge, in ISWI this region is called NegC, and in Snf2 Brace-II (Hauk 
et al. 2010, Clapier and Cairns, 2012, Liu et al. 2017). By superimposing the 
dMi-2 sequence on the CHD1 structure it is observable that L1217 falls within 
this alpha helix (Figure 5.3. B). Leucine is a hydrophobic amino acid that prefers 
alpha helical structures. The corresponding residue to dMi-2’s L1217 in yeast 
Snf2 is L1254. This leucine falls within the Brace-II region of Snf2 and when 
mutated to aspartic acid (L1254D) it was shown to reduce DNA and nuclesome 
stimulated ATP hydrolysis activity by two to five fold. Even more importantly, this 
mutant was shown to have severely diminished nucleosome remodelling (Liu et 
al. 2017). Considering this published data about a related remodeller, high 
conservation levels of this leucine and results of this study it is possible to 
conclude that this residue has an important role. 
However, Snf2 - L1254D still shows measurable levels of ATP hydrolysis, but 
dMi-2 - L1217P did not. This raises a question why L1217P showed no 
detectable ATP hydrolysis? An answer could be in the nature of amino acid 
change. Proline is an amino acid with distinct features compared to other amino 
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acids. It is often found in turns and outside of alpha helices and beta sheets. 
Because of its unique structure, mutations to proline often lead to disruption of 
entire regions and lead to protein instability. Therefore, it is conciveable that the 
effects that are observed in this study are combined effects of removing a 
functionally important leucine and its exchange with proline, an amino acid that 
will break the alpha helix in which this residue is likely located. This would lead 
to destabilisation of the protein structure and loss of enzymatic activity (Figure 
5.3.B). Interestingly, this mutation also affected the nucleosome binding ability 
of dMi-2, indicating that this region could have a possible regulatory role in 
dMi-2’s nucleosome binding (Figure 4.11.D). It is plausible, that the disruption of 
the entire region by introduction of proline could affect its interaction with the 
nucleosome. Furthermore, it is also feasible that leucine is directly binding to 
the nucleosome and loss of this interaction is leading to weaker binding to the 
nucleosome or formation of less stable nucleosome-protein complex. 
In conclusion, this mutation caused a severe reduction in ATP hydrolysis and 
remodelling activities. This can be due to disruption of intramolecular 
interactions within the protein, possibility that this region has a role in regulating 
protein-nucleosome interaction or that leucine is directly involved in nucleosome 
binding resulting in weaker interaction with the nucleosome when mutation is 
introduced. These three possibilities are not mutually exclusive and are to be 
resolved in future studies. This study identifies a putative regulatory region 
adjacent to the brace in CHD4/dMi-2 enzymes, that has a similar role to regions 
identified in CHD1, ISWI, and Snf2.
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Figure 5.4. L1217 belongs to putative regulatory region in dMi-2
(A) Part of multiple sequence alignement of yeast CHD1, yeast Snf2, Myceliophthora 
thermophila ISWI, human CHD4 and Drosophila Mi-2 showing Brace region in purple and 
Brace-II/NegC/C-terminal bridge region in green. Position of L1217P is marked with yellow. (B) 
yCHD1 structure (3MWY) with Brace in purple and C-terminal bridge in green, with 
superimposed dMi-2-L1217 amino acid residue indicated in yellow (Chromodomain 1 in light 
blue, chromodomain 2 in cyan, ATPase domain core 1 orange red, ATPase domain core 2 in 
red) Modified after Hauk et al. 2010.
A
L1217
B
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5.5. Other missense mutations within the ATPase 
domain 
5.5.1. An arginine finger mutant is crucial for efficient coupling 
of ATP hydrolysis and nucleosome remodelling
The only residue that was identified in exome sequencing to be affected by a 
mutation in several patients was arginine 1162, belonging to the highly 
conserved arginines in the helicase motif VI (Le Gallo et al 2012, Zhao et al. 
2012, The Cancer Genome Atlas Research Network, 2013) (Figure 5.5). In 
humans, this R1162 of CHD4 corresponds to R1164 in Drosophila dMi-2. This 
residue has been shown to be a hotspot, since the corresponding arginine was 
found to be mutated in CHD1 in prostate cancer (Huang et al. 2012). This motif 
located in ATPase domain core 2 is responsible for efficient coupling of ATP 
hydrolysis with nucleosome remodelling. The functional importance of this 
residue is in interaction of motif VI with ATP binding site of motif I in core 1 (Liu 
et al. 2017). Rotation of core 2 from its initial position by 40° to core 1 brings 
this two motifs together to couple efficient ATP hydrolysis with translocation 
(Farnung et al. 2017).
   
Figure 5.5. Arginine finger mutant in motif VI 
Part of multiple sequence alignement of yeast CHD1, yeast Snf2, Myceliophthora thermophila 
ISWI, human CHD4 and Drosophila Mi-2 showing part of the core 2 sequence with motif V 
indicated with blue, motif VI indicated in red and two arginine finger, with R1164Q indicated, 
marked with yellow.
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In the related SF2 protein, Drosophila RNA unwinding helicase Vasa, arginines 
corresponding to dMi-2 arginine fingers (R1161 and R1162) were identified to 
have somewhat distinct features. Arginine corresponding to R1161 was found to 
bind simultaneously ⍺-, β-, and γ-phosphates, while arginine corresponding to 
R1164 was shown to interact with γ-phosphate (Sengoku et al. 2006). In this 
study introducing glutamine at the position of the highly conserved R1164, 
caused considerable decrease in ATP hydrolysis and subsequently nucleosome 
remodelling (Figure 4.9. and 4.10.). However, ATP hydrolysis and nucleosome 
remodelling were not completely lost, indicating that R1164Q mutant is still able 
to perform hydrolysis and couple it to remodelling. Interestingly, in the related 
SF2 helicase DbpA of E.coli, mutation of arginines corresponding to the 
arginine fingers in dMi-2, conferred different effects on the protein. Mutation of 
first arginine in the DbpA arginine finger (R1161 in Drosophila), to alanine had a 
more dramatic effect on the protein function, with dramatically reduced ATPase 
activity and no helicase activity. Meanwhile, mutation of the second arginine in 
the arginine finger (R1164 in Drosophila) had considerably less drastic effects, 
although still significantly reduced ATPase activity (Elles et al. 2007). 
Considering this published data and results of the study presented here, this 
could argue that in the R1164Q mutant, arginine at position 1161 is still 
interacting with ATP, which results in low levels of ATP hydrolysis and 
nucleosome remodelling. However, these results indicate that both arginines 
are essential for efficient ATP hydrolysis and remodelling. 
Additionaly, a mutation from arginine to glutamine is introducing changes which 
are affecting charge and interaction with other amino acids. This change can 
also cause disruption of salt bridges which in turn would prevent efficient 
coupling of ATP hydrolysis with nucleosome remodelling. 
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5.5.2. The core 1 region mutation L914V leads to impaired ATP 
hydrolysis and nucleosome remodelling
The core 1 domain point mutant investigated in this study is L914V. This leucine 
is highly conserved throughout different chromatin remodellers (Figure 5.6) 
Exchanging this leucine with valine had a strong effect on ATP hydrolysis of 
dMi-2 (Figure 4.7.A). L914 is not a part of any known identified SF2 helicase 
motifs, but it is highly conserved throughout the Snf2 family of chromatin 
remodellers. It is located in the so-called conserved block H. These blocks are 
defined as unique structural features of Snf2 family enzymes (Flaus et al. 2006). 
Conserved block H comes right after helicase motif III and contains a few highly 
conserved aromatic residues (Figure 5.6). Motif III is involved in coupling of ATP 
hydrolysis and translocation. More specifically, it is interacting with ATP binding 
motif II (Walker B) in core 1 and with motifs V and VI in the core 2 domain that 
are involved in DNA binding and translocation (motif V), and interaction with 
motif I and II in ATP binding (motif VI) (Sengoku et al. 2006, Flaus et al. 2006). 
Mutation of L914 to valine resulted in significant loss of ATP hydrolysis and 
nucleosome remodelling. The change from leucine to valine represents a 
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Figure 5.6. Highly conserved core 1 mutant L914V is located in Block H 
in proximity of helicase motif III 
Part of multiple sequence alignement of yeast CHD1, yeast Snf2, Myceliophthora thermophila 
ISWI, human CHD4 and Drosophila Mi-2 showing part of the core 1 sequence with motif III 
indicated with green, block H in purpule and position of L914V indicated in yellow.
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conservative mutation. However, it is possible that this point mutation brings in 
subtle structural changes that are difficult to tolerate. It is conceivable that the 
mutation from leucine to valine is changing intramolecular interactions in the 
region. Indeed, it is known that structurally, valine has a lower rotational degree 
of freedom and higher free energy compared to leucine (Doig, 1996). This could 
have a significant effect on amino acid interactions in this region and result in 
impaired enzymatic function.
When observing the CHD1 structure it is noticeable that L914 is part of an alpha 
helix, preceded by a motif III loop region. Changes brought on by this mutation 
could affect motif III, which would subsequently affect its interaction with motifs 
II, V and VI. In fact, this mutation had an effect on nucleosome binding which 
was mildly reduced in the nucleosome bandshift assay (Figure 4.7.D). 
Considering that motif V has a role in binding of nucleosomal DNA it is 
conceivable that interaction between motif III and V is affected. This weaker 
interaction of protein and nucleosome could lead to inappropriate positioning of 
helicase motifs in relation to the nucleosome and ATP. Indeed, in the related S. 
cerevisiae chromatin remodeler Snf2 the core 1 and core 2 domains stack 
together in the resting state. Upon binding of the nucleosome, these domains 
rotate by approximately 80° which generates a new core 1 - core 2 interface 
(Liu et al, 2017). It is conciveable that L914 is involved in the generation of 
these new core interactions. Introduction of valine could disrupt some of these 
interactions that result in impaired ATP hydrolysis and translocation. 
In order to futher investigate the importance of this region, additional point 
mutations or deletions could be performed to more directly determine the role of 
this residue. 
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5.6. dMi-2 mutants disrupts Drosophila wing 
differentiation
Mutations introduced into dMi-2 exhibited a plethora of effects on protein activity 
in vitro. Different levels of ATP hydrolysis and nucleosome sliding suggested 
that, depending on the mutation, different consequences of these remodelling 
outcomes could be expected in vivo. To address this issue, several point 
mutations were introduced into Drosophila. Mutants analysed in this study were 
identified in endometrial cancer (Zhao et al. 2012., Le Gallo et. al 2012). 
Endometrial cancer develops when differentiation of epithelial cells of the 
endometrium is disrupted, which causes overproliferation. In order to study the 
consequences of these point mutations in an in vivo system, expression of point 
mutants was directed to the posterior part of the developing wing to study vein 
formation. Development of the Drosophila wing is an established model for 
epithelial morphogenesis (Restrepo et al. 2014). 
Overexpression of WT dMi-2 or the mutants caused perturbations in normal 
posterior crossvein (PCV) differentiation, as formation of additional vein material 
was observed in all cases. Mutants that were active in remodelling in vitro 
displayed only gain of vein material, while mutants impaired in remodelling in 
vitro displayed in addition loss of vein material. Interestingly, remodelling levels 
of each protein correlate with both penetrance and severity of the different PCV 
phenotypes (Figure 4.13. C). The hyperactive mutant H1198Y displayed 
increased remodeling activity compared to the WT protein in vitro. This increase 
of activity was reflected in a stronger penetrance of the gain of vein material 
phenotype compared to ectopic expression of the WT protein. Similarily, a high 
penetrance of phenotype was also observed in mutants that are impaired in 
remodelling in vitro, but they also displayed significant loss of vein material. 
However, the extent of reduced remodelling activity in vitro did not completely 
mirror the severity of the loss of vein material phenotype. Some mutants with 
severe loss of remodelling like H1153R and L1217P had a lower penetrance of 
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the loss of vein material phenotype, compared to R1164Q whose translocation 
ability was still detectable in remodelling assays, but showed the most striking 
loss of PCV material. This could be explained by different expression levels of 
the various mutants. Additionally, mutants could exhibit differences in 
remodelling that were not observable in remodelling assays used in this study. 
Testing these mutants on different nucleosomal templates, like di- or tri- 
nucleosomes, could determine more fine difference in remodelling, that could 
explain their phenotype. 
5.7. PCV differentiation and implications for 
endometrial cancer
In this experimental set up of the fly wing assay, overproliferation of epithelial 
cells was not observed. However, this analysis indicates that ectopic expression 
of dMi-2 is sufficient to perturb PCV differentiation. PCV differentiation is mostly 
under control of the TGF-β/BMP signalling pathway. In vertebrates the TGF-β 
(transforming growth factor β)/BMP (bone morphogenetic protein) axis plays an 
important role in bone organogenesis via activation of receptor serine/threonine 
kinases. Disturbance in this pathway can lead to the development of different 
types of clinical outcomes - skeletal anomalies, cardiovascular and autoimmune 
diseases or cancer (Rahman et al. 2015). In Drosophila, Decapentaplegic 
(Dpp), a homologue of BMP, is a morphogen that controls anterior-posterior 
patterning and growth of the wing (Matsuda et al. 2016). Similar phenotypes to 
the one observed in this study were detected with other chromatin regulators. 
Drosophila COMPASS-like complex, Cmi-Trr coactivator complex, contains Cmi 
as a core component which controls wing vein patterning through the conserved 
Dpp signaling pathway (Chauhan et al. 2013). Wing patterning was also found 
to be affected when LSD1/CoREST was depleted, which seems to affect the 
TGFβ/Dpp pathway (Curtis et al. 2012). Another example of a chromatin 
regulator and its role in wing patterning is given by Drosophila snr1, an essential 
component of the Brahma (SWI/SNF) complex. Impaired snr1 showed clear 
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defects in wing patterning, more specifically in PCV formation (Zraly et al. 
2004). These examples together with the results of this study show that PCV 
differentiation is very sensitive to epigenetic imbalance brought on by disruption 
of a certain chromatin regulator. These results suggest that dMi-2 mutants that 
are impaired in remodelling, change the outcome of TGF-β/BMP signalling. 
Several examples of mammalian CHD4 influencing the TGF-β/BMP pathway 
through interaction with its components or by regulation of its target genes have 
been shown previously. As a part of the NuRD complex, CHD4 interacts with 
ZNF521, a zinc finger protein that is involved in BMP signaling (Bond et al. 
2007). CHD4 was found to repress Sox9 during BMP2 induced chondrogenesis 
(Sun et al. 2013). In Xenopus, mutations of transcription factor Zeb2 (zinc-finger 
E-box-binding homeobox 2; also known as ZFHX1B or Sip1) lead to loss of 
NuRD recruitment and subsequent loss of transcriptional repression activity on 
the BMP4 gene promoter, another component of the BMP pathway (Verstappen 
et al. 2008). Another example of Zeb2 and NuRD interaction influencing TGF-β/
BMP signalling pathway was reported in Schwann cell differentiation (Wu et al. 
2016). Considering all the published reports and the data from this study it is 
possible to postulate that impaired or hyperactive dMi-2 can influence the 
outcome of TGF-β/BMP signalling pathway. How can this be done? 
Aberrant dMi-2 activity can influence expression of its target genes by different 
remodelling levels, that lead to altered nucleosome positioning. For the 
hyperactive H1198Y mutant it was observed that it remodels nuclesomes in a 
different pattern than the WT protein. While the WT protein mostly moved 
nucleosome to the central position, H1198Y did not show this type of 
preference, and it was remodeling nucleosomes with no preference for a 
certain position (Figure 4.12. B and C). This kind of remodelling activity 
indicates that in vivo this mutant could either occlude or provide access to the 
transcription machinery at transcription factor binding sites. This could result in 
different expression levels of the target genes in vivo or aberrant expression of 
unrelated genes. In case of loss of function mutants, similar scenarios could be 
expected. Depending on the remodeling activities of the mutants, dMi-2 could 
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produce different remodelling outcomes. Since nucleosomes could protect 
some transcription factor binding sites the outcome could be insufficent or lack 
of expression of the TGF-β/BMP target genes and misregulation of entire 
signaling pathway. Furthermore, since CHD4 is, together with HDAC, a part of 
the NuRD complex it is possible that reduced or increased remodelling levels 
could lead to more or less deacetlyation, which would affect transcription levels 
of many target genes. This types of misregulation finally can affect 
differentiation of the wing cells. 
The importance of the TGF-β/BMP pathway has been documented in the 
development and metastasis of endometrial cancer. Disturbing expression of 
TGF-β/BMP pathway components TGFβRII and SMAD4 can lead to the 
development of type I endometrial carcinomas (Piestrzeniewicz-Ulanska et al. 
2004). Another study reported that TGF-β/BMP signaling has a role in driving 
tumorigenesis in endometrial cancer cells (Lei et al. 2009). Taken together, it is 
conceivable that dMi-2 mutants that obstructed proper PCV differentiation, use 
related molecular mechanisms to the ones used by CHD4 mutants in a 
transformation of epithelial cells of the endometrium that ultimately lead to 
cancer. Recently, a role od CHD4/NuRD in cell type transition was 
demonstrated in oral cancer. More specifically, loss of NuRD subunit DOC1 
(deleted in oral cancer 1), was shown to affect NuRD-dependent repression of 
EMT (epithelial-mesenchymal transition) factors. Loss of NuRD-dependent 
repression drives the transition from mesenchymal to the epithelial cell type that 
leads to detachment of carcinoma cells and development of metastases in oral 
cancer (Mohd-Sarip et al. 2017). 
 
5.8. Gain-of-function and dominant negative effect of 
CHD4 in endometrial cancer
Most of the identified mutations in CHD4 are falling within highly conserved 
regulatory domains and are predicted to negatively impact enzymatic function 
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(Zhao et al. 2012., Le Gallo et. al 2012). In that regard, together with the results 
of this study, where most of the analysed mutants show reduced or completely 
impaired enzymatic activity, it is possible that cancerogenesis is driven by a 
general reduction in CHD4 activity. Considering that most of the mutations 
identified in exome sequencing were missense mutations (89%), this seems 
unlikely. Haploinsufficiency is usually driven by the loss of one copy of the gene, 
which results in lower levels of the protein. This is mostly caused by frameshift 
mutations and deletions that are very rare in endometrial cancer. Since most of 
the mutation in endometrial cancer are missense, it is assumed that CHD4 also 
contributes to cancerogenesis through gain-of-function or dominant negative 
effect mechanisms. This is supported by my results of ectopic expression in the 
fly wing. In these experiments, expression of dMi-2 mutants was sufficient to 
disturb PCV differentiation, although flies still retain two copies of the 
endogenous dMi-2 gene (Figure 4.13. A and B). 
As described above, these mutations could have an impact on nucleosome 
positioning in vivo. This was particularly clear for H1198Y that no longer has 
preferred directionality towards the center of the DNA fragment like the WT 
protein (Figure 4.12.B). Lower remodelling levels of these mutants could as well 
result in a different distribution of the nucleosomes, thereby changing 
expression levels of certain genes. These types of scenarios could lead to, for 
example, silencing of tumour suppressor genes (TSGs) like it was shown for 
human CHD4: In colorectal cancer, CHD4 can have an oncogenic function. 
More specifically, high expression of CHD4 was shown to maintain tumour 
suppressor gene silencing in colorectal cancer. To maintain this silencing and 
recruit other necessary factors, CHD4 ATPase activity is critical (Xia et al. 
2017).
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5.9. Conclusion 
In summary, this thesis has given a detailed biochemical analysis of CHD4 
cancer derived mutants. Analysed mutations revealed a plethora of effects on 
dMi-2 ATP hydrolysis and nucleosome remodelling. They displayed decreased 
ATP hydrolysis, impaired or increased nucleosome remodelling, decoupling of 
ATP hydrolysis from nucleosome remodelling, and changes in the pattern of 
nucleosome positioning. The difference in enzymatic activity and nucleosome 
positioning of each mutant will need to be taken into account when designing 
new drugs for cancer treatment. Therefore, in the design of new drugs for 
cancer treatment, a personalised approach might need to be taken. Drugs will 
need to be designed in a way that restores WT activity of CHD4. Furthermore, 
analysis of these mutants revealed possible new regulatory regions of dMi-2/
CHD4, and has given strong biochemical support to recent structural studies 
and models about the remodeller’s interaction with the nucleosome and how 
this interaction induces conformational changes that are relevant for the 
remodelling reaction.
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7. Appendix
List of abbreviations and acronyms
Å Ångstrom
ac acetylation
ACF ATP-utilising chromatin remodelling and assembly 
Factor
ADP adenosine diphosphate
APS ammonium persulfate
Arg arginine
ARP actin related protein
Asf1 histone chaperone asf1
ATP adenosine triphosphate
ATR ataxia telangiectasia and Rad3 related
attB bacterial attachment site
attP phage attachment site
BAF BRG1-associated factors
BMP bone morphogenetic protein
bp base pair
BRCA1 breast cancer type 1 susceptibility protein
BRG1 Brahma-associated gene 1
BRK Brahma and Kismet domain
BRM brahma
Bromo Bromodomains
BSA bovine serum albumine
c-MyB transcriptional activator MyB
C-terminal carboxy terminal
CATD domain CENP-A Targeting Domain
CenH3.3 centromere-specific histone 3 variant
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CENP-A Centromere protein A
CHD chromo-helicase-DNA- binding
CHRAC chromatin remodeling and assembly complex
Chromo Chromodomain
Ci Curie
CoREST corepressor for REST
cryo-EM cryo-electron microscopy
Cys cysteine
DBD  DNA binding domain
dCTP Deoxycytidine triphosphate
DDR DNA damage response 
dMec Drosophila MEP-1-containing complex
dMEP-1 mog interacting ectopic P granulocytes 1
DMSO Dimethyl sulfoxide 
DNA deoxyribonucleic acid
dNTP desoxyribonucleotidetriphosphate
DOC1 deleted in oral cancer 1
Dpp Decapentaplegic
dsDNA double stranded 
DTT Dithiothreitol
E. coli Escherichia coli
EcR ecdysone receptor
EDTA ethylenedioxy-diethylene-dinitrilo-tetraacetic acid
EGTA ethylene glycol-bis-(2-aminoethyl)-N,N,N', N'-
tetraacetic acid 
EMT epithelial-mesenchymal transition
en engrailed
EtBR ethidium bromide
F phenylalanine
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FBS fetal bovine serum
fwd forward
Gln glutamine
H histone
HAT’s histone acetyltransferases
HDAC histone deacetylases
HDAC histone deacetylase
His histidine
HMT’s histone methyltransferases
HP1 heterochromatin protein 1
HRP horseradish peroxidase
HSA helicase sant domain
HSP90 heat shock protein 90
HSS Hand sant domain
IgG immunoglobuline G
INO80 inositol requiring 80
ISWI imitation switch
K lysine
KDM lysine demethylases
L leucine
LB Luria Bertani
Leu leucine
LSD1 Lysine-specific histone demethylase 1A
M molar
MBD2  methylated DNA binding domains 2
MBT malignant brain tumour
MDC1 Mediator of DNA damage Checkpoint 1
me methylation
ml mililiter
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MTA metastasis-associated protein
N-terminal amino terminal 
Nap1 Nucleosome assembly protein
NASP Nuclear autoantigenic sperm protein
NuRD nucleosome remodelling and deacetylation
NURF nucleosome remodeling factor
P proline
p53 Cellular tumor antigen p53
PAA polyacrylamide
PAGE polyacrylamide gel electrophoresis 
PAR poly(ADP-ribose)
PARP Poly (ADP-ribose) polymerase 
PBAF polybromo-associated BAF 
PBS Phosphate Buffered Saline
Pc Polycomb
PCR polymerase chain reaction
PCV posterior cross vein
PHD plant homeodomain
Phe phenylalanine
postHSA post helicase sant domain
PP1 protein phosphatase 1
PRC2 Polycomb repressive complex 2
PRMT’s protein arginine methyltransferases
PVDF polyvinylidene difluoride membrane 
Q glutamine
R arginine
REA restriction enzyme accessibility 
rev reverse
RNA ribonucleic acid
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RNA Pol II RNA polymerase II
RNAi RNA interference 
RSC Remodelling the structure of chromatin 
RT room temperature
S serine
SDS sodium dodecyl sulphate
SEM standard error of mean
SET-domain Su(var)3-9, Enhancer-of-zeste and Trithorax
SF2 helicase superfamily 2
SHL superhelical location
SMAD4 Mothers against decapentaplegic homolog 4
SMAD4 Mothers against decapentaplegic homolog 4
SnAC Snf2 ATP coupling
SNF sucrose non-fermentation
ssDNA single stranded DNA
Sth1 SNF2 (Two) homolog 1
SWI mating type switch
SWI/SNF switch/sucrose non-fermenting
Swr1 Swi2/Snf2-related 1
T threonine
TE Tris-EDTA
TEMED tetramethyl-ethylene diamine
TGF-β transforming growth factor β
TGFβRII transforming growth factor beta receptor II
TSG tumour suppressor genes
Tyr tyrosine
UAS Upstream activation sequence
ub ubiquitination
UV Ultra violet
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V valine
Val valine
WT wild type
Y tyrosine
Zeb2 zinc-finger E-box-binding homeobox 2
ZNF521 Zinc finger protein 521
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